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ATP-binding cassette transporters comprise a large superfamily of proteins that are 
involved in a variety of biological phenomenon, from bacterial metabolism to cellular 
homeostasis, antigen-presentation, and drug resistance. These proteins are implicated in a 
variety of clinically relevant phenomenon, including the human diseases cystic fibrosis, 
macular degeneration, and cancer. Understanding their structure-function can guide 
therapeutics and contribute to our overall understanding of these biological phenomena. 
 This study focuses on understanding the motor protein of the bacterial ribose ABC 
transporter in the context of transport. This complex is required for the uptake of the 
nucleotide precursor, ribose. Using biophysical methods, we seek to better understand the 
protein conformational changes and dynamics that link ATP utilization with ribose uptake. 
We use site-directed spin-labeled electron paramagnetic resonance spectroscopy and 
fluorescence binding studies to understand how the motor protein interacts with ATP, and 
how conformational changes associated with this interaction fuel transport. 
 These studies reveal the motor protein, RbsA, is regulated from across the cell 
membrane by the availability of the transported substrate. This regulation comes from the 
form of a substrate-binding protein, RbsB, which binds ribose in the periplasm and delivers 
xvi 
 
it to the membrane spanning permease, RbsC. Transmembrane signaling connects RbsB 
arrival at RbsC with inward rotations of RbsA subdomains that stimulate ATP hydrolysis. 
This leads to ribose delivery to the permease translocation channel. Post-hydrolysis, 
outward rotation of RbsA subdomains then result in the release of RbsB from the transport 
complex. 
 This process is completed by an unusual mechanism. Though the topology of RbsA 
predicts two ATP binding sites, and ABC transporters typically possess two equivalent 
ATP binding sites in their motor proteins, loss-of-function mutations have rendered one 
site inactive. Fluorescence binding studies reveal both sites are occupied with ATP, yet 
only one remains active. Thus, the conformational changes that drive active transport are 
driven solely by one half of the motor.  
 These studies provide a model for how the ribose transporter functions. As more 
ABC transporters, and in particular human proteins, are observed with similar half-
motors, these studies may provide a general mechanism that can be applied globally to 
these systems. High-resolution structural information would provide a more complete 
picture of ribose transporter function. In collaboration with the University of Chicago, 
phage display experiments have identified several dozen crystallization chaperones in the 
form of high-affinity synthetic antibodies that will aid crystallization of ribose transporter 








1.1 Membrane Transporters: Cellular Gatekeepers 
 All cells are surrounded by semi-permeable membranes, which encase each cell in 
a protective lipid bilayer built to not only hold its contents but also to protect and preserve 
the treasures within. The costs of the protective function include special challenges for 
moving substances across this lipid-filled moat, which is impermeable to most relevant 
biomolecules except for the smallest of substances, such as oxygen and carbon dioxide. 
Relevant biomolecules include not only toxins and wastes, which must be exported in a 
timely manner, but also important cellular foodstuffs and critical ions, which must be 
efficiently imported to meet cellular metabolic demands. As a means to overcome such 
challenges, cells have evolved special classes of transport proteins. While costly to produce 
in terms of time and resources, these proteins provide the cell virtually complete control of 
everything that enters and exits its gates.  
 Broadly, these proteins can be classified as channels and primary and secondary 
active transporters (FIGURE 1.1) (Lodish, et al. 2000). Channels provide pathways for the 
passive movement of substances into or out of cells and their compartments. These include 
the primarily alpha-helical channels (such as those for ions and water) as well as the beta-
barrel outer-membrane porins found in gram-negative bacteria. Entry to these channels is 




FIGURE 1.1: Schematic view of transport systems spanning the cell membrane (yellow). 
(A) Left to right: Channels (blue) contain either intra- or extra-cellular gates that allow 
control of opening and closing of passive transport pathways for substrates (green); Pumps 
(maroon) utilize ATP hydrolysis to concentrate substrates (purple) on one side of the 
membrane; Transporters (orange) utilize a mechanism of alternating access of substrate 
binding sites to deliver substrates across membranes (bright red). (B) General transport 
mechanisms. Left to right: Uniporters (teal) provide passive pathways for substrate 
diffusion down concentration gradients; Symporters (light green) couple the favorable 
transport of one substrate (black) with the unfavorable transport of another (orange), both 
in the same direction across the membrane; Antiporters (royal blue) utilize a similar 
coupling, except the direction of transport is opposite for each substrate. 
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example, voltages and mechanical stress, and selectivity filters, which define cargo 
specificity (Roux, et al. 2011). Specific channels exist, for instance, for water, sodium, 
potassium, and calcium (Gouaux and MacKinnon 2005). 
 Transporters generally provide the ability to selectively concentrate substances 
inside or outside of cells, a process requiring expenditure of energy, and are grouped by 
energizing mechanisms (White 2009). Primary active transporters transport substances 
against their concentration gradients by utilizing the free energy released by ATP 
hydrolysis (Hobbs and Albers 1980). Examples include pumps such as the 
sodium/potassium ATPase and traffic ATPases, which will be discussed below. Secondary 
active transporters couple transport down favorable cellular gradients, such as those for 
sodium ions or protons, to the unfavorable transport of relevant substances (Forrest, 
Kramer and Ziegler 2011). These include uniporters, symporters, such as the sodium-




1.2 ABC Transporters: Powering the Processes of Life 
 Within these general classes of transport proteins exist conserved families that are 
ubiquitously distributed and, as a whole, involved in nearly every imaginable biological 
process (Higgins 1992). Over three hundred different families of channels and transporters 
have been identified (Saier, Tran and Barabote 2006). Among these, two of the largest 
superfamilies include the secondary transporter family known as secondary major 
facilitators (MFS) and the primary traffic ATPases, or ATP-binding cassette (ABC) 
transporters. ABC transporters are ATP-powered pumps, and broadly form one of the 
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largest superfamilies of paralagous proteins known (Davidson, et al. 2008). ABC 
transporters are found in nearly every species known, from the simplest of microorganisms 
to man (Holland, et al. 2003). Fully five percent of the Escherichia coli genome codes for 
ABC transporters, and nearly fifty have been identified in Homo sapiens (Rees, Johnson 
and Lewinson 2009). Their prevalence and ubiquitous distribution both account for their 
role in a variety of clinically-relevant phenomena (TABLE 1.1) including pathogenesis 
and virulence (Lewis, Ween and McDevitt 2012), drug resistance in bacteria and cancer, 
and the genetic diseases cystic fibrosis, Tangier disease, Stargardt disease, and age-related 
macular degeneration (Borst and Elferink 2002). In total, thirteen known genetic diseases 
have been directly linked to defects in fourteen human ABC transporters (Gottesman and 
Ambudkar 2001). 
The superfamily consists of three principal functional classes that likely diverged 
at an early stage of evolution: importers, exporters, and non-transport proteins, which as a 
group mediate an impressively diverse array of vital biological phenomena (FIGURE 1.2) 
(Davidson, et al. 2008). Importers are typically prokaryotic and fulfill the uptake of a 
variety of nutrients, including sugars, amino acids and peptides, ions, trace metals, and 
vitamins (Cui and Davidson 2011). Exporters, found in all domains of life, deliver a similar 
variety of substances out of cells and cellular compartments: peptides
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Table 1.1 – ABC transporters linked to human diseases and bacterial pathogenesis. 
Adapted from Gottesman and Ambudkar (2001) and 
http://www.genenames.org/genefamilies/ABC. 
 
Disease Transporter References 
Age-related macular 
degeneration 
ABCR (ABCC7) Allikmets, et al. 1997 
Cancer MDR1 (ABCB1), MRP1 
(ABCC1), MXR (ABCG2) 
Chen, et al. 1986 
 
Cystic Fibrosis CFTR (ABCC7) Riordan, et al. 1989 
Dubin-Johnson Syndrome MRP2 (ABCC2) Paulusma, et al. 1996 
Immune deficiency TAP1/TAP2  
(ABCB2/ABCB3) 
Momburg, et al. 1994 
Progressive familial 
intrahepatic cholestasis 
MDR2 (ABCB4),  
SPGP (ABCB11) 
de Vree, et al. 1998 
Tangier disease and 
Alzheimer’s Disease 
ABC1 (ABCA1) Brooks-Wilson, et al. 1999 
Bacterial pathogenesis – 
LPS production 
Wzt/Wzm (O-antigen, 
many species), MsbA (lipid 
A, many species), TagGH 
(Teichoic acid, B. subtilis, 
S. aureus) 
Kauffmann 1947 
Raetz, et al. 2007 
Whitfeld, Cuthbertson and 
Powers 2005 
Bacterial pathogenesis – 
toxin secretion 
HlyB (hemolysin, E. coli), 
CylT (cytolysin, E. 
faecalis) 
Blight and Holland 1990 
Bacterial pathogenesis – 
antibiotic/antimicrobial 
resistance 
DrrAB (doxorubicin, S. 
peucetius), McjD (microcin 
E. coli), MacB (E. coli), 
LmrA (L. lactis) and 
Sav1866 (S. aureus) 
(polyspecific xenobiotic 
exporters) 
Guilfoile and Hutchinson 
1991 
Choudhury, et al. 2014 
Davidson, et al. 2008 
Dawson and Locher 2006 
Bacterial virulence FbpABC (N. gonorrhoeae) 
and HitABC (H. influenzae) 
(iron acquisition) 
Strange, Zola and 
Cornelisson 2011 
Adhikari, et al. 1995 
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Figure 1-2: The diversity of ABC transporters. (A) Vitamin B12 is taken up in gram-
negative bacteria by the outer membrane receptor BtuB, which is coupled to the energy-
transducing complex ExbBD-TonB. B12 is then captured in the periplasm by BtuF, which 
delivers it to the inner membrane ABC transporter BtuCD for import. (B) Maltose diffuses 
into the periplasm through maltoporins like LamB, where it is captured by MalE and 
delivered to the ABC transporter MalFGK for cytoplasmic import. (C) ECF transporters 
deliver micronutrients like folate using a unique mechanism. (D) ABC exporters, like HlyB 
in E. coli, play a critical role in toxin export. HlyB complexes with a membrane fusion 
protein (MFP) and the outer membrane protein TolC to extrude hemolysin toxin. (E) MsbA 
is an ABC transporter that flips lipids from the inner to the outer leaflet of cell membranes 
in many species. (F) Gram-positive bacteria use ABC transporters with a membrane-
embedded substrate-binding domain, like the zinc importer from S. aureus. (G) P-
glycoprotein is a mammalian toxin exporter that has been implicated in cancer drug 
resistance. (H) CFTR is an ABC transporter that functions as a chloride channel, and 
contains a cytoplasmic regulatory domain and all other domains on a single polypeptide.  
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proteins, lipids, polysaccharides, toxins, and hydrophobic drugs (Locher, 2009). A recently 
identified third type of ABC transporter, termed energy-coupling factor (ECF) transporters, 
is structurally and functionally distinct from typical ABC importers and is involved in the 
uptake of trace metals and vitamins in prokaryotes (Slotboom, 2014). Finally, ABC 
proteins not obviously associated with transporters are ubiquitous and thought to be 
involved in mRNA translation and DNA repair (Hopfner & Tainer, 2003), although 
recently characterized “orphan ABCs” may participate in transport either directly or 
indirectly (Ferreira & de Sa-Nogueira, 2010). The latter two functional classes will be 




1.3 A Common Structural Organization 
 Despite the difference in substrate population and the direction of transport, both 
importers and exporters share common structural features. All ABC transporters contain, 
at minimum, two nucleotide-binding domains (NBD), present in the cytoplasm or lumen 
of organelles, and two hydrophobic transmembrane domains (TMD), spanning either the 
plasma or organellar membranes (Rees, Johnson, & Lewinson, 2009). These subunits 
assemble to form the basic functional unit of an ABC transporter (FIGURE 1.3). In 
prokaryotic importers, this assembly typically consists of each domain expressed as 
separate polypeptides (Davidson, Dassa, Orelle, & Chen, 2008). Thus, ABC importers
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 Figure 1-3: Organization of ABC transporters. Top: Importer organization. (A) ABC 
importers, like the pictured Vitamin B12 transporter, are composed of homodimers of the 
TMD (e.g. BtuC) and NBDs (BtuD). (B) The maltose importer is composed of 
heterodimers of the TMD (MalF and MalG) and homodimers of the NBD (MalK). (C) ECF 
transporters contain heterodimers of the TMD (EcfT and EcfS) and heterodimers of the 
NBDs (EcfA and EcfA’). (D) In rare cases, importers such as the arabinose transporter are 
composed of homodimers of the TMD and a fused NBD. (E) Typical exporters, like HlyB, 
contain a fused N-terminal TMD with C-terminal NBD, which forms dimers as intact 
transporters. (F) Some mammalian exporters contain all four domains on a single 
polypeptide (e.g. P-glycoprotein). (G) Some transporters also contain additional regulatory 
domains, like the cystic fibrosis transmembrane regulator (CFTR, RD is orange circle). (H) 
Non-transport ABC proteins, like the DNA-repair enzyme Rad50, contain NBDs fused by 
a linker region and additional domains involved in DNA recognition.
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normally exist as pairs of either homo- or heterodimers, as in the prototypical vitamin B12 
and maltose transporters in E. coli. Exceptions to this organization exist and will be 
discussed later. Exporters from all kingdoms usually possess a fused NBD-TMD 
arrangement, with each present as independently folded domains on a single polypeptide. 
These can be expressed as an N-terminal TMD with C-terminal NBD fusion, as in the case 
of the of hemolysin transporter HlyB, or with the more rarely seen NBD-TMD arrangement 
(Davidson, Dassa, Orelle, & Chen, 2008). An example of the latter organization is the 
macrolide exporter MacB found in E. coli, which contains a membrane insertion signal 
sequence following the N-terminal NBD (Kobayashi, Nishino, & Yamaguchi, 2001). The 
fused protein then assembles also as a homo- or heterodimer to form the functioning unit 
of the typical exporter. Notable exceptions include P-glycoprotein, a eukaryotic drug 
exporter also known as MDR1 (Gottesman & Pastan, 1993), and the cystic fibrosis 
transmembrane conductance regulator (CFTR), the chloride channel implicated in the 
eponymous genetic disease, which both have all four domains expressed on the same 
polypeptide (Dean, Hamon, & Chimini, 2001). In certain exporters, the NBDs are 
expressed separately and assemble with the TMDs post-translation (Cuthbertson, Kos, & 
Whitfield, 2010). Finally, ABC proteins not involved in transport typically consist of fused 
NBDs and no associated TMDs (Hopfner & Tainer, 2003). These proteins are marked by 










1.4 Conserved Elements: The Nucleotide-binding Domain 
 All ABC proteins share highly-conserved sequence elements that are required for 
the binding and hydrolysis of ATP (FIGURE 1.4A). Indeed, these features define and link 
all members of this protein family. Structurally, each NBD is roughly L-shaped, with a 
larger, RecA-like subdomain that is typical of P-loop ATPases and a smaller helical domain 
that is unique to ABC proteins (FIGURE 1.4B). In the RecA-like domain, an aromatic 
amino acid, usually tyrosine, and the Walker A motif [GXXGXGK(S/T)] form the ATP-
binding site, with the aromatic positioning the ATP via ring-stacking and backbone amides 
and the lysine amino group from the Walker A motif forming interactions with the β- and 
γ-phosphates (Higgins & Hinton, The ATP switch model for ABC transporters, 2004). The 
Walker B motif (φφφφDE, φ = any hydrophobic amino acid) is involved with hydrolysis, 
with the conserved aspartate coordinating a magnesium ion and the glutamate coordinating 
an attacking water molecule. This water is critical for hydrolysis, and supports the 
traditionally accepted “general base” model for catalysis (Oldham, Davidson, & Chen, 
2008). In addition, the H-loop contributes a conserved histidine that disrupts the stability 
of the binding site once the bond between the β- and γ-phosphates is cleaved. For this 
reason, it is also known as the switch histidine (Higgins & Hinton, The ATP switch model 
for ABC transporters, 2004). The D-loop (SALD) stabilizes the binding site by interacting 
with its cognate partner in the opposite monomer
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Figure 1-4: Structure and organization of ABC transporter nucleotide-binding domains. (A) 
Schematic diagram of NBD protein sequence from N- to C-terminus with conserved 
sequence motifs highlighted in color.  (B) Cartoon representation of HlyB (hemolysin toxin 
transporter) composite NBD dimer with bound ATP (brown) and Mg2+ (PDB ID: 1XEF). 
RecA-like subdomain is shown in cyan and helical domain in light blue. Conserved 
sequence motifs highlighted in color: Walker A (red), Walker B (magenta), ABC signature 
(orange), Q-loop (blue), D-loop (dark blue), and H-loop (green). 
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(Jones & George, 2012). The Q-loop, lying between the two subdomains, is the major site 
of interaction with the TMD, and is critical for the signal transduction linking ATP 
hydrolysis with substrate transport (Jones & George, 2002). ABC exporters contain an 
additional short sequence motif (TEVGERV) in the structurally diverse helical region of 
exporter NBDs that is also thought to be required for signal transduction between opposing 
domains (Locher, 2009). Finally, the signature sequence (LSGGQ), unique to ABC 
proteins and located at the N-terminus of a long alpha helix in the helical domain, 
completes the binding site by directing the positive charges of the helical dipole towards 
the γ-phosphate (ter Beek, Guskov, & Slotboom, 2014). Some NBDs also possess an 
additional regulatory domain (RD) that mediates active transport depending upon the 
abundance of the transported substrate, a process known as trans-inhibition (Biemans-
Oldehinkel, Doeven, & Poolman, 2006). 
 The NBDs of ABC proteins typically function as dimers, with the canonical system 
forming two equivalent ATP binding sites at the interface of the two monomers, related to 
one another by pseudo two-fold symmetry. Structural and functional studies have revealed 
distinct conformations of the monomers relative to one another, and in the absence of ATP 
they remain separated in an “open” conformation. ATP binding results in the “closed” 
conformation, where the signature sequence from one monomer moves close, via rigid-
body rotations, to the Walker A and B motifs and the A-, H-, and D-loops of the opposing 
monomer to form the intact binding site (Chen, Lu, Lin, Davidson, & Quiocho, 2003). In 
essence, each monomer contributes a half-binding site, and dimerization results in two 
equivalent ATP-binding sites, at least in canonical systems. Examples of such systems 
include the well-characterized maltose, vitamin B12, and histidine transporters, which have 
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been studied extensively both biochemically and structurally (Wen & Tajkhorshid, 2008). 
These studies have revealed a closure of dimers upon ATP and magnesium binding, with 
hydrolysis subsequently resulting in a “semi-open” conformation, as the bonds supporting 
the γ-phosphate are broken (Orelle, Ayvaz, Everly, Klug, & Davidson, 2008). The NBDs 
are then reset to “open” once ADP and magnesium are ejected. While it is tempting, given 
the equivalency, to assume both ATPs are hydrolyzed per transport cycle, experimental 
evidence is at best mixed for this model (Oswald, Holland, & Schmitt, 2006). A thorough 
discussion of the stoichiometry of transport, the conformational changes in NBDs, and 




1.5 Non-conserved Elements: The Transmembrane Domains 
 While the ABC protein provides the conserved elements that are hallmarks of this 
protein family, the transmembrane domains exhibit little conservation with respect to the 
sequence level (Davidson, Dassa, Orelle, & Chen, 2008). This is unsurprising: given the 
diverse chemistry of substrates recognized and transported by ABC transporters, it should 
be expected that each transporter contain binding pockets designed to recognize its specific 
cargo. What is surprising is that the evidence for such binding pockets is hardly ubiquitous 
for this family. Well-defined substrate-binding sites have been found in several cases, but 
not all; importers such as the vitamin B12 transporter lack clear substrate-binding sites in 
the TMDs (Korkhov, Mireku, & Locher, 2012), while the maltose transporter has a well-
characterized maltose-binding pocket (Oldham, Khare, Quiocho, Davidson, & Chen, 2007) 
(Oldham, Chen, & Chen, 2013). Perhaps more surprisingly, there exist several transporters, 
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primarily exporters, which are each capable of recognizing a range of substrates, in some 
cases with widely differing chemistries (Siarheyeva, Lopez, & Glaubitz, 2006). The most 
well-known example of this promiscuity is found in the eukaryotic exporter P-glycoprotein, 
which recognizes hydrophobic drugs, toxins, peptides, and proteins using a large and varied 
patch of amino acids in the inner lining of its transmembrane cavity (Sharom, 2011).  
 What, then, can be considered a typical TMD for ABC transporters, and do any 
shared features exist? Here it is most convenient to consider importers, exporters, and ECF 
transporters separately (FIGURE 1.5). The simplest description can be made for exporters, 
which typically consist of six core TM helices per TMD, forming translocation pathway 
lined by twelve total TM helices in the dimer assembly (ter Beek, Guskov, & Slotboom, 
2014). These helices typically extend far into the cytoplasm, positioning the NBDs nearly 
25 Å from the membrane. (Importer NBDs lie much closer to the membrane.) Substrate 
binding sites generally line the exposed cytoplasmic surfaces of
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Figure 1-5: Diversity of ABC transporter transmembrane domains. Grey bar is membrane. 
(A) Type I ABC importers contain 6-8 TM helices per monomer, as shown with MalF 
(yellow, 8 TM helices) and MalG (pink, 6 TM helices) (PDB ID: 2R6G). The core is 
formed by 6 helices. (B) Type II ABC importers contain 10 TM helices per monomer, as 
shown with BtuC2 (blue and green monomers) (PDB ID: 1L7V). (C) ECF transporters 
(Type III ABC importers), such as the folate transporter (PDB ID: 4HUQ), contain 4 TM 
helices in both the EcfT domain (yellow) and the EcfS domain (pink), each with different 
amino acid properties. (D) ABC exporters, such as Sav1866 (PDB ID: 2HYD), contain 6 
TM helices per monomer (blue and green), each with a large cytoplasmic region known as 
the intracellular domain (ICD) or intracellular loop region (ICL). 
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each TMD. The primary site of communication between the TMDs and the NBDs is the 
coupling helix, also known as intracellular loop 1 (ICL1), which links TM helices 2 and 3 
in crystal structures thus far solved (Prasad & Goffeau, 2012). In rare cases, the TMDs 
contain only 4 putative TM helices, such as the E. coli macrolide exporter (Kobayashi, 
Nishino, Hirata, & Yamaguchi, 2003); less is known about how such transporters function. 
 The picture is more complex for importers, including ECF transporters (Rice, Park, 
& Pinkett, 2014). As crystallographic studies began to provide structural information of 
ABC transporters, importers were segregated into two subtypes based initially on the 
number of TM helices per monomer. Type I systems contained 6-8 TM helices per 
monomer, with the lining of the pore formed by six core TM helices. The most well 
characterized example of this importer subtype is the E. coli maltose transporter, which 
contains a heterodimer of TMDs (Davidson, Dassa, Orelle, & Chen, 2008). Structural 
studies have identified a clear maltose-binding pocket present in one of the two TMDs 
(Oldham, Chen, & Chen, 2013). Transport is fulfilled by rigid-body rotations in the TMDs 
relative to one another (Khare, Oldham, Orelle, Davidson, & Chen, 2009); these changes, 
along with a more thorough description of importer subtypes, will be discussed more 
thoroughly in a subsequent section. 
 Type II importers typically contain 10 TM helices per monomer and thus 20 in total 
in the assembled dimer. Structures of the vitamin B12 transporter and molybdate transporter 
initially shed light into the organization of these “large” ABC importers, which have more 
voluminous translocation pathways with limited conformational changes to fulfill transport 
(Rice, Park, & Pinkett, 2014). However, none these nor studies of additional Type II 
importers revealed the presence of a clearly defined substrate binding site in the TMD. 
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Rather, a hydrophobic surface forms the inner lining of the substrate pocket, preventing 
interactions with the hydrophilic substrate to form a “Teflon-like” transport channel, with 
the accessory binding protein providing the key regulatory step in the transport pathway 
(Korkhov, Mireku, & Locher, 2012). The role of the binding protein will be elucidated in 
the next section. 
 The inclusion of ECF transporters as a third type of ABC importer is recent, though 
their existence has been known since the 1970s. Much like other ABC importers, ECF 
transporters are critical for the uptake of nutrients in bacteria and archaea, and possess 
dimers of NBDs to provide the energy required for active transport. ECF transporters 
diverge at the TMD level: unlike ABC transporters, this group is obligatorily heterodimeric, 
with each TMD unrelated to the other both functionally and structurally (Slotboom, 2014). 
One TMD, termed the EcfT subunit, consists of a predicted 4 to 8 TM helices, although 
recent crystal structures of intact transporters have 5. The other TMD is known as the S 
component, an integral membrane protein with 6 core helices that binds the transported 
substrate with high affinity, in the low nanomolar range. No translocation pathway exists, 
and transport appears to be fulfilled solely by conformational changes of the S-component, 
which appear to be sensitive to the presence of ATP. Each S-component contains a single, 
extracellular binding site, which is capped by a loop between TM1 and TM2. Interestingly, 
only the EcfT subunit, which contains two long cytoplasmic helices, appears to interact 
with the NBDs, and in much the same manner and location as other ABC transporters (Xu, 
et al., 2013). How ATP hydrolysis is linked to transport is still a matter under investigation, 
not just for ECF transporters but also for other ABC importers and exporters, but cannot 
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thoroughly be appreciated without first considering the critical role of the substrate binding 




1.6 Not Just An Accessory After the Fact: The Substrate Binding Protein 
 A variety of pathways and complexes, including transport and non-transport related 
systems, involve substrate binding proteins (SBP), or substrate binding domains (SBD). In 
this section only the SBPs involved in ABC transporter systems will be considered. The 
SBPs are critical components of ABC importers, as involved in the process as the TMDs 
and NBDs. They are intracellular scavengers, capturing their prey – the substrates – with 
high affinity (0.01 to 1 µM) and navigating promptly to the translocators, the TMDs, which 
cajole them to finally release the substrate for transport (Davidson, Dassa, Orelle, & Chen, 
2008). However, SBPs are not just specialized delivery systems that enable substrate 
transport at low concentrations; even at high substrate concentrations, they are required for 
uptake, and thus are active participants in the process of active transport (Shuman, 1982). 
The interplay of the SBP, TMDs, and NBDs as they assemble and ultimately deliver their 
cargo represents an elegant demonstration of signal transduction across the cell membrane, 
tightly linking the hydrolysis of ATP with the presence of the transported substrate (Chen 
J. , 2013).  
 Before describing the current mechanistic understanding of how the SBP interacts 
with the TMD and how this information is communicated to the NBD, it is instructive to 
consider the diversity of SBPs themselves. Much like ABC transporter TMDs, there is little 
sequence conservation among SBPs, perhaps unsurprising given the diverse chemistries of 
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their substrate. SBPs are, much like the TMDS, related at the structural level, and are 
segregated into several distinct classes based on conserved three-dimensional folds 
(TABLE 1.2) (Berntsson, Smits, Schmitt, Slotboom, & Poolman, 2010). The differences, 
however, are subtle: all SBPs share the same basic architecture, a bilobal structure 
connected by a hinge that causes the lobes to snap shut, thus capturing the substrate by a 
“Venus fly trap” mechanism, where a single binding site exists between the two lobes (Mao, 
Pear, McCammon, & Quiocho, 1982). Each lobe of the SBP must then interact with each 
TMD monomer to reopen the trap and release the prey (Bohm, Licht, Wuttge, Schneider, 
& Bordignon, 2013).  
From this basic bilobal outline, six different clusters of SBPs arise (FIGURE 1.6), 
each containing structural or chemical properties allowing for recognition of specific 
substrates and transporter subtypes (Berntsson, Smits, Schmitt, Slotboom, & Poolman, 
2010). The nature of classification and details of all six clusters, which include many SBPs 
not involved with transport, can be found in the review by Berntsson et al; here we consider 
only those relevant to ABC transporters.  
Cluster A contains SBPs associated exclusively with ABC transporters and these 
proteins are defined by an α-helix serving as the hinge region between the two lobes. This 
confers rigidity to Cluster A SBPs, where limited rotation of the two lobes results in closure 
upon substrate binding. For example, structures of BtuF, the vitamin B12 binding protein, 
reveal only a 4° rotation from the apo to holo forms (Rice, Park, & Pinkett, 2014). All 
Cluster A SBPs are involved with metal binding either directly, such as the iron, manganese, 




Table 1-2: Substrate-binding protein classification, associated ligand specificity and 
transporter type, and available PDB structures of representative proteins. Adapted from 
Berntsson et al. 
SBP 
Cluster 
Ligands Association Example SBPs 
(PDB IDs) 
A Metal ions,  
siderophores 
ABC transporters only BtuF (1N2Z, 1N4A, 1N4D, 
2QI9) 
MntC (1XVL) 
B Carbohydrates,  
amino acids (L, I, 
V),  
small peptides 





MBP (1ANF, 1DMB,  
1EZ9, 1EZ0, 1EZP…) 
RBP (1BA2, 1DBP, 1DRJ,  
1URP, 2DRI, 2FN8, 2FN9) 
C Arginine,  
small peptides,  
nickel 
ABC transporters only, 
large extra domain 
OppA (3DRF, 3DRG, 
3DRH,  
3DRI, 3DRJ, 3DRK, 3FTO) 
D Carbohydrates,  
thiamine,  
oxyanions, iron 
ABC transporters only 
Carbohydrate binders have extra 
domain 
FbpA (1SI0, 1SI1, 1Q35) 
PotD (1POT, 1POY) 
TbpA (2QRY) 
E Sialic acid,  
2-keto acids,  
lactate,  
ectoine 
TRAP transporters only SiaP (2CEY, 2CEX) 
TTHA0766 (2ZZV, 2ZZW, 
2ZZX) 





ligand-gated ion channels 
GPCRs 
ArtJ (2PVU, 2Q2A, 2Q2C) 
HisJ (1HPB, 1HSL) 










Cluster B contains SBPs that interact with ABC transporters, two-component signal 
transducers, and certain peptide receptors, and are homologues of the lac-repressor type 
transcription factors (Mauzy & Hermodson, 1992). Rather than a single helix, cluster B 
SBPs contain three hinges between the two lobes, conferring greater flexibility. Indeed, 
structures of cluster B SBPs reveal a significant rotation of the two lobes upon substrate 
binding (Bjorkman & Mowbray, 1998). These proteins are involved in the binding of 
simple sugars, such as arabinose, galactose, and ribose, as well as branched-chain amino 
acids and small peptides. 
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Figure 1-6: Representative structures of SBPs from each cluster. Hinge regions and distinct 
features colored in brick red (A) Cluster A contains SBPs with helical hinge region, like 
BtuF (PDB ID: 1N2Z). (B) Cluster B contains proteins with three loops forming a flexible 
hinge, like RbsB (ribose-binding protein, PDB ID: 1BA2). (C) Cluster C contains proteins 
with a large extra domain, which extends the substrate-binding site for larger substrates, 
such as in OppA (oligopeptide-binding protein, PDB ID: 3DRF). (D) Cluster D contains 
SBPs with short hinges, like in FbpA (iron-binding protein, PDB ID: 1S10). (E) Cluster E 
contains SBPs of TRAP transporters with a large helical hinge, like SiaP (sialic acid-
binding protein, 2CEY). (F) Cluster F contains SBPs with two hinges for greater flexibility, 
like ModA (molybdate-binding protein, PDB ID: 2ONR). 
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The bilobal forms with either rigid or flexible hinges represent the two extremes in 
SBP structural diversity. All of the other clusters include designs similar to these, but with 
slight variations. Cluster C also includes SBPs only associated with ABC transporters. This 
group is marked by an additional domain that extends the substrate-binding site, 
accommodating the larger oligopeptides that these proteins bind. Interestingly, not every 
Cluster C SBP binds large substrates. Cluster D, which features a flexible hinge containing 
two short strands (4-5 amino acids), also includes ABC transporter SBPs. Some of these, 
such as the well-characterized maltose-binding protein (MBP) (Sharff, Rodseth, Spurlino, 
& Quiocho, 1992), include an extra domain, while others are involved in the capture of 
tetrahedral oxyanions. Cluster F includes some SBPs that participate in ABC-dependent 
transport, and is marked by a two-stranded hinge consisting of 8-10 amino acids, which 
allows greater flexibility to capture larger ionic substrates. Finally, Cluster E includes SBPs 
that are components of tripartite ATP-independent periplasmic (TRAP) transporters. 
While substrate-binding proteins are critical components of most ABC importers 
and other transport and non-transport systems, they are not employed by ECF transporters 
or by ABC exporters. Exporters contain substrate-binding sites within the cytoplasmic 
portion of their TMDs. ECF transporters, as described earlier, contain the recently 
characterized S-component, which binds substrates with pM to nM affinity (Berntsson, et 
al., 2012). Domain-wide structural changes of the S-component, linked to ATP-hydrolysis 







1.7 Structures of Intact Transporters: General Mechanisms and Major Differences 
 The past fourteen years represent a golden age for ABC transporter structural 
biology, with thirty-three crystal structures solved of twenty different intact transporters, 
including nine bacterial importers and one human mitochondrial exporter (TABLE 1.3). 
In addition, two recent crystal structures have been solved for intact ECF transporters. 
These structures have provided tremendous insight into the organization and assembly of 
these transporters while guiding biochemical and biophysical studies that have elucidated 
the mechanistic details of their function. While many open questions remain, it is useful to 
consider what we have thus far learned from this structural information. 
A simple two-state model (Jardetzky, 1966) can be used to describe the function of 
a given transporter, provided three structural criteria are fulfilled: i) it must contain a cavity 
to admit the transporter molecule; ii) it must be able to assume two different configurations, 
alternately open to each side of the membrane; and iii) it must contain a binding site for 
the transported molecule. Crystallographic studies have provided the structural basis for 
this two-state transport model: alternating access of transmembrane helices that transfers 
the substrate from one side of the membrane to the other (FIGURE 1.7). All ABC 









Table 1-3: Structures of intact ABC transporters.
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Table 1-3: Structures of intact ABC transporters (continued). 1) (Locher, Lee, & Rees, 
2002); 2) (Hvorup, et al., 2007); 3) (Korkhov, Mireku, & Locher, 2012); 4) (Hollenstein, 
Frei, & Locher, 2007); 5) (Gerber, Comellas-Bigler, Goetz, & Locher, 2008); 6) (Pinkett, 
Lee, Lum, Locher, & Rees, 2007); 7) (Tirado-Lee, Lee, Rees, & Pinkett, 2011); 8) (Oldham, 
Khare, Quiocho, Davidson, & Chen, 2007); 9) (Oldham & Chen, 2011); 10) (Khare, 
Oldham, Orelle, Davidson, & Chen, 2009) 11) (Chen, Oldham, Davidson, & Chen, 2013); 
12) (Kadaba, Kaiser, Johnson, Lee, & Rees, 2008); 13) (Woo, Zeltina, Goetz, & Locher, 
2012); 14) (Yu, Ge, Heuveling, Schneider, & Yang, 2015); 15) (Maruyama, et al., 2015); 
16) (Dawson & Locher, 2006); 17) (Ward, Reyes, Yu, Roth, & Chang, 2007); 18) (Aller, 
et al., 2009); 19) (Li, Jaimes, & Aller, 2014); 20) (Szewczyk, et al., 2015); 21) (Jin, Oldham, 
Zhang, & Chen, 2012); 22) (Kodan, et al., 2014); 23) (Hohl, Briand, Grutter, & Seeger, 
2012); 24) (Hohl, et al., 2014); 25) (Shintre, et al., 2013); 26) (Lee, Yang, Zhitnitsky, 
Lewinson, & Rees, 2014); 27) (Srinivasan, Pierik, & Lill, 2014); 28) (Choudhury, et al., 
2014); 29) (Lin, Huang, & Chen, 2015); 30) (Perez, et al., 2015); 31) (Xu, et al., 2013); 32) 





Figure 1-7: The alternating access model for ABC transporters. Grey bar is cell membrane. 
(A) Cut-away surface representation of maltose transporter structure in apo- state without 
maltose-binding protein (MBP) (PDB ID: 3RLF). Translocation channel faces cytoplasm 
(red bars; inward-facing). (B) Cut-away surface representation of maltose transporter 
structure with MBP and bound Mg2+-AMP-PNP (PDB ID: 3HF6). Translocation channel 
faces periplasm (red bars; outward-facing). (C) Schematic diagram of alternating access 
model showing rotation of TMDs upon ATP binding and hydrolysis. 
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delivery of the substrate. Structures have revealed the number of core helices and the 
degree of helical rotation differs for each type of transporter, with significant differences 
related to the nature of the transported substrate (ter Beek, Guskov, & Slotboom, 2014) 
(Rice, Park, & Pinkett, 2014). A common driving force fuels the alternating access of 
transmembrane helices: hydrolysis of ATP by the NBDs, thus leading to active transport 
of the substrate.  This is also known as the Switch Model (Higgins, 1992). 
What are the structural changes associated with this driving force? Here, we lean 
on functional studies of the maltose transporter using electron paramagnetic resonance 
(EPR) spectroscopy for insight into ABC domain function (Orelle, et al., 2010). These 
studies focused on conformational changes of the NBD homodimers of MalK and revealed 
a 10° rotation of each α-helical subdomain relative to the opposing RecA-like subdomain 
upon the binding of ATP. The ATP binding, in turn, required the presence of MBP, forming 
a key regulatory step in the transport pathway against futile hydrolysis cycles. Neither ATP 
nor MBP alone could trigger this domain motion, suggesting the association of the α-
helical and RecA-like subdomains is stabilized by interactions with the bound nucleotide. 
In addition, the conserved Q-loop, which interacts with the coupling helix, was found to 
engage with the active site upon ATP binding. The results also provided a pathway for 
domain separation post-hydrolysis, when the interactions between the domains are likely 
to be destabilized. These results were supported by high-resolution structures of the intact 
maltose transporter with different ATP analogs bound, which revealed a network of 
interactions from both domains coordinating ATP binding (Oldham & Chen, 2011), 
including the Q-loop glutamine. 
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 Similar studies have yet to be performed on ABC exporters and ECF transporters 
and crystal structures in different conformations for the same exporter have yet to be 
determined at sufficient resolution to obtain mechanistic details. However, molecular 
dynamics simulations have provided a similar framework for ATP-induced domain closure 
of the NBDs (Wen, Verhalen, Wilkens, Mchaourab, & Tajkhorshid, 2013). These 
experiments, along with extensive studies of importers, have shown related, yet slightly 
different, transport pathways for each transporter type. For instance, the coupling helix is 
a common structural feature of each transporter type, providing a physical link between the 
TMDs and the NBDs and ability to “sense” the nucleotide state. The details of how 
precisely this is accomplished are still under investigation and in the next sections we will 
discuss what is known about the mechanisms of each type of transporter and how each 




1.8 ABC Exporters: A Guide for Leaving 
 The crystal structures of nine different ABC exporters have been solved to date 
with resolution ranging from 2.5 Å for the glutathione-bound form of the Atm1 exporter to 
5.5 Å for the closed-apo form of the MsbA structure. These structures include the first 
human ABC transporter structure solved, a mitochondrial exporter, eukaryotic and 
bacterial drug exporters, two peptide translocators, two lipid flippases, and one 
heterodimeric archeal exporter. While none of the structures include the same exporter in 
multiple conformations, based on the expected model of alternating access, different 
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exporters have been captured in various conformations and their crystal structures provide 
insight into the mechanical changes associated with transport. 
 The arrangement of monomers in ABC exporters is distinct and 
significantly impacts how each interacts with the other in intact transporters. Unlike ABC 
importers and ECF transporters, ABC exporters display domain swapping by intertwining 
of transmembrane helices, with each subunit forming “wings” that pack tightly with the 
opposite monomer (Bies, 2015). These wings are typically formed by TM segments 1 and 
2, which pack against TM3-6 of the other subunit in the intact transporter (FIGURE 1.8A). 
Further, each wing contributes an intracellular loop (ICL) that forms a short intracellular 
helix (IH1) between TM2 and TM3. In tandem with a second short helix contributed by an 
intracellular loop connecting TM4 and TM5 (IH4), these conserved structural features form 
a salt bridge with the NBD Q-loop (FIGURE 1.8B) that serves as the couple between 
membrane-spanning domains and the cytoplasmic domains ( (Jin, Oldham, Zhang, & Chen, 
2012). While the substrate binding sites of exporters have not yet been clearly resolved, 
the wings and intracellular helices provide a pathway to connect hydrolysis and transport 
across both monomers. 
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Figure 1-8: Structure and mechanism of ABC exporters. (A) Domain-swapping in exporter 
TMDs, demonstrated in the crystal structure of MsbA (PDB ID: 3B60). TM 1 and 2 (red) 
from one monomer primarily interact with TM 3-6 of the opposing monomer (grey). (B) 
Interactions of exporter TMDs with NBDs. TM helix 1 (blue) and TM helix 3 (orange) 
interact with the Q-loop of the NBD (grey). Interacting residues are represented as stick 
models. (C) Exporter transport mechanism. The cycle begins in the inward-open 
conformation (PDB ID: 4F4C). 1: Futile hydrolysis cycles set the exporter in the ADP-
bound outward-occluded configuration (PDB ID: 5C73). 2: Substrate (red) binding triggers 
an exchange of ADP for ATP in the catalytic sites, setting the transporter in the outward-
open configuration (PDB ID: 2HYD). 3: ATP hydrolysis results in the outward-occluded 
conformation. 4) The substrate is pinched from the core binding site within the TMDs, 
leading to export. 
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With respect to the model of NBD rotation proposed by Orelle et al (2010), the 
structural changes associated with nucleotide binding in exporters remain unresolved. 
Multiple structures of exporters in the inward-open configuration have been solved 
(FIGURE 1.8C), and the NBDs are typically displaced far from one another, with the 
interfacial distance spanning up to 45 Å. In addition, structures of the outward-open and 
outward-occluded conformations of exporters have been solved, demonstrating, similarly 
to ABC importers and isolated NBD structures (Zaitseva, et al., 2005), an association of 
NBD monomers with bound nucleotides at their interface. These structures thus require a 
significant rotation of NBDs with a radical rearrangement of TM helices to promote such 
domain closure, which is triggered perhaps by substrate and subsequently ATP binding.  
 A key missing link was provided by three structures of the PglK lipid flippase from 
C. jejuni (Perez, et al., 2015). In addition to two structures of the homodimer PglK in the 
inward-open conformation, a third structure provided an unprecedented ADP-bound 
outward-occluded state. These structures showed engagement of the NBDs post-hydrolysis, 
and functional studies showed a full separation of the monomers, as expected based on 
inward-open crystal structures, was not required for transport. Combined with the AMP-
PNP-bound structure of the bacterial peptide exporter McjD (Choudhury, et al., 2014), 
these structures provide a pathway for substrate transfer to the extracellular/periplasmic 
surface not requiring a complete displacement of NBDs after each successful transport 
cycle, and form the basis of a three-state model that best represents the current 
understanding for exporter function (FIGURE 1.8C). In this model, futile ATP hydrolysis 
sets the transporter in the ADP-bound outward-occluded conformation. Substrate binding 
triggers exchange of ADP for ATP and results in the outward-open conformation, which 
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transfers the cargo through the cytoplasmic membrane (Dawson & Locher, 2006). 
Hydrolysis then resets the transporter to the outward-occluded conformation, pinching the 
substrate away from the transporter to complete delivery. Whether this model can 
accommodate large substrates, including peptides and large protein toxins such as HlyA 
(Olson & Gouaux, 2005), or simply small substrates such as lipids and hydrophobic drugs, 




1.9 ABC Importers Types I and II 
 ABC transporters are ancient and efficient pumps for their respective substrates, 
and given their ubiquity, likely segregated into functional types at an early stage of 
evolution (Saurin, Hofnung, & Dassa, 1999), and only diverged ever once in evolution. 
While eukaryotes contain only ABC exporters and prefer to use secondary active 
transporters for uptake, prokaryotes maintained both systems, and have developed an 
extensive and diverse system of binding protein-dependent importers.  
 Structures for nine different bacterial importers have been solved, including a few 
in multiple conformations. These include the most detailed structural and functional 
characterizations that have been performed for any transport system: studies of the E. coli 
vitamin B12 and maltose transporters, which have provided tremendous insight into the 
current understanding of all ABC transporters. Structures of these and other import systems 
revealed a divergence of importers, which remains a point of investigation, based primarily 
on the topology of TMDs and the mechanism of transport. We consider, compare, and 
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contrast the mechanisms of transport for both types in the next subsections, and briefly 




1.9.1 Type I ABC Importers: Symmetry versus Asymmetry 
Structurally characterized type I importers include the maltose transporter 
MalFGK2, the methionine transporter MetNI, the molybdate transporters ModBC, the 
amino acid transporter ArtN2Q2, and the alginate transporter AlgM1M2SS (TABLE 1.3), 
all prokaryotic (FIGURE 1.9A). In general, these type I importers contain fewer TM 
helices (5-8) than type II importers, and include TMDs which are heterodimers (such as 
the maltose transporter TMDs MalF and MalG, with 8 and 6 TM helices, respectively). 
Comparison of type I TMDs reveal a core of four TM helices that share a common topology 
(Rice, Park, & Pinkett, 2014). Biochemical studies have shown these transportes show little 
basal hydrolysis activity and are maximally stimulated in the presence of their respective 
substrate-binding proteins (Davidson, Shuman, & Nikaido, 1992). In addition, all type I 
importer structures with the exception of ArtN2Q2 and A. fulgidus ModBC contain 
additional regulatory domains (RDs) attached to their respective NBDs. The RD, composed 
of two beta-sandwich motifs, modulates the transporter by binding the transported substrate, 
thus inactivating hydrolysis and subsequently shutting off transport. 
 In general, importers, like all other transporters, fulfil transport by the alternating 
access mechanism. As in exporters, this alternating access is sensitive to the presence of 
substrate and nucleotide. Transmembrane signaling is accomplished through the coupling 
helices, which for importers consist of a single cytoplasmic loop of the TMDs (typically 
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between TM4 and TM5 for type I importers, and TM6 and TM7 for type II importers). 
Structures of the maltose transporter have provided the physical basis for alternating access 
in type I importers (FIGURE 1.9B). Maltose-loaded maltose-binding protein initiates the 
transport process by docking onto the nucleotide-free resting-state conformation of the 
transporter MalFGK2 (J. Chen, 2013; Khare, et al. 2009; Davidson, Shuman and Nikaido, 
1992). This promotes a closure of the NBDs and a pinching on the cytoplasmic side of the 
TMDs via rigid-body rotations, although the periplasmic gate remains closed (Oldham & 
Chen, 2011). ATP-binding subsequently induces domain closure between the two subunits 
of MalK (Orelle, Ayvaz, Everly, Klug, & Davidson, 2008), which then promotes the 
outward-facing state, MBP opening, and release of maltose to the TM binding site in MalF 
(Oldham, Chen, & Chen, 2013). ATP is then
  
37 
 Figure 1-9: ABC importers type I structure and mechanism. (A) Representative structures 
of type I ABC importers (left to right): Outward-facing maltose transporter (MalFGK2) in 
complex with MBP-maltose and bound ATP (PDB ID: 2R6G); Inward-facing methionine 
transporter (MetN2I2) with bouth Met in RD (PDB ID: 3DHW); Inward-facing substrate-
free molybdate transporter (ModB2C2) in complex with ModA (PDB ID: 2ONK); Inward-
facing ATP-bound structure of arginine/glutamine transporter (ArtN2Q2) with bound 
arginine in TMD cleft (PDB ID: 4YMU). (B) Type I importer mechanism based on maltose 
transporter structures (left to right): resting-state substrate-free MalFGK2 (PDB ID: 36F6) 
accepts maltose-loaded MBP (1) and transitions to occluded pre-translocation state (PDB 
ID: 3PV0); Docked maltose-bound MBP promotes ATP binding and hydrolysis (2) and 
transitions transporter to outward-facing conformation (PDB ID: 3RLF). Maltose is bound 
in transient site in MalF. Post-hydrolysis state (no structure) results in MBP release and 
transition to inward-facing conformation, leading to maltose uptake. 
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hydrolyzed, reverting the transporter to the inward-state, destabilizing MBP-MalFG 
interactions and thus delivering maltose to the cytoplasm (Bohm, et al., 2013). This 
mechanism has been confirmed by the nucleotide-free resting-state structures of MetNI 
and ArtN2Q2 and SBP-bound structures of ModABC (A fuldigus) and AlgM1M2SS, as well 
as mechanistic studies showing SBP-induced ATPase activity. Finally, the structural basis 
of inactivation by RDs was demonstrated by the tungstate-bound structure of ModBC 
(Gerber, et al., 2008), which showed an unusually large separation of coupling helices upon 
substrate binding to the regulatory domain. A structure of the maltose transporter bound 
with two molecules EIIAglu protein demonstrated an additional means of allosteric 
regulation for this protein family, although this mechanism may yet prove to be more 
universal. 
 A prevailing theme of the type I importer structures, in addition to the significant 
conformational changes, is symmetry: homodimers of NBDs and (generally) TMDs show 
identical rearrangements during alternating access and the SBPs of these transporters 
belong to Clusters B and F, which contain flexible hinge regions. At the functional level, 
the hydrolysis of ATP at both binding sites is typically required for transport (Davidson & 
Sharma, 1997), although measurements for the stoichiometry of ATP:substrate have not 
consistently shown a 2:1 dependence per transport cycle (Procko, et al., 2009). However, 
asymmetry in these proteins is also apparent: MalFGK2 contains only a single TMD 
maltose-binding site (Oldham, et al., 2013), and recent EPR experiments demonstrate MBP 
dissociates in an asymmetric manner (Bohm, et al., 2013). This leaves open a significant 
question: if both the SBP and substrate interact with the transporter asymmetrically, how 
is ATP hydrolyzed in a equivalent manner and how are symmetric NBD structural changes 
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communicated in an asymmetric way? Future detailed studies of other type I importers may 




1.9.2 Type II ABC Importers: Subtle Movements and Complex Issues 
 Structural evidence for type II ABC importers is more limited; three structures of 
intact importers have been solved (FIGURE 1.10A), and only one – the vitamin B12 
transporter – in multiple conformations and complexed with its cognate binding protein. 
However, all three structures have revealed a conserved TMD fold: ten transmembrane 
helices per monomer and homodimers of the TMDs. In addition, the NBDs are typically 
homodimers and lack regulatory domains. These transporters were first described as 
“large”, alluding to the twenty total TM helices but also to the larger substrates of these 
transporters, such as vitamin B12 and heme. However, the latter descriptor has since been 
revised due to the discovery of type II small substrate transporters, such as the elucidation 
of HI1470/1471 as a molybdate importer (Tirado-Lee, et al., 2011) and several other 
putative type II transporters with small substrates. 
 Further revisions may accompany characterizations of other putative type II 
importers. Of significance is the strict accompaniment of Cluster A SBPs, which contain a 
rigid helical linker region, with type II importers. However, X-ray structures of putative 
type II importers, such as the arabinose transporter, which has a Cluster B SBP, can revise 
this model of exclusivity. As observed for type I importers, substrate specificity is defined 
by the SBP, and type II importers uptake a range of substrates with diverse chemistries 
(Rice, Park, & Pinkett, 2014). Despite the diversity, limited conformational changes upon 
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substrate binding have thus far been observed for Cluster A SBPs for both large and small 
substrates. 
 These subtle conformational changes are not limited to the SBPs and extend to the 
core of type II importers. X-ray structures of type II importers have revealed 
conformational changes are limited to TM helices 2, 3, 4, 5, 5a (a partial helix), and 10, 
and thus are predominantly intra-domain movements, in stark contrast with the inter-
domain rigid-body movements found in type I importers. These helices combine to control 
access to a central translocation channel formed at the interface of the two monomers. In 
the outward-facing BtuCD-F structure (Hvorup, et al., 2007), the cavity has a maximum 
diameter of 9 Å and an internal volume of 3400 Å3, which can accommodate vitamin B12 
with some steric hindrance. In comparison, the outward-facing SBP-free structure of 
HmuUV (Woo, et al., 2012), a heme importer, revealed a translocation pathway with a 
maximum diameter of 15 Å but an overall smaller internal volume of 1300 Å3, enough to 
contain the smaller substrate. Three gates, one periplasmic and two cytoplasmic, alternately 
control access of the cavity to deliver the substrate. No
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Figure 1-10: ABC importer type II structures and mechanism. (A) Representative 
structures of type II ABC importers (left to right): Outward-facing ATP-bound vitamin 
B12 transporter (BtuC2D2, PDB ID: 1L7V); Inward-facing substrate-free 
molybdate/tungstate transporter HI1470/1471 (ModB2C2, PDB ID: 2NQ2); Inward-facing 
substrate-free heme transporter (HmuU2V2, PDB ID: 4G1U). (B) Type II importer 
mechanism based on vitamin B12 importer structures (left to right): basal ATP hydrolysis 
results in ATP-bound outward-facing state of BtuCD (1L7V), which promotes binding of 
B12-bound BtuF to the core transporter (1) (PDB ID: 4FI3). Upon binding BtuF releases 
B12 and subsequent hydrolysis results in its dissociation (2), promoting the substrate-free 
inward-facing conformation (from HI1470/71, PDB ID: 2NQ2) and import of B12. In the 
absence of substrate in the periplasm (3), BtuF stably associates with the substrate-free 




 substrate binding nor clear binding sites have been observed in these regions, unlike type 
I importers. The structural differences between these type II importers also have subtle 
mechanistic consequences (FIGURE 1.10B). For the vitamin B12, transport is initiated by 
docking of the substrate-loaded binding protein, BtuF onto the outward-facing 
conformation of the BtuCD (Lewinson, et al., 2010). This conformation is set by the 
binding of ATP to BtuCD (Korkhov, et al., 2014), which opens cytoplasmic gate I and 
closes cytoplasmic gate II. In general, it appears type II importers have higher basal 
ATPase activity than type I importers, and do not show clear substrate-stimulated increases 
in rates of hydrolysis (Rice, et al., 2014). Docking of BtuF onto the transporter results in 
substrate release into the cavity and collapse of the periplasmic gate, as observed in the 
structure of the outward-occluded BtuCD-F (Korkhov, et al., 2012). The movement of 
periplasmic gating helices is more subtle for small substrate type II importers, both in 
detergents (Rice, et al., 2013) and native lipid bilayers (Rice, Harrison, et al., 2014). ATP 
is subsequently hydrolyzed, which results in dissociation of the the BtuD subunits, driving 
apart the coupling helices and the cytoplasmic gate II. This pulls the transporter into a 
symmetric inward-open conformation, visualized by the H. influenzae MolBC structure 
(Pinkett, et al., 2007), allowing the substrate to enter the cytoplasm. This is proposed to be 
a transient state, with the resting conformation a substrate- and ATP-free complex of 
BtuCD-F (Hvorup, et al., 2007) featuring asymmetric closure of the cytoplasmic gate to 
restrict access to the cytoplasm. In the small substrate transporters, the cytoplasmic gating 
is not apparent from structures and biophysical experiments. Given the substrate size 
differences, it is unsurprising that different uptake mechanisms have evolved. 
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 The nature of the substrate- and ATP-free complex of type II importers is of great 
interest. BtuCD-F form a stable and long-lived complex in vitro in the absence of vitamin 
B12 and nucleotide, and the interaction of BtuF with BtuCD is significantly destabilized by 
the presence of both (Lewinson, et al., 2010). It is proposed that the tripartite complex 
represents the resting state of the complex, and the availability of substrate awakens the 
transporter, prompting it to activity. Additionally, the NBDs of these complexes lack RDs 
found in type I importers or any other identified mechanism of post-translational 
modulation, and instead regulation is likely fulfilled at the transcriptional level (Rice, 
Harrison, et al., 2014; Chao, et al., 2005) by the transported substrate. Finally, the 
observation of asymmetric gating in the apo BtuCD-F structure is unexpected and, much 
like for type I importers, begets a still-unresolved questions: how is asymmetry achieved 




1.9.3 ECF Transporters: Type III ABC Importers? 
 Despite their discovery in the 1970s, ECF transporters were only recently classified 
as a third type of ABC importer (Rodionov, et al., 2009). Two intact structures of ECF 
transporters have now been solved, and several structures of their isolated substrate-
binding S-components have been determined. Studies of these components have identified 
proteins that are more modular in nature than other ABC importers. Multiple S-components 
interact with the same core ECF transporter, formed by a single TMD (EcfT) that interacts 
with dimers of NBDs (EcfA and EcfA’) in a similar fashion to other ABC transporters. 
Unlike the typical ABC transporter organization, coupling with the NBDs is accomplished 
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solely by the EcfT, which contains two long cytoplasmic helices that dock into the Q-loops 
of the NBDs (FIGURE 1.11A) by forming an X-shape.  
 The current transport model is based entirely on two ECF transporter X-ray 
structures and several isolated S-component structures. Most unexpectedly, structures of 
whole ECF transporters showed S-components lying parallel to the plane of the membrane, 
and substrate binding sites and NBDs unoccupied in both structures. In these structures, 
TM helices 1,2, and 6 of EcfS primarily contact the EcfT domain, fitting into a groove 
between the TM and cytoplasmic helices. Studies of isolated S-components suggested 
these proteins span membranes in a perpendicular orientation. These observations led to a 
hypothetical and unprecedented toppling transport mechanism (FIGURE 1.11B) 
(Slotboom, 2014), where the substrate-free S-component first binds the core transporter. 
ATP binding in the NBDs tilts the S-component perpendicular to the membrane, exposing 
the substrate binding site to the extracellular/periplasmic surface. The substrate binds the 
S-component and ATP is hydrolyzed by the NBDs, tilting the S-
  
45 
Figure 1-11: ECF transporter/ABC importer type III structures and mechanism. (A) 
Structures of ECF transporters (left to right): Inward-facing folate ECF transporter with 
bound S-component (PDB ID: 4HUQ); Inward-facing hydroxymethylpyridine ECF 
transporter with bound S-component (PDB ID: 4HZU); Unbound biotin S-component 
(PDB ID: 4DVE). (B) Mechanism of ECF transporters (left to right): Unbound outward-
facing structure of ECF transporter with substrate-specific S-component (speculative based 
on isolated S-component structures). Substrate binding (1) triggers unknown 
conformational changes, perhaps due to ATP binding and hydrolysis (2), resulting in 
toppling of S-component to deliver susbtrate (3). 
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component conformation back to the parallel orientation, wherein substrate is then 
delivered to the cytoplasm. This model is speculative, and the connection between 
hydrolysis and S-component conformation is currently unknown. Nevertheless, these 
transporters have a distinct architecture, reflecting the diversity of ABC transporter 




1.10 Outstanding Questions 
 The “Golden Age” of ABC transporter structure determination has yielded a wealth 
of information regarding their architecture and function while providing a glimpse at the 
tremendous diversity lying just below the surface of our current knowledge of these 
transporters. Despite these advances, the “mastodon-in-the-room” remains an elucidation 
of the link between hydrolysis and transport. How precisely is substrate binding sensed by 
the nucleotide-binding domains? How does hydrolysis in turn confer the structural changes 
that drive transport? How do energetics drive active substrate transport? Structural and 
functional studies have yielded nearly as many new questions as answers. 
 The diversity of ABC transporters may shed some light onto this quandry. Whether 
two or one ATP are hydrolyzed simultaneously or processively and the structural 
consequences of this process remain unclear, and biochemical studies of homodimeric 
transporters have yet to yield a unifying answer. Evidence of positive cooperativity for 
ATP binding exists in some (Davidson, Laghaeian, & Mannering, 1996), a 2:1 
ATP:substrate ratio has been measured in one during transport (Patzlaff, van der Heide, & 
Poolman, 2003), and still others have been engineered to transport with a single active site 
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without deleterious effects (Tal, Ovcharenko, & Lewinson, 2013). However, genetic 
studies have revealed a number of naturally-occurring ABC transporters that are formed 
from heterodimers of NBDs or contain non-equivalent NBDs on a single polypeptide. This 
non-equivalency arises from function-altering mutations present in one of two ATP-
binding sites and has been shown to have interesting functional and structural 
consequences. This will be discussed in more detail in the upcoming sections and chapters 
as the motivation for the current study. What is clear is that transport can be fulfilled for 
many ABC transporters by hydrolysis at a single active site. How this is understood and 
how these transporters fulfill their respective delivery functions will be explored by studies 




1.11 The Uptake and Processing of D-ribose, a Building Block for Life 
 In a publication over a half-century prior, it was found that the “penetration of 
ribose into cells requires a permease and that the formation of this permease depends on 
the presence of ribose in the medium” (Eggleston & Krebs, 1959). It was shown that cells 
could not ferment ribose unless they had been grown in the presence of ribose, providing 
the initial evidence for an inducible ribose transport system in E. coli. Selective permeation 
systems had recently begun to be characterized (Cohen & Monod, 1957), and evidence for 
ATP as the energizing mechanism for active transport was demonstrated several years later 
when it was found ribose uptake was sensitive to Mg2+ availability and could be inhibited 
by aresenate (Curtis, 1974). The proteins involved in uptake and processsing of ribose were 
later identified as gene products mapped to the 84th minute of the E. coli chromosome 
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(Lopilato, et al., 1984), and sequencing of this region revealed the existence of five genes, 
rbsDACBK, involved in the high-affinity uptake of this metabolite under the control of 
distally-located inducible repressor, rbsR (Groarke, et al., 1983; Bell, et al., 1986; Hope, et 
al., 1986; Mauzy & Hermodson, 1992).  
 Detailed biochemical studies have identified the function of each gene product and 
an overall pathway for uptake has been proposed (FIGURE 1.12). Ribose is captured in 
the periplasm by ribose-binding protein (RBP), or RbsB, with an apparent affinity of 0.3 
µM (Willis and Furlong 1974). RbsB is essential for the high-affinity uptake of D-ribose 
(Lopilato, et al., 1984) and plays a critical role in chemotaxis, coordinating the taxis 
towards ribose by interacting with inner-membrane receptor Trg (Binnie, et al., 1992). 
RbsC and RbsA form an inner membrane energy-transducing complex and combine with 
RbsB to form the intact ABC transporter for the import of ribose. Once inside the cell, 
ribose is phosphorylated by ribokinase, or RbsK, completing the first step in ribose 
utilization. Interestingly, from a survey of knock-outs, only rbsK was shown to be required 
for E. coli to utilize ribose as the sole carbon source (Hope, et al., 1986),
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Figure 1-12: The ribose import pathway. Ribose (brown) diffuses into the periplasmic 
space by an outer-membrane (OM) porin (blue), where it is captured by RbsB (green). 
RbsB-ribose docks onto the core ABC transport complex in the inner membrane (IM) 
formed by RbsC (red) and RbsA (orange). ATP is hydrolyzed by RbsA to drive active 
uptake of ribose, where it is converted between furanose and pyranose forms by RbsD and 
phosphorylated by RbsK. Ribose-5-phosphate is then shuttled to biosynthetic pathways, 




 suggesting the existence of alternative low-affinity uptake pathways. RbsD processes 
ribose and ribose-5-phosphate by catalyzing the conversion between the pyranose and 
furanose ring forms (Kim, et al., 2003), a process required for RbsK function, and appears 
to enhance the uptake of ribose when overexpressed (Oh, et al., 1999). Ribose-5-phosphate 
then proceeds into pathways leading to nucleotide and amino acid synthesis. 
 Genetic, biochemical, and structural studies in the Hermodson and Stauffacher labs 
at Purdue University have elucidated rbs operon regulation, the function of proteins 
involved in this pathway, and the protein-protein interactions that ultimately drive ribose 
uptake. These studies have primarily focused on the tripartite ABC transporter complex 
formed by RbsA, RbsB, and RbsC. In the next sections, we consider what has been learned 
about each protein individually, starting from the periplasm and working our way into the 




1.11.1 The Ribose-binding Protein, RbsB 
 RbsB is a member of the large family of SBPs previously discussed, and is 
structurally classified as a Cluster B binding protein with a flexible hinge domain 
consisting of three loops (Bjorkman, et al., 1994; Bjorkman & Mowbray, 1998). A 30º 
rotation of the hinge region snaps the N- and C-terminal lobes of RbsB together, trapping 
ribose in a Venus Flytrap-type manner. From this ribose-bound conformation, RbsB fulfills 
its biological role by interacting with its specific transport complex to uptake 
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Figure 1-13: Structure of ribose-binding protein (PDB ID: 1DRK). Ribose is bound in a 
cleft between the N- and C-terminal lobes. Mutations affecting ribose transport and 




ribose into the cytoplasm and participating in transmembrane signal transduction involved 
in the chemotactic response (Bjorkman, et al., 1994).  
RbsB is a 271-amino acid protein with an N-terminal localizing signal directing it 
to the periplasm post-translation, much like all other SBPs in gram-negative bacteria. 
Structures of its apo- and ribose-bound forms reveal a closure of 20 Å across the substrate-
binding cleft between the N- and C-terminal lobes. Like other SBPs of ABC importers, 
RbsB interacts stably with the transmembrane homodimers formed by RbsC. While no 
intact structures of the transport complex exist, functional residues of RbsB critical for 
substrate binding and transport have been mapped to its surface (Binnie, et al., 1992) 
(FIGURE 1.13), and mutation of any of these result in decreased or complete loss of 
transport function. These residues are mapped in general to its inferior surface and likely 
affect the ability of RbsB to interact with RbsC, although one has been shown to stabilize 
the open form of RbsB (Bjorkman & Mowbray, 1998). Interestingly, the mutations are 
disproportionately located on the N-terminal lobe; this suggests an asymmetry of 
interaction and function that will be discussed later. Many of the same residues critical for 
transport are also critical for chemotaxis, likely affecting interactions with the chemotaxis 
receptor Trg. Two additional residues on the superior surface of RbsB are also critical for 
the chemotactic response. These positions are conserved for other SBPs with dual 
transport-chemotactic functions (Bjorkman, et al., 1994; Kondoh, Ball, & Adler, 1979).  
 Finally, as an excellent demonstration of the efficiency of evolution, RbsB is 
structurally related to the LacI-type rbs operon repressor, RbsR (Mauzy & Hermodson, 
1992). Homology modeling reveals a similar two-domain hinged binding region in RbsR 
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and an additional N-terminal DNA binding domain. Following ribose binding, RbsR 




1.11.2 The Transmembrane Domain, RbsC 
 While homology is evident for SBPs and NBDs, and can be used to infer a common 
functional mechanism for these components in ABC transporters, less is definitively 
known about TMDs. As has been discussed earlier, four separate folds of TMDs have been 
identified, revealing the majority of ABC transporters contain 5-10 TM helices per 
monomer. In addition, two types of importers have been identified, one containing 6 core 
TM helices and TM substrate-binding sites, with the other containing 10 helices and no 
obvious binding sites.  
 No structure of the 321-amino acid protein RbsC is currently available, although 
sequence-based analysis shows 21% identity with BtuC. Topological studies of RbsC, 
using cysteine-scanning mutagenesis, revealed a structural model with 10 TM helices 
(Stewart & Hermodson, 2003) (FIGURE 1.14). While RbsC was generally tolerant of 
cysteine mutations introduced by this technique, the few inactivating mutations mapped 
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Figure 1-14: Topology of RbsC. Cysteine-scanning mutagenesis predicts 10 TM segments 
per RbsC monomer. Regions of limited accessibility – likely TM helices, shown as red bars 
– are indicated as red bars with numerical labels for starting and ending amino acids. The 




nearly entirely to predicted periplasmic regions, suggesting the importance of RbsB-RbsC 
interactions for transport. 
In addition to identifying TM regions and potential sites of RbsB-RbsC interactions, 
the study also revealed the position of the coupling helix, based on the presence of the 
conserved EAA motif, as a cytoplasmic loop between TM helices 6 and 7. Much like the 
prediction of 10 TM helices, the location of the coupling helix also resembles the 
architecture of type II importers. No evidence of a ribose-binding site in the TMDs is 
readily apparent from analysis of the RbsC primary structure. 
 Finally, tests of the oligomeric state of isolated, detergent-solubilized RbsC using 
analytical ultracentrifugation demonstrate it also functions as a dimer, much like other 
ABC transporters (Clifton, et al., 2016). No changes in oligomeric state are apparent due 
to presence of ribose. These studies also suggest RbsC assembly and interactions in the 
intact transporter complex are canonical, although an in vivo study using RbsA-RbsC 




1.11.3 The Motor Domain, RbsA 
 RbsA is a 501-amino acid protein required for the high-affinity transport of ribose 
in E. coli. Analysis of its sequence identified it as ATP-binding cassette transporter NBD, 
based on the presence of the aforementioned conserved motifs (Walker A and B, ABC 
signature, etc.) albeit with an atypical organization (Buckel, et al., 1986). This primary 
structure analysis (FIGURE 1.15) showed homologous N- and C-terminal domains  
present in RbsA; thus, rbsA likely formed as a duplication of the primordial gene resulting 
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in a protein with fused NBDs connected by a short linker. This organization is uncommon 
for bacterial importers, but such end-to-end fusions of proteins gave rise to MDR 
transporters (Chen, et al., 1986), the aforementioned CFTR (Riordan, et al., 1989), and 
many other eukaryotic and bacterial exporters. However, as discussed in earlier sections, 
the former two proteins are formed from N-TMD-NBD-TMD-NBD-C fusions and typical 
exporters contain N-TMD-NBD-C and occasionally N-NBD-TMD-C fusions (Davidson, 
et al., 2008). RbsA, based on its sequence, and a few similar bacterial NBDs contain the 
rarely seen N-NBD-NBD-C arrangement. 
 A three-dimensional structure of the full-length RbsA protein is currently 
unavailable. The 2.5Å crystal structure of the 259-amino acid RbsA N-terminal NBD 
represented the first successful structural study of an ABC transporter (Armstrong, et al., 
1998) (FIGURE 1.16). This structure revealed the L-shaped NBD that is now considered 
typical for ABC proteins, with the mixed α/β RecA-like subdomain and the helical 
subdomain containing the conserved motifs that are hallmarks of this protein family. 
Interestingly, Mg2+ and ADP were found bound in the RecA-like subdomain, inidicating 
active hydrolysis, although no non-crystallographic symmetry or evidence of dimerization 
was evident from the crystal structure. A similar effort to obtain the crystal 
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Figure 1-15: Sequence alignment between the N and C terminal domains of RbsA.  
Sequences were aligned using ClustalW. Identical residues are shown in blue, highly 
similar in orange, and similar in green. Conserved sequences are boxed including the 
Walker A domain in black, the signature sequence in red, the Walker B in blue, and the 
conserved histidine in purple. Adapted from (Clifton, et al., 2016). 
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Figure 1-16: Crystal structure of RbsA N-terminal domain (residues 1-259), reported to 
2.5-angstrom resolution (Armstrong, Tabernero, Zhang, Hermodson, & Stauffacher, 1998). 
Conserved regions are color-coded and labeled. Structure includes bound ADP (yellow) 
and magnesium (black). RecA-like subdomain in cyan, helical subdomain in light blue. 
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structure of the C-terminal NBD proved unsuccessful and the structure of the full-length 
protein remains elusive. These efforts will be discussed in the fourth chapter. 
An analysis of the primary structure reveals an apparent non-equivalency of the 
NBDs. While both contain the conserved motifs that are typical of ABC family proteins, a 
clear asymmetry arises in the C-terminal NBD. The Q-loop, which contains a conserved 
glutamine (Q86 in the N-terminal NBD) that completes the active site, is substituted with 
a glutamate (E334) in the C-terminal NBD. The conserved lysine of the Walker A motif is 
replaced with arginine in the C-terminal NBD; while the chemical properties are similar, 
this may affect the geometry of the binding site. Most critically, the conserved switch 
histidine (H199 in the N-terminal NBD) has been substituted for a serine (S453) in the C-
terminal NBD. Mutagenesis studies of RbsA have demonstrated only a single active site 
of ATP hydrolysis is present, and that these mutants have interesting and varied functional 
consequences both in the context of substrate transport and bacterial chemotaxis 
(unpublished data from Hermodson and Stauffacher laboratories), providing direct 
evidence of signal transduction in the tripartite complex. These studies will be discussed 




1.11.4 Isolating and Characterizing the Intact RbsABC Transporter 
 Prior to crystallographic structural analysis of ABC transporters, biochemical 
studies, notably in vitro assembly experiments, provided the initial evidence for the 
arrangement of domains in intact transport complexes (Sharma, et al., 2005; Borths, et al., 
2005; Liu & Ames, 1998; Vigonsky, et al., 2013). These experiments have been performed 
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by overexpressing and isolating detergent-solubilized transporters, and varying the 
presence of nucleotides and substrates to determine which promote assembly of complexes. 
Critical to these studies has been the observation that orthovanadate (V3O4) inhibits the 
ATPase function by mimicking the “ADP+PO4” state and locking the NBDs in a bound 
conformation (Sharma & Davidson, 2000) so that they may be stably co-purified. Non-
hydrolyzable ATP analogs have also provided useful cofactors. These studies have also 
contributed to the understanding of type I and type II ABC importers: while the presence 
of nucleotides and substrates promotes complex formation in type I importers, it has a 
destabilizing effect on the assembly of components, notably the SBP, in type II importers. 
 Similar studies have also been performed on the ribose transporter and have 
observed a divergent phenotype [ (Clifton, et al., 2015), (Clifton, 2005) (FIGURE 1.17). 
In these studies, RbsA and RbsC have been overexpressed together on a single plasmid, 
while RbsB is expressed and purified separately. The RbsA-RbsC complex is purified by 
detergent extraction, using n-dodecyl-β-D-maltoside, in the presence of Mg2+, ATP or 
ADP, and orthovanadate. Addition of RbsB to the assembly mixture allowed purification 
of the intact complex, RbsABC, by utilizing a poly-histidine tag on any of the three 
components, typically RbsC. The RbsAC complex could be isolated as above without the 
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Figure 1-17: Complex assembly studies of the ribose transporter using affinity 
chromatography and his-tagged RbsC. Data shown is 15% SDS-PAGE of elution fractions 
from cofactor-varied assembly experiments. Lanes with numbered gel bands is molecular 
weight marker, in kDa. Figure is adapated from (Clifton, et al., 2015). (A) Lane 1 – purified 
RbsA; 2 – Purified RbsB; 3 – purified RbsC; 4 – RbsAC with Mg-ATP-VO4; 5 – RbsABC 
with Mg-ATP-VO4; 6 – RbsABC with no cofactors (only RbsBC co-elute); 7 – MW 
marker. (B) RbsAC with Mg-ADP and MW marker. (C) RbsABC with ribose along as 
cofactor (only RbsC elutes) and MW marker. 
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addition of RbsB or using Mg2+ and ADP as the cofactor combination. In the absence of 
cofactors, the previously unobserved SBP-TMD complex of RbsB-RbsC could be isolated. 
The requirement of nucleotide for the isolation of the TMD-NBD complex had not 
previously been observed as these components had typically been shown to assemble and 
co-elute without addition of cofactors in similar transporters, and suggested a weak 
interaction between RbsA and RbsC. This was the first evidence of atypical behavior in 
the ribose transporter. 
 When these experiments were repeated in the presence of the transported substrate, 
ribose, a destabilization between the RbsB and RbsC complex was observed. Thus, when 
ribose was added in the presence of nucleotide, only the RbsAC complex could be isolated. 
In the absence of nucleotides and the presence of ribose, only his-tagged RbsC could be 
isolated by affinity purifcation. Unlike the atypical behavior of the RbsA-RbsC complex, 
this substrate-induced destabilization resembled observations of type II importers. Further, 
it was demonstrated that binding of RbsB to RbsC resulted in substrate release (Simon, 
2011). Combined with the observation that RbsC contains 10 TM helices per monomer, 
this initially led to the characterization that RbsABC was perhaps a poorly-behaved type II 
importer. 
 However, other lines of evidence clashed with this observation. SBPs cluster along 
clear lines with their cognate transporters: type I importers utilize clusters of SBPs with 
flexible hinges, marking more significant conformational changes, while type II importers 
interact with SBPs with rigid hinges, in line with the more limited conformational changes 
observed in their structures. RbsB is a cluster B SBP with a flexible hinge, and structures 
of its closed and open forms support the notion of significant conformational changes upon 
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ribose binding (Bjorkman & Mowbray, 1998). EPR experiments, utilizing the placement 
of spin probes opposite one another in both the N- and C-terminal lobes of RbsB, 
demonstrate the same conformational changes are observed during the function of the 
intact transporter (FIGURE 1.18; (Erramilli, et al., 2016); Simon, 2011). In these 
experiments, distance measurements between the spin probes revealed a RbsB lobe 
opening of over 20 Å in the vanadate-trapped RbsABC state, while in the RbsBC state the 
lobe-separation was less than 8 Å. Further, previous results demonstrated a RbsB- and 
ribose-stimulated increase in ATPase activity in RbsA (Clifton, et al., 2015).This provided 
a pathway for ATP-dependent substrate transport in the manner of type I ABC importers. 
 The evidence thus far suggests a mechanism of ribose transport by a hybrid type I-
type II approach, with RbsB releasing substrate upon docking to RbsC, and subsequent 
hydrolysis in RbsA accelerating the dissociation of RbB from the core transporter 
(FIGURE 1.19). Following hydrolysis, it appears RbsA then dissociates from RbsC, 
although this observation may not be biologically relevant given cellular concentrations of 
ATP and magnesium (typically 1-10 mM). However, not all evidence supports this 
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Figure 1-18: EPR spectra of doubly labeled RbsB. (A) Apo (green, PDB ID: 1BA2) and 
ribose-bound (blue, 2DR1) structures of RbsB with N41 and I132 represented as color-
coordinated spheres in apo and ribose-bound forms. Bound ribose represented as red 
spheres. (B) EPR spectra of spin-labeled N41C/I132C RbsB in: cofactor free conditions 
with RbsC (black) and RbsAC (green); vanadate-trapped conditions with RbsAC (red); 
trapped with non-hydrolyzable ATP analog (blue); Mg2+ and ADP with RbsAC (gold). 
All cofactors used at 1 mM. All spectra are background-subtracted and amplitude 




Figure 1-19: Proposed model for ribose transport. (A) RbsB (green) captures ribose via an 
induced-fit mechanism. In the absence of substrate, RbsA (orange) is dissociated from 
RbsC (red). (B) Ribose-loaded RbsB binds RbsC and samples multiple conformations 
based on EPR results, leading to ribose release. (C) Mg-ATP bound RbsA binds RbsBC, 
which promote hydrolysis, leading to the open conformation of RbsB and the outward 
facing state of the transport complex. (D) Post hydrolysis, the complex resets to an inward 
facing conformation, leading to the closed conformation of RbsB and subsequent release, 
allowing it to scavenge additional molecules of ribose. Adapted from (Erramilli, Simon, 
Clifton, & Stauffacher, 2016). 
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model, as substrate-induced rate increases and a clear RbsB lobe-opening upon hydrolysis 
provide a clear link between ATP utilization and substrate release from the binding protein. 
On balance, it appears RbsABC contains features typical of both canonical importer 




1.12 Outstanding Questions 
 While the current model provides some detail of the biochemistry and 
conformational changes related to transport, there remains the unanswered question of how 
a single functional active site contributes to this model. In importers characterized thus far, 
equivalent sites of hydrolysis lead to substrate uptake. An engineered version of the vitamin 
B12 transporter demonstrated that a single active site could fulfill transport in this system, 
while a similar approach could not do so for the maltose transporter. The current 
explanation for this discrepancy is that molecules required in trace quantities can be taken 
up by single-site hydrolysis, while those required in abundance require hydrolysis of both 
ATPs for efficient substrate accumulation. As it has been observed that E. coli can subsist 
on ribose as the sole carbon source, this model does not satisfactorily address the energetics 
of substrate transport for the ribose transporter. Addressing this question will thus lead to 
a broader understanding of ABC transporter function in a naturally-occurring system.  
 In chapter two of this thesis, we address whether RbsA binds one or two molecules 
of ATP. While it appears only one ATP is hydrolyzed in a given cycle, whether both are 
bound remains unclear. Studies of other transporters have provided an intriguing and 
relevant model, which will be discussed in detail in that section. In order to conduct this 
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study in a natural environment, the transporter has been reconstituted into nanodiscs, and 
this chapter explores the details of this process. 
 In chapter three, we explore the conformational changes in the full-length RbsA 
protein during transport. As different complexes have been identified, it has been inferred 
from cofactor combinations and the conformation of RbsB how different stages of the 
transport cycle can be structurally modeled. The conformation of RbsA can be then 
deduced from studies of other ABC transporters. However, as has been discussed, the 
arrangement of NBDs in RbsA is atypical and no study has thus far been undertaken to 
address the function of such a protein. Using homology modeling and EPR spectroscopy, 
we explore the conformational changes in both the active and inactive NBDs in the context 
of transporter function. The impact of catalytic mutations will also be explored in the 
context of conformational changes both in RbsA and in RbsB. 
 Three-dimensional structures of ribose transporter proteins, with the exception of 
RbsB and the N-terminal NBD of RbsA, remain elusive, despite extensive crystallization 
trials. These trials have been pursued in a variety of cofactor combinations and using 
complex-stabilizing mutations, which have shown to be successful in the crystallization of 
other ABC transporters. Details of these trials will be reported in chapter four. In addition, 
a new approach, utilizing synthetic antibodies from phage-display selection, has yielded 
potential crystallization chaperones. The rationale for this approach and the crystallization 
chaperones obtained and characterized thus-far will be reported. In addition, these synthetic 
antibodies have been shown to not just bind with high affinity, but to also be 
conformationally selective. We will discuss what these antibodies tell us about ribose 
transporter assembly and function.  
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 Finally, in chapter five we will conclude with an update of ABC transporter 
understanding by applying lessons learned from studies, including this one, of the ribose 
transporter and other asymmetric ABC transporters. 
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2.1: An Enduring Question: One or Two ATP? 
 The mechanism of ATP hydrolysis in ABC transporters is still unresolved. Elegant 
structural and functional studies have provided working models for the choreography of 
the transport mechanism, but gaps remain in our knowledge. Many of these missing details 
surrond the mechanics of ATP binding and hydrolysis, in particular how conformational 
changes in the NBDs drive changes in the TMDs and how these ultimately lead to substrate 
transport. 
 An enduring question is whether one or two ATP are hydrolyzed per transport cycle, 
one that remains unanswered despite a surplus of biochemical data from a variety of ABC 
systems (Patzlaff, van der Heide, & Poolman, 2003; Sharma & Davidson, 2000; Lewinson, 
Lee, Locher, & Rees, 2010). This can in part be ascribed to the difficulty of making such 
measurements, including the amount of substrate transported and the amount of ATP 
hydrolyzed per transport cycle due to basal ATP hydrolysis. Still, at the heart of this answer 
lie the mechanics of the transport process and our fundamental understanding of how the 
transporter interacts with the transported substrate.  
 In general, the core transporter consists of NBD sandwich dimers, which bind ATP 
at their interface, and TMD dimers, which form substrate translocation pathways. Prior to 
the availability of crystal structures, biochemical studies of exporters provided the basis 
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for a transport model derived from Jardetzky’s predictions for transmembrane transporters. 
This model was known as the twin-cylinder model, and posited that each hydrolysis event 
contributed to the transport of one substrate molecule (Jones & George, 2012). In this 
model, the transport pathway consists of high- and low-affinity substrate binding sites in 
the TMDs, with each TMD contributing one such pathway. Substrate accessibility to the 
high-affinity site is thus coupled to an inward-facing ATP-bound state of the transporters. 
Upon binding of a substrate molecule to the high-affinity site, hydrolysis occurs at one 
NBD site, resulting in conformational changes that rearrange the TMDs and flip the 
substrate to a low-affinity site, completing transport. A second substrate molecule can then 
be transported using the second ATP and translocation pathway, before the entire 
transporter is reset to an inward-facing state by an exchange of ATP for ADP/Pi.  
 While this model is generated for exporters, a similar model can be readily 
imagined for importers. Here, the ATP-bound state sets the transporter in an outward-
facing configuration, primed to receive substrate-loaded SBP. Upon docking of the SBP, 
the substrate is released to a transient substrate-binding site in the TMDs and signal 
transduction events lead to ATP hydrolysis at one site. This results in rearrangements of 
the TMDs such that the substrate is flipped to a low-affinity site in the ADP-bound inward-
facing state of the transporter and subsequently imported. Protein-protein interactions on 
the outside are destabilized, leading to SBP release. The process then resumes with a 
second substrate-loaded SBP docking onto the transporter.  
 While this model readily accommodates the “one ATP per substrate” concept, it is 
in conflict with crystallographic evidence that has become available since its development. 
For both importers and exporters, the balance of evidence suggests that TMD substrate-
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binding sites, when present, are limited to one per TMD dimer. The NBDs appear to act in 
an equivalent manner, as demonstrated both by nucleotide occupancy of NBDs in intact 
transporter crystal structures (ter Beek, Guskov, & Slotboom, 2014) and by biophysical 
studies of protein conformational changes (Orelle, et al., 2010). A two-state model is 
readily apparent, with an ATP-bound closed-NBD dimer state and an ADP/Pi-bound open-
NBD dimer state. NBD dimerization induces changes in TMD gating to allow substrate 
access to the translocation pathway. Sequential hydrolysis then drives conformational 
changes in the TMDs to facilitate substrate transport by a dissociation of NBDs, which then 
resets the transporter for the upcoming cycle, much like an on/off switch. Hence, this is 
popularly known as the ATP Switch model (Linton & Higgins, 2007) and provides the 
basis for a “2 ATP per substrate” transport cycle (FIGURE 2-1A). 
 These seemingly clear-cut observations have been challenged by molecular 
dynamics simulations of ABC transporters, guided by high-resolution crystal structures 
solved in multiple states (Wen & Tajkhorshid, 2010). These simulations demonstrate a
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Figure 2-1: Switch versus Constant Contact Models. A) The Switch Model for ATP 
hydrolysis. ATP are bound cooperatively and hydrolyzed processively to complete a 
catalytic cycle. Two ATP are hydrolyzed per transport cycle. B) The Constant Contact 
Model. ATP are hydrolyzed one at a time and exchanged for ADP, with helical domains 
rotating away to facilitate exchange. The NBDs remain in contact during the catalytic cycle, 
and the model leaves open the possibility for one ATP hydrolyzed per transport cycle.
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dissociation of NBDs after each hydrolysis event, allowing for an asymmetric substrate 
translocation process that is not readily apparent from most crystal structures and ensemble 
data from biophysical studies. Alternatively, each site might hydrolyze ATP processively 
to fully complete a single trnalocation event. From these studies, a second model for NBD 
function, termed the “Constant Contact Model”, has been proposed (FIGURE 2-1B). In 
this model, ATPs are hydrolyzed processively, as in the Switch Model, but a complete 
dissociation of NBDs is never observed. Instead, partial disengagement of the first 
hydrolysis site allows release of products, which are exchanged for ATP while hydrolysis 
occurs in the second site. The partial disengagement drives changes in the TMD gating 
regions, allowing for substrate transport. In addition to MD simulations, the rapid exchange 
and occupancy of each site rationalizes biochemical affinity measurements for ATP with 
cellular ATP concentrations, which are an order of magnitude or more in excess. In this 
view, crystal structures of apo forms of the transporters can be thought of as non-
physiologic states.  
 While this model is appealing, particularly for exporters, it remains incongruent 
with experimental evidence. However, recent crystal structures of an unusual 
heterodimeric exporter provide compelling visual evidence for a Constant Contact-type 
translocation pathway. We will discuss this in the next section, and how this model applies 








2.2 The Archaeal Exporter, TM287/288 
 Until recently, all crystal structures solved of ABC transporters contained fully 
equivalent nucleotide-binding sites – all formed from homodimers of NBDs. These 
included exporter TMD-NBD homodimers and importer NBD-NBD homodimers that 
assembled with TMDS to form intact transporters. As expected, these nucleotide-binding 
sites behaved as pairs, all either occupied or unoccupied by nucleotides, and always both 
with the same nucleotides bound (either ATP, ADP, or some non-hydrolyzable analog). As 
described earlier, biophysical studies demonstrated a functional equivalency of the two 
sites. 
 In 2012, an AMP-PNP bound crystal structure of a heterodimeric archaeal ABC 
exporter was determined at high-resolution and produced an unexpected result (Hohl, 
Briand, Grutter, & Seeger, 2012). The drug transporter is formed by heterodimers of TMD-
NBD fusion proteins, as is typical for exporters, known as TM287 and TM288. Sequence-
based analyses of the heterodimers revealed degeneracy in the nucleotide-binding sites, 
with substitutions present for the catalytic glutamate (aspartic acid) and the switch histidine 
(glutamine) in the NBD of TM287. These mutations implied reduced or abolished activity 
of this NBD, as is the case for several human ABC transporters, including the 
aforementioned CFTR, the peptide transloctor TAP1/TAP2, and the ion channel regulator 
SUR1. Similar mutations impair the function of the C-terminal NBD of the ribose 
transporter ATPase subunit, RbsA, most notably a serine substitution for the switch 
histidine. Unexpectedly, the crystal structure revealed the degenerate site occupied by 
AMP-PNP and the consensus site unoccupied with partial disengagement of the NBDs 
where the nucleotide was absent (FIGURE 2-2). Biochemical analyses revealed the 
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degenerate site bound nucleotide preferentially. This suggested the bound AMP-PNP 
stabilized the interactions of the degenerate site, replacing some of the interactions 
normally provided by the Q-loop and switch histidine. In addition, the D-loop, which 
stabilizes the closed state of NBDs by contacting with the opposing D-loop, contained an 
unusual SNVD sequence (consensus: SALD), with the asparagine located within hydrogen 
bonding distance of the AMP-PNP γ-phosphate. This analysis was supported by studies of 
TM287/288 conformational changes, which demonstrated that the NBD1 D-loop and 
catalytic residues experienced significant motion during hydrolysis while NBD2 was 
restricted (Hohl, et al., 2014). This provided the structural basis for allosteric cooperativity 
in the consensus site and a transport model where conformational changes across the intact 
half of the protein drove substrate export (FIGURE 2-3). The unusual mechanism then 
suggested the possibility that the constant contact model could be applied in certain cases, 
such as to heterodimeric exporters and atypical human ABC proteins such as CFTR and 
SUR1. Appealingly, this demonstrated structurally how hydrolysis of a single ATP could 
lead to transport. Whether this model can be universally applied remains to be determined 
and requires analysis of other and varied systems. Recent MD simulations of CFTR using 
a homology model based on TM287/288 found
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Figure 2-2: X-ray structure of AMP-PNP bound TM287-288 solved to 2.6 Å resolution. 
Bound AMP-PNP is colored orange. Grey bar represents schematic of cell membrane. 
AMP-PNP is bound at degenerate site (top, inset), and unoccupied consensus site (bottom, 
inset) demonstrates disengagement of NBD relative to occupied degenerate site. 
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Figure 2-3: Proposed transport and catalytic cycles for asymmetric TM287-288 exporter. 
Left: Following hydrolysis, partial disengagement of helical domain of NBD1 allows 
exchange of nucleotide. NBD2 remains bound with ATP and lacks, through naturally-
occurring mutations, the requisite catalytic residues. Right: Substrate (blue) docks onto 
binding cleft in inward-facing state. NBD1 is stimulated to bind ATP, resulting in 
engagement of binding interface and structural rearrangement of TMDs to outward-facing 
state, allowing transport of substrate. Subsequent ATP hydrolysis in NBD1 resets 
transporter to inward-facing state. 
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the asymmetric inward-open conformation of the latter could rationalize experimental 
evidence of CFTR gating with the proposed model (Corradi, Vergani, & Tieleman, 2015). 
These models may provide a guide for understanding common gating-defects in CFTR that 
cause its eponymous disease. Further studies of similar systems, particularly those from 
bacterial sources that are readily expressed and purified, can provide us more detailed 




2.3 The Curious Case of RbsA 
  Much like TM287-288, CFTR, and many other asymmetric eukaryotic ABC 
transporter NBDs, RbsA contains both consensus and degenerate nucleotide-binding sites. 
While a full-length three-dimensional structure for RbsA is not available, sequence-based 
analyses followed by biochemical studies have revealed its functional asymmetry. As 
described in the previous chapter (FIGURE 1-15), the RbsA primary structure contains 
several deviations in conserved domains from what are commonly thought of as canonical 
ABC protein sequences. In addition to the aforementioned deviations in the Q-loop and H-
loop of the C-terminal NBD (E334 and S453, respectively), several other variations exist. 
In the Walker A motif of the C-terminal domain, the conserved lysine and serine at the C-
terminus of the sequence are mutated to arginine and threonine, respectively. Whether 
these impact ATP binding is unclear and remains to-be-determined. In the N-terminal 
Signature Sequence, rather than the canonical LSGGQ, RbsA contains an LSIGDNQ 
sequence (LSGGNQ in the N-terminal domain). As this motif stabilizes the phosphate 
groups of ATP, primarily via hydrogen bonds formed by the conserved serine and 
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glutamate, it is unclear how these substitutions impact the binding of ATP. Finally, the 
conserved D-loop, which stabilizes interdomain interactions once ATP is bound, is 
peppered with mutations in both NBDs of RbsA. In the N-terminal NBD, the canonical 
SALD motif is instead DALT, while in the C-terminal NDB contains a more radical 
departure, RGVD. Since its primary role in catalysis is to stabilize, through hydrogen 
bonding, the catalytic glutamate from the Walker B motif, it is possible the D-loop is 
unaffected by these substitutions.  
 In addition to the analysis of primary structure, biochemical and in vivo studies of 
RbsA catalytic mutants have provided the most persuasive evidence for ribose transport 
via hydrolysis at a single active site. A summary of several of these mutations and their 
impact on activity, transport, and cell growth can be found in Table 2-1. A full list of 
mutations and strains produced for this project can be found in the APPENDIX. Of 
significance are the two mutations that have previously been shown to have the most 
dramatic impact on ATPase activity in similar ABC transporters. The initial structures of 
BtuCD were produced from crystallization of an inactivating and complex-stabilizing 
mutation of the conserved Walker B glutamate, required for the currently-accepted general 
base catalysis mechanism, to glutamine (E159Q in that system) (Locher, Lee, & Rees, 








Table 2-1: Impact of catalytic mutations on RbsABC complex assembly in the presence of 
the cofactors Mg-ATP-VO4, ATPase activity of the intact transporter, and ribose transport 
into vesicles. ATPase activity measured by NADH-coupled enzyme assay. Ribose uptake 
into vesicles measured using C-14 labeled ribose. 
 







wild-type - ABC 100 100 
K43R Walker A AC (some ABC) 0 10 
S44A Walker A BC 0 10 
Q86A Q-loop AC (some BC) 50 60 
E167Q Walker B ABC 0 0 
H199A H-loop ABC 0 0 




the success of this stabilization led to a similar effort employed to produce the first well-
diffracting crystals and subsequent structure of the maltose transporter (Oldham, et al., 
2007). In addition to the critical glutamate, mutation of the switch histidine, which 
coordinates and positions the ATP γ-phosphate, has also been shown to impact function. 
Structures of the hemolysin transporter HlyB NBDs complexed with ATP were achieved 
by an inactivating mutation of this histidine (H662A) (Zaitseva, et al., 2005). 
 Since single mutations in a fused NBD could theoretically produce an active 
ATPase if both sites were functional, it was tested whether these RbsA mutants retained 
any functionality, both in the context of hydrolysis and transport. Further, the impact of 
these mutations on E. coli growth using ribose as a carbon source was tested in strains that 
lacked wild-type RbsA. ATPase activity was measured by a phosphate-based detection 
method (Baykov, et al., 1988) and transport was assayed by accumulation of C-14 
radiolabeled ribose in vesicles containing RbsAC, with RbsB and ribose added outside. 
The E167Q (the N-terminal positions of the aforementioned catalytic residues) mutation 
abolished nearly 100% of ATPase activity compared with the wild-type when measured by 
this method and no ribose accumulation could be detected in vesicles. Transformation of 
the mutation-carrying plasmids into cell lines lacking endogenous RbsA resulted in 
phenotypes unresponsive to ribose availability as the sole carbon source, consistent with 
the ATPase and transport assays. Interestingly, while the H199A mutation severely 
impaired ATPase activity, both transport and cell responsiveness proceeded at detectable, 
albeit significantly reduced, levels. This may point to a more significant role for the 
catalytic glutamate via this mechanism or compensation for the absence of the switch 
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histidine by other residues. In either case, the data strongly support hydrolysis by a single 
active site in the intact RbsA protein. 
 What then, is the role of the second site? Does it provide allosteric cooperativity by 
binding ATP, much like the NBDs of TM287-288? Or is it a mere bystander, a useless and 
vestigial limb dragged on through the millenia by bacteria that have long learned to get by 
efficiently and effectively through more parsimonious means? In this chapter the role of 
the second site is explored by ATP-binding studies of the transporter in modular membrane 
bilayers known as nanodiscs. Reconstitution and characterization of the ribose transporter 





2.4 Nanodiscs: Membrane Modules for Functional Studies 
 A variety of membrane-based media exist for studies of membrane proteins in 
native environments. Their development is motivated by the inability of detergents, 
required for membrane protein extraction, purification, and solubilization, to faithfully 
replicate the native cell membrane. A significant aspect of membrane protein stability 
concerns the lateral pressure profiles of native lipid bilayers, as well as acyl chain length 
to provide a “hydrophobic match” to membrane-spanning helical segments (Cantor, 
Lateral pressure in cell membranes: a mechanism for modulation of protein function., 
1997). These properties are defined by the type and composition of cell membranes, and 
are subject to local fluctuations that can accommodate a diverse array of membrane 
proteins (Cantor, 1999). Screening detergents during purification can result in one or a 
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combination of two or more than produce a stable reconstitution; the choice is generally 
made through empirical characterization following extraction from native membranes 
during protein purification (Seddon, Curnow, & Booth, 2004). 
 Despite their usefulness, detergents are poor membrane mimetics, and have 
contributed to the significant lag of membrane protein structure determination progress 
compared with the field as a whole (Zhou & Cross, 2013). This problem will be addressed 
in greater detail in Chapter 4. In addition to the difficulties of solving membrane protein 
structures, the inability of detergents to faithfully stabilize membrane proteins also 
contributes to challenges for functional studies of these systems. A variety of methods have 
been developed to better replicate the membrane environment, including liposomes 
(Rigaud, et al., 1995), bicelles (Durr, et al., 2012), and, more recently nanodiscs. A 
nanodisc is a modular membrane bilayer surrounded by an engineered protein derived from 
the apolipoprotein A-1 scaffold proteins (Ritchie, et al., 2009) (FIGURE 2-4). The efficacy 
of nanodiscs in membrane protein functional studies is well-documented and widespread, 
including biochemical experiments of ABC 
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Figure 2-4: Nanodiscs are modular lipid bilayers enveloped by an amphipathic membrane 
scaffold protein that forms a belt around the hydrophobic segments. The size of the 
nanodisc is restrained by the length of the belt protein and the particle diameter can vary 




transporters (Alvarez, et al., 2010), and the technology has more recently been applied to 
modern structure determination techniques (Kim, et al., 2015). Unlike liposomes, they 
offer no orientation bias, although this may be considered a limitation for transport assays. 
Unlike bicelles, they do not require maintenance of high concentrations of lipids and 
detergents to preserve their integrity, and thus are most convenient for biochemical and 
biophysical studies where substrate accumulation is not the primary objective. 
 Nanodiscs are assembled spontaneously by the combination of the membrane 
scaffold protein (MSP), lipids, and the target membrane protein following removal of 
detergent. Each disk is formed by two copies of MSP encapsulating a circular bilayer to 
form a modular membrane system. Variants of MSP have been engineered to produce 
nanodiscs with diameters ranging from 9.6 to 17 nm. Lipid content can be varied as desired 
to find arrangements suitable to particular membrane proteins, adding to a range of 
customizations that are possible within the nanodisc framework. The number of copies of 
the target membrane too can be varied by altering the lipid:target ratio during nanodisc 
assembly, allowing for optimization in cases where one target protein per disc is desired. 
 Previously, a protocol for reconstitution of an ABC transporter, the maltose 
transporter, has been described (Alvarez, Orelle, & Davidson, 2010). In this study, 
nanodiscs of ~13 nm diameter were produced using soybean L-α-phosphatidylcholine 
(1,2-Diacyl-sn-glycero-3-phosphocholine) as the lipid medium and the MSP variant 
MSP1E3D1, which carries three additional helical segments than MSP1. In this chapter, a 
method to reconstitute the ribose transporter derived from this protocol is described. 
Nanodisc-reconstituted RbsABC was then utilized in biophysical experiments to 
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characterize the binding of fluorescent ATP substrates to the transporter. The background 




2.5 TNP-ATP as a Probe for Nucleotide Binding Sites 
 Trinitrophenyl-ATP (TNP-ATP) is a modified nucleotide analog carrying a 
fluorescent moiety on the ribose ring (FIGURE 2-5), allowing it to function as robust 
sensor for protein-nucleotide binding and enabling the determination of kinetic and 
equilibrium constants. TNP-nucleotides generally act as non-hydrolyzable nucleotide 
analogs that fluoresce weakly in solution and can bind proteins with generally higher 
affinity than natural nucleotides. The quantum yield of fluorescence increases greatly when 
bound to the more hydrophobic environment of a protein’s substrate binding site, making 
TNP-nucleotides sensitive probes for binding. These probes have been shown to have great 
utility for the determination of thermodynamic binding isotherms for a variety of systems, 
including kinases (Stewart, et al., 1998), F1-ATPases (Yamagata & Tainer, 2007), and 
recently ABC transporters (Bao & Duong, 2013). 
 In aqueous solutions, TNP-ATP demonstrates a single fluorescence emission 
maximum at 561 nm following excitation at 408 nm. This maximum is blue-shifted and 
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Figure 2-5: TNP-ATP carries the trinitrophenyl moiety on the ribose ring of ATP, resulting 
in a weakly fluorescent molecule with a maximum emission output of 561 nm. Adapated 
from manufacturer’s website (Jena Bioscience). 
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accompanied by a 75-fold increase in quantum yield when TNP-ATP is placed in an 
organic solvent; thus, the wavelengths of absorbance maximum of TNP-ATP depend 
strongly on solvent polarity. This property is exploited to gain information about the probe 
environment, notably by studying changes in absorption properties during binding and 
dissociation of TNP-ATP from nucleotide binding sites. 
 Here we utilize TNP-ATP to determine the binding properties of the ribose 
transporter NBD, RbsA. The data described above strongly suggest RbsA hydrolyzes ATP 
using only its single active site. However, whether a model of allosteric cooperativity can 
be applied to RbsA in a similar fashion as TM287-288 is unclear, and more information 
about the binding stoichiometry is required to draw such a conclusion. This information 
can then be exploited to refine the current transport model for RbsABC. Reconstitution of 
RbsABC into nanodiscs allows for the study of nucleotide binding in natural environments. 
The reconstitution experiments and subsequent binding and kinetic studies are described 




2.6 Methods and Materials 
 The expression, assembly, and purification of the various ribose transporter 
complexes and individual components have been previously described (Clifton, et al., 
2015;, Simon, 2011; Clifton, 2005; Barroga, et al., 1996; Binnie, et al., 1992) and these 
sources should be consulted as detailed references for these protocols. These protocols has 
been employed with slight variations throughout this study. These variations will be 
described when applicable, but the readers are referred elsewhere for complete details. 
  
89 
2.6.1 Expression and Purification of Ribose Transporter Complexes 
 The complexes were expressed as described (Clifton, et al., 2015) with slight 
modifications. Plasmids bearing RbsAC (pTATHC) or RbsC (pTCH-14) were transformed 
into BL21-AI (Invitrogen) cells and plated on LB media containing ampicillin (100 µg/mL 
final concentration). Colonies for expression were selected the following day and grown 
overnight in 10 mL LB liquid media supplemented with ampicillin. The overnight cultures 
were used the following morning to inoculate 1 L 2XYT media supplemented with 
ampicillin as above. Growth was monitored by spectrophotometer (Ultraspec 3100 pro) 
and cells were grown (37°C with shaking at 230 RPM) until an OD600 of 0.6, after which 
they were briefly cooled to 16°C. The cultures were induced with 0.01% arabinose 
(Narayanan, et al., 2011) and grown for 20 h post-induction (16°C with shaking at 200 
RPM). The cells were harvested the following morning by centrifugation (5000 RPM for 
10 min). Transport complexes were purified as described using the appropriate cofactor 
combinations (Clifton, et al., 2015). Following purification, imidazole was removed by 
overnight dialysis (Buffer A: 20 mM Tris, pH 8.0, 200 mM NaCl, 20% glycerol, 0.05% 
DDM, and appropriate cofactors) or by two rounds of buffer exchange using 10DG 
desalting columns (Bio-Rad). Vanadate-trapped RbsABC could be produced, by this 
method, to yields of 10-15 mg purified protein per liter of 2XYT cell culture. Expression 
was previously optimized by varying cell lines, induction conditions (optical density, time, 
and temperature) and inducer concentration [IPTG (100 µM – 1 mM) and arabinose (0.01 
– 0.1 %)] (FIGURE 2-6). Ribose transporter complexes were concentrated to 50 µM and 
stored at -20°C for long-term storage. 
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2.6.2 Expression and Purification of MSP 
 Membrane scaffold protein (MSP) variants MSP1D1 and MSPE3D1 were purified 
as previously described (Ritchie, et al., 2009) with slight modifications during the column 
washing procedure. These are described in Alvarez et al (2010). Following purification 
and dialysis, the poly-histidine tag was removed by overnight TEV protease digest using a 
1:100 TEV:MSP ratio in 20 mM Tris-HCl pH 8.0, 100 mM NaCl, 1 mM EDTA, and 2 mM 
2-mercaptoethanol. TEV protease was purified as described in the APPENDIX. Following 
digestion, EDTA was removed by dialysis into the same buffer lacking EDTA. The 
digested sample was then reversed purified as previously described (Alvarez, et al., 2010) 
using 10 mL of TALON cobalt affinity resin (Clontech). Samples were analyzed by SDS-
PAGE. Samples containing digested MSP were pooled, dialyzed into buffer (20 mM Tris-
HCl pH 8.0, 100 mM NaCl), and concentrated to approximately 100 µM, aliquoted and 
subsequently stored at -20°C for long-term storage. By this method, purified and digested 




2.6.3 Lipid Preparation for Nanodisc Assembly 
 Soy lipids were prepared as previously described (Alvarez, et al., 2010) with slight 
modifications. One-hundred mg of soy phosphatidylcholine (Sigma) were suspended in 8.5 
mL of buffer (50 mM Tris-HCl, pH 8.0) and sonicated on ice with 5-10 one-minute cycles 
(1 sec on/1 sec off), allowing solution to cool on ice in between cycles. Once the solution 
became clear and yellow, 1.5 mL of a 10% DDM solution was added, producing a mixed 
micelle solution containing final concentrations of 10 mM soy PC and 30 mM DDM, which 
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was subsequently used for nanodisc assembly. A separate lipid solution made from a 
mixture of chicken egg PC (Avanti) was prepared as previously described (Dominik & 
Kossiakoff, 2015), producing an identical mixed micelle solution containing 10 mM egg 




2.6.4 Nanodisc Assembly and Purification 
 Nanodiscs were assembled using a protocol adapted from those previously 
described (Alvarez, et al., 2010; Dominik & Kossiakoff, 2015; Ritchie, et al., 2009). Prior 
to reconstitution, Bio-beads (Bio-Rad) were activated by methanol followed by washing 
with copious amounts of water. A 50% Bio-beads suspension was made with water and 
could be stored for several months at 4°C. The requisite amount of beads was washed with 
buffer and then dried immediately prior to usage for assembly experiments. 
  Nanodisc preparation was optimized by varying the ratios of transporter:MSP and 
MSP:lipid, and the type of lipid used. In general, the experiments were designed to produce 
an excess of empty nanodiscs relative to transporter-incorporated discs. This ensured a 
maximum of one transporter per disc is produced. For initial experiments, ratios of 1:5, 1:8, 
and 1:10 transporter:MSP, and ratios of 1:50, 1:80, and 1:200 MSP:lipid were utilized. 
These were later optimized to 1:5:325 transporter:MSP:lipid, as will be discussed during 
the RESULTS section. 
 The amount of transporter added to the experiments was calculated to ensure the 
final glycerol concentration in the assembly mixture was less than 3% (Ritchie, et al., 2009). 
The assembly mixture was designed for a total volume of less than 1.5 mL. Larger volume 
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mixtures resulted in inefficient assembly of nanodiscs. Transporter was first combined with 
excess buffer (Buffer A, as above with appropriate cofactors but excluding glycerol) and 
incubated on ice for 10 minutes. The lipid solution was then added and the resulting mixture 
was incubated on ice an additional 20 minutes. MSP was added and, following a brief 
incubation on ice, the mixture was transferred to dried Bio-beads, triggering the assembly 
reaction. Reconstitution mixtures were incubated overnight at 4°C with agitation. 
 The following morning, the assembly mixture was removed from Bio-beads (the 
remaining beads were washed once with 0.5 mL of buffer and added to the assembly 
mixture) and transferred onto 2 mL of Ni-NTA resin (Qiagen) pre-equilibrated with buffer 
(Buffer A, as above with appropriate cofactors but lacking DDM). The suspension was 
placed on a rocker at  4°C and allowed to bind with shaking for approximately 1.5 hours. 
The suspension was then transferred to 14 mL PD-10 columns (Bio-Rad) and the resin was 
allowed to settle. Flow-through was collected and the column was washed with 10 column 
volumes (Buffer A with 25 mM imidazole, no DDM) and proteins were subsequently 
eluted with 6 column volumes (same buffer but with 250 mM imidazole). Fractions (2 mL 
each) were collected and analyzed by SDS-PAGE using 15% gels.  
 Fractions containing transporter-incorporated nanodiscs were pooled and dialyzed 
against Buffer A (no DDM), then concentrated for size-exclusion chromatography using a 
50 kDa MWCO centrifugal spin filter (Amicon). Prior to nanodisc injection, the column 
was calibrated by the injection of standards of 673, 158, 67, 44, and 18 kDa. The 
concentrated sample (~500 µL) was then injected onto a Superdex200 10/300 GL column 
(GE Healthcare) pre-equilibrated with 2 CVs of Buffer A with appropriate cofactors (no 
detergent and no glycerol) and run at 0.5 mL/min (maximum column pressure was 1.5 
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MPa). Fractions (1 mL) were collected in 1.5 mL Eppendorf tubes and peak fractions were 
analyzed by SDS-PAGE. Samples containing reconstituted nanodiscs were pooled, 
concentrated to 5-10 µM, and transferred to a storage buffer (as above with 20% glycerol) 




2.6.5 Activity Assays with Nanodiscs 
 ATPase activity of the transporter-incorporated nanodiscs was tested using an 
NADH-coupled enzyme assay utilizing pyruvate kinase (PK, Sigma) and lactate 
dehydrogenase (LDH, Sigma) as previously described [ (Alvarez, Orelle, & Davidson, 
2010), (Kiianitsa, Solinger, & Heyer, 2003)]. The assay utilizes a regeneration system: PK 
uses phosphoenolpyruvate (PEP) to convert ADP to ATP while also producing pyruvate, 
which is subsequently converted to lactate by LDH while oxidizing NADH to NAD. 
Following NADH oxidation by the decline of absorption at 340 nm allows the real-time 
monitoring of steady state ATP hydrolysis. As an added convenience, the assay is readily 
adaptable to a high-throughput, 96-well format.  
 Crude nanodiscs from Ni-NTA purifications were used for the activity assays. The 
concentration of nanodiscs was determined by Bradford or BCA assays, since ATP 
interfered with the direct measurements of protein absorbance. Cofactors used during 
purification were removed by overnight dialysis followed by several rounds of buffer 
exchange into Buffer A (minus cofactors). The concentration was re-evaluated following 
this procedure by the same methods. Typically, 1-3 ug of nanodisc-reconstituted RbsAC 
were added to the reaction solution (50 mM Tris-HCl, pH 7.5, 100 mM KCl, 10 mM MgCl2, 
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4 mM PEP, 0.3 mM NADH, 60 µg/ml PK, 32 µg/ml LDH, and the presence or absence of 
100 µM ribose and 5 µM RbsB). In addition, ATP was added in a series of concentrations 
from 0 – 500 µM, producing a typical total reaction volume of 200 µL. All reactions were 
performed at 37°C and in triplicate. Reactions were performed in 96-well UV-transparent 
plates (Corning) and measured using a microplate reader with temperature control and 
automated shaking (BioTek). The turnover of ATP was calculated as previously described, 
using the equation below (Kiianitsa, Solinger, & Heyer, 2003): 
 
Here, Kpath is the molar extinction coefficient of NADH at 340 nm and a given path length. 
Kinetic parameters were subsequently determined using the graphing software, Prism 




2.6.6 TNP-ATP Binding Assays 
 TNP-ATP binding assays were carried out as previously described (Stewart, 
VanBruggen, Ellefson, & Wolfe, 1998) with modifications for this particular system. Both 
wild-type RbsAC and the catalytic mutant transporter, RbsA(E167Q)C, were reconstituted 
into nanodiscs (as described above). The choice of the catalytic mutant was made to control 
for the possibility of hydrolysis of TNP-ATP. While it is generally assumed TNP-ATP is 
non-hydrolyzable, there are many published reports of non-hydrolyzable analogs that are 
actually “weakly hydrolyzable”, such as ATPγS (Jones & George, 2012). As a control, 
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RbsABC assembly experiments were performed using TNP-ATP instead of AMP-PNP as 
previously described (Clifton, et al., 2015).  
 Titrations were performed using RbsA, nanodisc-reconstituted RbsAC and 
RbsA(E167Q)C, and detergent-reconstituted RbsAC, all at three different protein 
concentrations. All experiments were performed in identical buffer conditions (25 mM 
Tris-HCl pH 7.5, 100 mM KCl, and 10 mM MgCl2). Additionally, in experiments 
involving transport complexes, RbsB was added at 5 µM final concentration. 
 Experiments were performed using a Jobin Yvon Fluoromax-3 fluorimeter 
(Horiba). Samples were incubated at room temperature and stirred constantly. Using a 
reaction volume of 2.5 mL and protein concentrations of 0.5, 1.0, and 2.0 µM, titrations of 
TNP-ATP (Molecular Probes) were performed over a range of concentrations, from 0.01 
to 5 µM. Control reactions without protein were also performed. TNP-ATP fluorescence 
was stimulated by an excitation wavelength of 403 nm with a pathlength of 2 nm. 
Fluorescence emission was monitored over a range of 480 – 650 nm using the same 
pathlength. Spectra were background corrected using the buffer-only titrations and protein-
only control measurements. The peak emission wavelength was chosen and normalized 
fluorescence at this wavelenght was plotted against substrate concentration for each protein 
concentration tested. Using a previously described method (Stewart, VanBruggen, Ellefson, 
& Wolfe, 1998), the amount of bound nucleotide per transporter molecule could be 




Every given normalized fluorescence point includes contributions from bound and 
unbound nucleotide. By measuring TNP-ATP fluorescence for a series of transporter 
concentrations, the amount of unbound nucleotide at each titration point could effectively 
be determined from the data series (Bujalowski & Klonowska, 1993). Thus the slope of a 
series of normalized fluorescence values could be determined and extrapolated to 





 The results of the nanodisc assembly, activity assays, and binding studies are 




2.7.1 Optimization of RbsAC Expression 
 To facilitate structural studies, a variety of expression conditions and cell lines were 
tested to optimize expression. These included typical expression cell lines, such as BL21-
DE3 and BL21-C43, and the less typically used cell line BL21-AI. Cells were grown in 
LB, 2XYT, and TB media, and allowed to grow to cell densities ranging from 0.6 – 2.5 
prior to induction. Cells were induced with either IPTG, at 0.1 – 1.0 mM final 
concentrations, arabinose, at 0.01-0.1% final concentrations, or a combination of IPTG and 
arabinose. A variety of induction temperatures were tested from 37°C to 16°C, with 
induction times ranging from 3 h to 20 h. A summary of several successful conditions can 
be found in FIGURE 2-6, judged by the final yield of RbsABC from 1 liter of cells. The 
highest yield was obtained using 0.01% arabinose to induce at cell densities of 0.6-1.0 
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followed by a 20 h induction at 16-18°C. Glycerol stocks were made and maintained for 




2.7.2 Purification and Removal of His-tag from MSP 
 MSP was purified as described above and the fractions from affinity 
chromatography were analyzed by SDS-PAGE (FIGURE 2-7A). Elution fractions were 
estimated to be over 80% pure. Fractions were pooled and digested overnight using a 1:100 
molar ratio of TEV protease. The digested sample was applied to 10 mL cobalt-charged 
TALON resin and reversed purified following 1.5-hours of incubation with rocking to 
allow binding to resin. Fractions were collected and analyzed by SDS-PAGE (FIGURE 2-
7B). Digested MSP samples could be found in the flow-through and wash fractions, and 
are over 90% pure based on SDS-PAGE analysis. A lack of MSP in the
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Figure 2-6: Improving ribose transporter expression. All conditions evaluated by yield of 
purified protein complex, RbsABC, of which RbsAC are co-expressed using a T7 promoter 
system. Purified RbsB is added separately in the presence of cofactors to form the intact 
transport complex. LB = Luria Broth, TB = Terrific Broth. A) 0.2 mM IPTG, 3 h induction 
at 37 deg in LB. B) 0.5 mM IPTG, 3 h induction at 37 deg in LB. C) 0.5 mM IPTG, 3 h 
induction at 37 deg in TB. D) 0.5 mM IPTG, 0.01% arabinose, 5 h induction at 25 deg in 
TB. E) 0.01% arabinose, 12 h induction at 25 deg. F) 0.01% arabinose, 20 h induction at 




Figure 2-7: SDS-PAGE of purification and his-tag cleavage of MSP1D1. A) MSP1D1 
purified from 1 L TB media by TALON affinity chromatography. FT = flow-through; W 
= wash; E = elution. Standards molecular-weight given in kDa. B) MSP1D1 reverse 
purified following overnight TEV protease cleavage. I = input mixture post reaction; FT = 




elution suggested the TEV protease digest was run to near completion. The MSP fractions 




2.7.3 Assembly of Ribose Transporter-Nanodiscs 
 Nanodiscs were assembled as described and initially purified by affinity 
chromatography. Fractions were collected and analyzed by SDS-PAGE (FIGURE 2-8). 
Fractions containg transporter-incorporated nanodiscs could be found in the elution due to 
the presence of a poly-histidine tag on RbsC. Visual inspection of the band intensity 
suggested the ratio of RbsC to MSP was 1:1, implying one molecule of transporter was 
reconstituted per nanodisc. Based on the intensity of RbsA and RbsC bands in the flow-
through and wash, the reconstitution was determined to be about 50% efficient. Efforts to 
improve the efficiency significantly were unsuccessful. The protocol could not be scaled 
to larger sample volumes, and was most efficient at 2 mL or less for the assembly mixture 
volume.  
 Based on SDS-PAGE analysis of affinity chromatography, the most successful 
reconstitution occurred using MSP1D1 to form nanodiscs. Nanodiscs made from 
MSPE3D1 were also analyzed by SDS-PAGE. The transporter bands were found to be 
more faint by comparison with 1D1 reconstitutions (data not shown). Elution fractions 
from MSP1D1 and E3D1 reconstitutions were pooled and concentrated to 500 µL or less 
samples volumes and subsequently injected into a Superdex200 10/300 GL gel-filtration
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Figure 2-8: SDS-PAGE of purification of nanodiscs using Ni-NTA affinity 
chromatography following assembly reaction. His-tag is on RbsC. Left to right: MW 
marker, flow-through (FT), wash (W), elution 1 (E1), and elution 2 (E2). Ribose transporter 
proteins and MSP are labeled. Bands are visualized by Coomassie staining. 
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column. Successful reconstitutions using MSP1D1 eluted in well-defined peaks 
approximately at 11.5 mL while empty nanodiscs from both 1D1 and E3D1 eluted at 12.5 
mL (FIGURE 2-9). Samples from E3D1 reconstitutions did not produce well-defined 
peaks and eluted in a diffuse manner, suggesting poor reconstitutions. Efforts to optimize 
reconstitutions using E3D1 failed. Sizes of RbsABC nanodiscs were estimated by 




2.7.4 ATPase Activity of RbsAC Nanodiscs 
 ATPase activity was evaluated by the NADH-coupled enzyme assay described 
above. Experiments were performed using a series of ATP concentrations and in triplicate 
using 200 µL reaction volumes in a 96-well plate. The oxidation of NADH was monitored 
and then used to calculate the rate of hydrolysis for each concentration using the equation 
above.  
 Reconstituted RbsAC demonstrated a significant RbsB- and substrate-stimulated 
rate of ATP hydrolysis (FIGURE 2-11, circles), calculated to be 420 ng ATP/min/mg 
RbsA. Hydrolysis in the absence of ribose and RbsB was limited (squares) and calculated 
to be 30 ng/min/mg RbsA. The activity for RbsA alone was too low to be measured by this 
method (data not shown). The data compare favorably to the rates measured in liposomes 
for RbsAC with RbsB and ribose added, suggesting a successful
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Figure 2-9: Gel filtration of RbsABC-reconstituted nanodiscs following affinity 
purification using Superdex200 10/300 GL column. SEC buffer: 20 mM Tris-HCl pH 7.5, 
200 mM NaCl, 1 mM Mg-ATP-VO4. Red curve – injection of empty MSP1D1 nanodiscs 
formed from 1:130 MSP:Lipid ratio. Blue curve – injection of RbsABC in MSP1D1 using 
1:5:325 RbsABC:MSP1D1:soyPC ratio. Orange curve – ratio of 1:5:400. Cyan curve – 
ratio of 1:5:600. All injections following purification of nanodiscs using affinity 
chromatography.




















Figure 2-10: Elution profile of RbsABC nanodiscs compared with gel-filtration standards 
(GE Healthcare). Molecular weight of ribose transporter in nanodiscs was estimated based 
upon the standard curve for thyroglobulin (670 kDa), aldolase (158 kDa), and albumin (67 
kDa). 
 






















Figure 2-11 (above): ATPase activity of ribose transporter reconstituted into MSP1D1 
nanodiscs. Hydrolysis was measured for 60 minutes at 2-minute intervals using an NADH-
coupled assay. Activity was determined from the rate of hydrolysis using a range of ATP 
concentrations given above. Activity of transporter with RbsB and ribose (circles) and 




Table 2-2 (below): Kinetic data for activity assays of RbsAC in nanodiscs in the presence 
and absence of RbsB and ribose, as described. All values given in nmoles ATP hydrolyzed 
per minute per mg transporter.  
 Vmax Vmax Error Km Km Error Replicates 
RbsAC + RbsB and ribose 114.7 6.35 26.71 5.77 4 
RbsAC 9.72 0.80 22.30 7.35 4 




































reconstitution. Previous experiments in detergent did not demonstrate a RbsB- and ribose-
stimulated rate of hydrolysis for RbsAC (data not shown). Kinetic constants for RbsAC in 
1D1 nanodiscs with and without RbsB and ribose are reported in Table 2-2. Similar 
constants in experiments previously performed in liposomes were not calculated (Clifton, 




2.7.5 Complex Formation Experiments with TNP-ATP 
 As a control to ensure binding and behavior as a non-hydrolyzable analog, TNP-
ATP was used as a substitute for AMP-PNP to repeat RbsAC complex formation 
experiments (Clifton, 2005). Due to cost, TNP-ATP was used at 100 µM concentrations 
rather than 1 mM as had previously been used. As before, magnesium chloride was added 
as a required cofactor for ATP binding.  
 SDS-PAGE analysis of the fractions (FIGURE 2-11) collected from affinity 
chromatography revealed the presence of both RbsA and RbsC in the elutions fractions, a 
signature for successful complex formation. The band intensity was judged to be roughly 
1:1 RbsA to RbsC, suggesting an efficient complex formation between the two proteins. 
This demonstrated both that RbsA bound TNP-ATP in an expected manner, but also 
promoted complex formation with RbsC, which carries the affinity tag for such 









2.7.6 Fluorescent Analog Binding Experiments with RbsA 
 Binding of TNP-ATP with RbsA was shown to promote a 1.5-2-fold increase in 
fluorescence intensity compared with measurements made in the absence of protein 
(FIGURE 2-12). Fluorescence intesity was measured over a 10-fold concentration range 
above and below the target protein concentrations. Each titration was performed at a fixed 
RbsA concentration. Background-corrected intensity values demonstrated saturation in the 
increase of fluorescence emission at higher substrate concentrations in the presence of 
protein. For each experiment, fluorescence intensity values were normalized to the 
maximum measured fluorescence emission for the particular replicate. 
 Titration data were collected in replicates for all three RbsA concentrations. 
Average intensity values were plotted against TNP-ATP concentrations for each protein 
concentration (FIGURE 2-13), revealing saturation kinetics for all three concentrations 
during the course of the experiment. These best-fit results provided the total binding and 
total fluorescent output, including unbound nucleotide.  
To remove contributions of unbound nucleotide, fluorescence measurements at 
each TNP-ATP concentration were compared for each protein concentration, and 
normalized intensity was plotted against nucleotide concentration for a given RbsA 
concentration. The slope of each line corresponded to the amount of nucleotide bound per 
RbsA molecule (FIGURE 2-14), as described in the experimental methods section and in
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Figure 2-12: Increase in fluorescence emission of TNP-ATP due to protein binding. 
Emission intensity following stimulation at 410 nm was monitored in buffer (blank, blue) 
and in the presence of protein (red). Increase in emission was also accompanied by a blue 
shift.




















Figure 2-13: Fluorescence-monitored titration of RbsA with TNP-ATP. Three different 
RbsA concentrations were tested (0.5, green; 1.0, red; and 2.0; blue; all values in 
micromolar). For each titration, the average fluorescence values were normalized with the 
highest measured intensity for that set. 





















Figure 2-14: For each measured intensity value, the total nucleotide concentration versus 
the protein concentration were plotted. The slopes of these lines were determined to 
calculate binding stoichiometry. Five different intensity values are shown here (0.1, circles; 
0.25, squares; 0.5, triangles; 0.75, inverted triangles; 0.9, diamonds). 























FIGURE 2-15: Relative fluorescence values versus TNP-ATP per RbsA molecule. Data 
are plotted over a range of values and fit using linear regression. Extrapolation of the data 
to saturation (normalized fluorescnence = 1) reveals a binding stoichiometry of 1.9. 



















the method by Bujalowski (1993). The average slope values were then plotted against 
normalized intensity values and extrapolated to saturation (Y=1, FIGURE 2-15).  These 
revealed an average binding stoichiometry of 1.9 TNP-ATP molecules per RbsA molecule. 
Binding isotherms were determined by non-linear regression using a two-site 
cooperative binding model and one-site binding model. Both the shape of the curves and 
the binding analysis suggest that both NBDs of RbsA do not contribute equally to the 
spectral changes and that the first site generates a greater change than the second. 
Macroscopic dissociation constants were determined for each site using the binding models. 
The first site Kd was calculated to be 0.035±0.019 mM with a Bmax of 0.502. The second 
site Kd was calculated to be 0.97±0.68 mM with a Bmax of 0.728. Neither value could be 





 This chapter described the reconstitution of the ribose transport complex into 
nanodiscs and subsequent validation efforts using activity assays. Subsequently, nanodiscs 
and isolated RbsA were used to assess the stoichiometry of ATP binding. This data filled 





2.8.1 Tools for Biophysical and Biochemical Analyses 
 The long-term goal of this study is to provide detailed structural information about 
an unusual ABC transporter and to use this information to improve our understanding of 
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this well-studied yet incompletely understood protein superfamily. This endeavor is greatly 
aided by improving yields of protein purifications and by utilizing modern technology for 
the study of membrane proteins in native environments.  
 This chapter described efforts to improve the yield of the ribose transporter RbsAC 
complex through optimization of expression conditions. This involved many variables to 
identify an optimum condition. The most suitable condition utilized the technique 
“restrained expression”, which takes advantage of the repressor-operator relationship to 
reduce the amount of target mRNA produced. This method has previously been shown to 
increase yields of both soluble and membrane-embedded proteins. For this system, the 
RbsAC complex could be produced at 10-15 mg of purified protein per L of 2XYT cell 
culture. This represented an increase of 10-15 times in yield from the IPTG-based method 
that had been used previously.  
 Nanodiscs have been shown to be a robust platform for the study of integral 
membrane proteins in vitro and can be optimized to successfully mimic the native 
environments of a variety of membrane proteins (Ritchie, et al., 2009). These modular 
membrane mimetics can be applied to biochemical and biophysical experiments, and have 
recently been adapted for use in Cryo-EM structure determination (Kim, et al., 2015). 
 Here it has been shown that RbsAC can be successfully reconstituted into nanodiscs 
formed from MSP1D1 and a soybean phosphotidylcholine lipid mixture, which form 
nanodiscs roughly 10 nm in diameter. Analysis of gel band intensity suggests the nanodiscs 
form with a ratio of 1 MSP to 1 RbsC molecule. In addition, RbsABC-reconstituted 
nanodiscs (formed in the presence of cofactors) elute at 11.5 mL on a Superdex200 10/300 
GL gel filtration column. Comparison of the elution volume with known standards suggests 
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a particle size in between 158 and 670 kDa in size. Empty nanodiscs eluted at 
approximately the same position as the 158 kDa standard. The molecular weight of the 
RbsABC complex has previously been determined to be roughly 150 kDa (Clifton, et al., 
2016). This would suggest a particle size of 300 – 330 kDa in size if one transporter is 
incorporated per nanodisc.  
 Although two transporters per nanodiscs would yield a size falling within the range 
provided by the molecular weight standards, this is unsupported by the intensity of bands 
in SDS-PAGE. However, estimating band ratios from such analysis is notoriously 
inaccurate, particularly for membrane proteins that cannot be adequately solubilized by 
SDS. Given this, the number of transporters per nanodisc is ambiguous and requires 
additional analysis. 
 NADH-coupled activity assays demonstrated conclusively that the integrity of the 
transmembrane domains is preserved in the nanodiscs. RbsAC nanodiscs showed a 
significant stimulation of activity in the presence of RbsB and ribose, a demonstration of 
signal transduction that is not achieved for this system in detergent reconstitution. The data 
compare favorably to results of the maltose transporter in nanodiscs, which also shows a 
binding protein- and substrate-stimulated increase in hydrolysis activity.  
 Finally, it is noteworthy that the smaller nanodiscs were the most accommodating 
for RbsC. Previously nanodiscs made from the larger MSPE3D1 had shown utility for 
several other ABC transporter systems. The larger, ~13 nm nanodiscs have been thought 
ideal for systems with 6-10 TM helices per monomer. The significance of this result in the 




2.8.2 Fluorescence Titrations Reveal 2 ATP binding sites in RbsA 
 The behavior of unusual ABC transporters has been sparsely studied, and the lack 
of detailed understanding of these has contributed to the overall insufficiency of the current 
global models. Currently, Type I and Type II ABC importer models have been derived 
from transporters with functionally equivalent NBDs. The implications for importers with 
non-equivalent sites remain largely unstudied. Yet, these systems may address basic 
questions about the energetics of transport and whether some organisms have exploited a 
potential efficiency for improved evolutionary fitness. This is largely speculation. 
 Fluorescence titration experiments described here reveal both NBDs of RbsA are 
able to bind ATP, albeit with non-equivalent capabilities. The results suggest a cooperative 
mode of binding, with the affinity of one site for ATP an order of magnitude higher than 
the other. Evidence of cooperativity is apprent in activity assays, which demonstrate an 
increased rate of hydrolysis as ATP concentrations increased. Both curves also carried the 
characteristic “S-shape” that is a signature for cooperativity. The non-equivalent binding 
could be a consequence of Walker A mutations, specifically the substitution of the 
conserved lysine for an arginine, which may retard the ability of that site to bind ATP. As 
the titrations proceeded to completion, both sites became saturated. Given cellular 
concentrations of ATP and the respective affinity constants of both sites, it is reasonable to 
expect that this result is physiological. 
 These results provide the basis for a model of the catalytic cycle of RbsA. The first 
site captures ATP, promoting closure of one NBD and an overall reduction in distance 
between both lobes of RbsA. This allows the second site to bind ATP efficiently, perhaps 
setting the transporter in the most efficient position for alternating access. ATP in one site 
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is subsequently hydrolyzed, alternating access occurs, and ribose is delivered to the 
cytoplasm. ADP is released from the consensus site, and the transporter is reset for the next 
transport process.  
 There, however, remains an unanswered question – which is the higher affinity site? 
Like TM287-288, does the degenerate site become readily saturated, allowing the 
consensus site to function optimally? Does the bound ATP replace some of the interactions 
lost by degeneracy? Of significance are mutations in the C-terminal Walker A and D-loop 
motifs, which direct both ATP binding and completion of the intact site.  
Or is binding at the second site an artifact of this experiment, and does it hang listlessly 
like a vestigial appendage during the hydrolysis cycle? No parallel is currently available 
for the ribose transporter, and the application of an exporter model to an importer is 
questionable. This question and many others cannot be resolved without a better 
understanding of the conformational changes of RbsA during transport. This is pursued in 
the next chapter, which describes EPR experiments for the study of conformational changes 
in the NBDs. 
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CHAPTER THREE: PROBING RBSA CONFORMATIONAL CHANGES  




3.1 The ABCs of ABC Transporters 
 All ABC transporters contain a basic functional unit comprised of two 
transmembrane domains (TMDs) and two cytoplasmic nucleotide-binding domains 
(NBDs). The cytosolic domains, also known as the ATP-binding cassette, have a conserved 
topology that has been observed ubiquitously from the X-ray structures of over 50 different 
NBDs (Haffke, et al., 2010).  
This topology consists of two distinct portions, as described earlier: a RecA-like 
subdomain and a helical subdomain. The RecA-like subdomain is formed from α-helices 
and typically two β-sheets, and contains several conserved motifs. These include the 
Walker A motif that interacts with the β- and γ-phosphates of ATP, the Walker B motif 
that contains the catalytic glutamate, the switch histidine (or H-loop), the D-loop, and the 
A-loop, which contains a conserved aromatic amino acid involved in π-stacking 
interactions with the adenine base of ATP.  
The helical subdomain consists of an α-helical bundle that is a signature for ABC 
transporter-type NBDs. Indeed, the ABC signature motif is located in this subdomain, part 
of a long α-helix that directs its helical dipole towards the γ-phosphate of ATP. The NBDs 
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of ABC transporters form sandwich dimers, where the RecA-like subdomain of one NBD 
binds ATP at its interface with the helical subdomain from the opposing NBD. In this 
manner, each NBD contributes half of a nucleotide binding site (NBS), each one 
complementing the other, and the typical ABC transporter forms two catalytically-
equivalent NBS (FIGURE 1-4).  
Recently the structural changes and ATP binding of heterodimeric NBDs with non-
equivalent NBS have been characterized. In these NBDs, catalytic residues at one 
nucleotide binding site impaired its function. For instance, the conserved glutamate is often 
an aspartate, and the switch histidine is typically a glutamine. This substitution pattern has 
been observed in clinically important ABC transporters, such as CFTR (Csanady, et al., 
2013), SUR1, TAP1/2 (Grossmann, et al., 2014), and several others. The mutations result 
in hydrolysis only at a single active site. 
The functional consequences of these substitutions have only begun to be 
understood and, as discussed earlier, have structurally only been characterized in a single 
intact system. The TM287-288 exporter studies showed the catalytic cycle typical for ABC 
transporters during substrate delivery was observed only in the consensus site, which solely 
contributed to alternating access of the transmembrane domains to complete transport 
(Hohl, et al., 2012; Hohl, et al., 2014). The degenerate site remained bound for the majority 
of cycles and rarely turned over (Bukowska, et al., 2015). A similar model has been 
developed for CFTR (Grossmann, et al., 2014).  
Can these same principles be applied to importers such as the ribose transporter? 
While alternating access is a general principle of ABC transporters, importers utilize signal 
transduction across membranes in a manner not required for exporters. This 
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transmembrane signalling links docking of the SBP with ATP binding and hydrolysis in 
the NBDs, which is then communicated to the SBP to promote dissociation. Further, the 
NBD-TMD interface of importers, linked by a single coupling helix from one TMD, is 
rather different than exporters, which utilize coupling helices from both TMDs to link 
hydrolysis with transport. We discuss in the next section what is known about importer 





3.2 Maltose Transporter NBD Dynamics 
 The maltose transporter remains the best studied ABC transporter, and detailed 
structural and functional analyses of this system have provided the general principles for 
ABC transporter conformational changes. These studies have revealed that maltose-
binding protein (MBP) initially docks onto the inward-facing transporter, and stimulates 
ATP binding by NBD domain closure. This closure involves a rotation of the helical 
subdomain towards its complementary RecA-like subdomain (Orelle, et al., 2010), and 
provides direct structural evidence for MBP-stimulated ATP hydrolysis observed for this 
system (Davidson, et al., 1996). While positive cooperativity is observed in this system for 
ATP hydrolysis, no evidence of asymmetric conformational changes has been found in X-
ray structures or from biophysical studies of protein dynamics. Similar subdomain rotations 
are observed in exporter NBDs, suggesting this is a global phenomenon (Dawson & Locher, 
2006). A possibility remains that ATP are hydrolyzed consequtively, a model that would 
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fit well with both cooperativity and the observed conformational changes driving 
alternating access. 
 However, an engineered MalK dimer with only a single active site showed severely 
impaired transport compared to wild-type transporter (Davidson & Sharma, 1997). While 
conformational changes were not studied for this system, no MBP-stimulated increase in 
hydrolysis rate was observed for this system, showing cooperativity between NBD subunits 
was required for transmembrane signalling to function like normal. Interestingly, a similar 
study with the vitamin B12 transporter demonstrated normal levels of substrate transport, 
although conformational changes were not probed (Tal, et al., 2013). The authors argued 
that molecules required in trace amounts, like vitamin B12, can be taken up without 
detriment by a transporter with a single active site. This assessment stands in contrast to 
empirical observations of RbsABC function, which drives normal E. coli growth on media 
with ribose as the sole carbon souce despite hydrolysis at a single consensus site of RbsA. 
Although not discussed in the paper, a second possibility is that hydrolysis of both 
ATP molecules is necessary to drive with efficiency the conformational changes required 
for MBP to release maltose. In contrast, BtuF is rigid and small rotations drive its substrate 
binding and release. Further, it has been demonstrated that docking of BtuF onto the 
transporter is sufficient to drive vitamin B12 release, and hydrolysis destabilizes its 
otherwise tight interactions with the TMD interface. The free energy of a single ATP 
hydrolysis may be sufficient to drive this release. 
 Could dynamics of NBD rotation be impacted by an impaired NBS? How are these 
structural changes then contributed to symmetric TMDs and a SBP with MBP-type 
conformational changes? These questions remain unanswered and require a more detailed 
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analysis of RbsA and RbsC. In this chapter, the conformational changes that occur in RbsA 
during its catalytic cycle will be probed using EPR spectroscopy and site-directed spin-
labeling. EPR spectroscopy has proven to have great utility in the study of ABC transporter 
function in solution state. A similar approach will be applied to this system to harness this 
powerful technique. Before discussing experimental methods, the theory of EPR 





3.3 Basic Theory of Electron Paramagnetic Resonance Spectroscopy and Spin Labeling 
 EPR spectroscopy has proven to be a robust structural biology technique (Klug & 
Feix, 2008). At first glance, its applications to the study of proteins would appear to be 
limited. EPR spectroscopy measures the absorption of microwave radiation by unpaired 
electrons, which are generally in limited supply as stable species in biological systems. 
Except for the relatively few proteins with certain transition metal prosthetic groups, few 
obvious examples of proteins with stable free radicals exist. However, advances in 
molecular biology techniques led to the development of spin traps colocalized to reactive 
labels that can recognize specific biological chemical moieties, typically thiol groups on 
cysteine residues in proteins (Columbus & Hubbell, 2002). These advances led to the full 
embrace of EPR spectroscopy as a structural biology tool, and have spurred the 




 Site-directed spin-labeling (SDSL) EPR spectroscopy involves the covalent 
attachment of a spin probe to the protein backbone. The most commonly used spin label is 
2,2,5,5-tetramethyl-1-oxyl-3-methyl methanethiosulfonate (FIGURE 3-1), a thiol-reactive 
nitroxide label that contains an unpaired electron primarily localized to the pz orbital of the 
14N. The spin label can be introduced to cysteines, allowing for a specific probe of the local 
environment that can follow conformational changes and protein dynamics. Ideally, these 
cysteines will be placed using molecular biology techniques at sites of interest, and thus 
the technique requires the mutation of native cysteines to unreactive side chains, such as 
serine, alanine, and methionine, or that the cysteines are rendered unreactive due to 
participation in disulfide bonds. 
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Figure 3-1: 2,2,5,5-tetramethyl-1-oxyl-3-methyl methanethiosulfonate (MTSL) spin label 




EPR spectroscopy measures the absorption of microwave radiation by unpaired electrons 
at specific resonance frequencies. Unpaired electrons exist in one of two spin states, either 
+1/2 or -1/2. In the absence of a magnetic field, no statistical preference exists for either 
state. Once an external magnetic field is applied to the sample, the spins separate into two 
well-defined low- (-1/2) and high-energy (+1/2) spin states, the relative amounts of each 
given by the Boltzmann distribution (Equation 3-1).  
 (Eq. 3-1) 
The distribution dictates that, at room temperature, the higher energy state has a 
slightly smaller population than the lower energy state (ratio of 0.998). This segregation of 
unpaired electrons into discrete energetic states due to the magnetic field is known as the 
Zeeman Interaction (Equation 3-2). The energy required (ΔE) for the transition between 
the two states is proportional to the strength of the applied magnetic field (H0) (FIGURE 
3-2) (Equation 3-3).  
 (Eq. 3-2) 
 (Eq. 3-3) 
 Here, ms is the electronic spin number, ge is the electron g-factor (an intrinsic 
property of electrons depending on their environment), and µB is a spectroscopic constant 
known as the Bohr magneton. The traditional EPR spectroscopy experiment uses a constant 
frequency of microwave radiation while sweeping across a range of magnetic
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Figure 3-2: Application of an external magnetic field to an unpaired electron leads to 
separation of energy levels. This separation is proportional to field strength. Absorption of 
microwave radiation at the resonance frequecy, Hres, results in transition from low- to high-
energy level. The first derivative of this absorption is plotted as a function of field strength. 
Figure adapted with permission from Michael J. Simon. 
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field strength. Thus, when the energy difference between the two spin states matches the 
frequency of the incident microwave radiation, microwave energy is absorbed by the 
sample and the transition from low- to high-energy spin state occurs (Equation 3-4).  
 (Eq. 3-4) 
This is the fundamental equation of EPR spectroscopy. 
When no interacting nuclei are present near the spin label, a single transition occurs, 
as is depicted in FIGURE 3-2. In the EPR tradition, the first derivative of the absorption 
signal is plotted as a function of magnetic field strength. This is due to the relatively broad 
spectral lines produced due to absorption, and lead to loss of information that will make 
the choice of this convention apparent in the following segment. 
The presence of certain nearby nuclei can induce splitting of the energy levels. This 
is known as the hyperfine interaction, A. For nitroxide spin labels, the presence of the 
nitrogen nucleus leads to a splitting that depends on the nuclear spin number (Equation 3-
5).  
 (Eq. 3-5) 
Here, mI is the nuclear spin number. Thus, for spin labels with the predominant 14N 
nitrogen nucleus, the I = 1 nucleus gives rise to 2I + 1 energy levels, or three quantized 
energy levels, leading to a three-line EPR spectra (FIGURE 3-3) corresponding to 
transitions due to each spin state (+1, 0, -1). As a consequence of this
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Figure 3-3: Hyperfine splitting of the nitroxide spin label. The nearby N-14 nuclei 
has a net nuclear spin (I=1), resulting in three distinct energetic states (2I+1). These 




condition, nearby nuclei such as 16O or 12C will produce no such splitting of energy levels 
(both have nuclear spin numbers of 0). 
In SDSL EPR spectroscopy, the phenomenon of most interest is typically the 
motion of the spin-label chain. This is sensitive to the local environment of the label, and 
can thus be used to probe protein folding, dynamics, and conformational changes. The 
effects of motion on spin labels can be dramatic and spectra can be interpreted by casual 
inspection using qualitative measures such as “mobile” or “immobile”.  
For the case of isotropic motion, an electron is sampling all possible states at a 
given time. As a result, all electrons contribute equally and the result is three sharply even 
spectral lines, as see in FIGURE 3-3. However, the spin label motion is not typically 
isotropic, and thus has different amplitudes in different directions. Anisotropic motion 
results in asymmetric orbitals, leading to sampling of a limited number of states. The 
absorbance of radiation will then depend on how the electron is oriented relative to the 
magnetic field, given by the anisotropic hyperfine interaction. This will result in many 
different energetic transitions, leading to broad spectral lines (FIGURE 3-4).  
The degree of peak splitting correlates to the rotational freedom of the label, and 
can be interpreted in the context of protein secondary structure, tertiary interactions, or 
quaternary structure depending upon the placement of the spin label. In addition to 
qualitative inspection, assessment of mobility can also be performed using the inverse of 
the center line-width, known as the mobility parameter (Perozo, Cortes, & Cuello, 1998).
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Figure 3-4: Spectral broadening of the nitroxide spin label due to limitations of side chain 
mobility. A) Isotropic motion resulting from fast motion of the spin label. This spectra is 
typical of a spin label free in solution. B) Spectral broadening due to slowing motion. This 
spectra is typical of a spin label attached to a protein. C) Inhomogenous spectral broadening 
and splitting caused by anisotropic hyperfine interactions resulting from further immobility. 
Two spectral features are apparent, denoting a sharp mobile portion and a broad immobile 
portion. D) Increase of immobile portion of spectrum caused by decreased spin label 
mobility. Figure adapted with permission from Michael J. Simon. 
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This is proportional to spin label mobility and is typically normalized relative to the most 
mobile spectrum recorded for a given data set, and the parameter is typically reported on a 
scale of 0 to 1. 
 Other quantitative measures using spin labels to probe protein structure can be 
obtained using pairs of unpaired electrons in relatively close proximity to make distance 
measurements. When in close proximity, unpaired electrons can undergo dipolar coupling, 
resulting in additional peak splitting depending upon the degree of dipole-dipole 
interactions (Equation 3.6).  
 (Eq. 3.6) 
 Here, θ represents the angle between the two dipoles, and r represents the distance 
between the two dipoles. The splitting results in significant broadening of spectral lines, 
and can be described mathematically as a convolution between the probability of 
interaction, known as the Pake Function, and the non-interacting portion of both spectra 
(Pake & Purcell, 1948). Experimentally, this interaction serves to flatten the spectrum, 
increasing the peak area of the +1 and -1 field lines while decreasing the area of the center-
field line (Equation 3.7).  
 (Eq. 3.7) 
These interactions can thus be assessed qualitatively (FIGURE 3-5) and 
quantitatively using the relationships described above. In practice, interpretation of this
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Figure 3-5: The effects of spin-spin interactions on EPR spectral lines. Top – non-
interacting spectrum of anisotropic doubly-labeled protein sample. Middle – spin-spin 
interactions result in broadening of spectral lines. Bottom – normalized interacting 
spectrum (red) overlayed onto non-interacting spectrum. Red spectrum normalized using 
peak-peak height of center line. 
  
132 
interaction is complicated by sample heterogeniety, which can lead to broad distributions 
of dipolar distances. Nevertheless, the technique has been employed routinely and has 




3.4 Shots in the Dark: Sites for Labeling RbsA 
 It should be readily apparent from the previous section that the optimum strategy 
for the design of SDSL EPR experiments is using a high-resolution protein structure as a 
starting point to guide sites for cysteine mutagenesis and susbequent spin-labeling. No 
crystal structure of the full-length RbsA protein is currently available, and approaches 
using simply secondary structure prediction algorithms can prove to be haphazard 
endeavors. Fortunately, NBDs of ABC transporters share a conserved three-dimensional 
topology, and homology models can provide reasonable guides for developing a SDSL 
strategy. 
 The primary motivation of this study is three-fold. One, the conformational changes 
of the consensus site of RbsA are of interest. It has been shown through mutagenesis of 
catalytically-important residues that RbsA contains a single, consensus ATPase site. 
Studies of other ABC transporters have provided the structural basis for conformational 
changes in the RbsA consensus NBS; these changes were thus probed by EPR spectroscopy 
in this study by placing labels across the NBS interface on the opposing domains. 
 Two, the conformational changes of the degenerate site of RbsA were also be 
probed by EPR spectroscopy. Here, no precedence exists for this study in importers, as no 
well-studied examples exist. The aforementioned heterodimeric exporter currently 
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provides the only framework to understand RbsA degenerate site function. Whether this 
model is sufficient to describe an asymmetric importer NBD function has yet to be 
determined. These conformational changes were also probed by the placement of labels 
across the dimer interface of the degenerate site. 
 Three, the association of RbsA with RbsC was probed by the placement of labels 
near the primary sites of interaction of RbsA with RbsC. In addition to the asymmetry, an 
unusual property of the ribose transporter relative to other importers is the observed 
dissociation of RbsA from RbsC in the absence of magnesium and nucleotide. The 
physiological relevance of the dissociation remains unclear, as does the conformation of 
RbsA immediately before and after. Given that RbsB stimulates ATP hydrolysis by RbsA, 
the current model can be described as “open” RbsA binding to RbsBC and becoming 
“semi-open” ATP-bound RbsA, which is rapidly converted to “closed” RbsA, primed for 
hydrolysis. Hydrolysis leads to RbsB dissociation followed by cycling of the transporter to 
an inward-facing conformation. No direct evidence of these conformations was available 
prior to this study. RbsA then presumably dissociates from RbsC. What is less clear is how 
an asymmetric ABC interacts with a symmetric TMD, and whether any conformational 













3.5 Methods and Materials 
 The following sections describe the strategy for modeling, mutating, labeling, and 
collecting EPR spectroscopic measurements for RbsA in the context of transporter function, 




3.5.1 Homology Modeling RbsA 
 RbsA was modeled using the Phyre2 web server by allowing the server to identify 
the best homology (Kelley, et al., 2015) using the entire RbsA amino acid sequence from 
the E. coli K-12 strain (Bell, et al., 1986). This models proteins using a combination of 
sequence-based homology modeling and secondary structure prediction. In addition, 
potential ligand-binding sites were predicted by the 3DLigandSite Server (Wass, et al., 
2010). This server identifies patterns of amino acids commonly found in ligand binding 
sites from the PDB and analyzes a given model for these patterns. The best model was 




3.5.2 Mutating Native Cysteines 
 Three cysteines are present in the ribose transporter: two in RbsA (C208 and C264) 
and one in RbsC (C227). All three were mutated to serines using the PCR-based Quick 
Change method (Stratagene). Primers were typically designed with 30-40 bases, GC 
contents between 40-60%, melting temperatures over 70°C, and the mismatched bases at 
the center of the primer to introduce the desired mutation. Mutagenesis was performed on 
the pTATHC plasmid as a template, which expresses RbsA and RbsC using separate T7 
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sites, by mutating each cysteine by turn. Reactions were setup according to the 
manufacturer’s protocol for the Phusion enzyme. Typical PCR protocols used 35 cycles of 
98°C for 30 s, 55°C for 60 s, and 72°C for 6 min. Parental strands were digested after PCR 
by adding 0.5 µL restriction enzyme Dpn1 directly to the PCR reaction mix and incubating 
at 37°C for 3 hours. Digestion reactions were cooled briefly on ice and 5 µL was used to 
transform 20 µL of DH5α competent cells. Following recovery and 2-3 hours growth in 
LB media, cells were plated on LB solid media supplemented with 200 µg/mL ampicillin. 
Colonies (at least 3 per plate) were selected the following morning and used to inoculate 5 
mL of LB-ampicillin liquid media. Cultures were grown for 8-12 h. Mutant plasmids were 
prepared from 5 mL cultures using the Qiagen kit and protocol. Mutations were confirmed 




3.5.3 Activity Assays for Cysteine-free RbsAC 
 Cysteine-free RbsAC (cf-RbsAC) was expressed and purified in the same manner 
as the wild-type transporter. Imidazole and cofactors were removed by multiple rounds 
buffer exchange following purification. ATPase assays for the cysteine-free RbsAC 
transporter were performed as described in Chapter 2 using an NADH-coupled colorimetric 
assay, except done in detergent and without RbsB and ribose. It has previously been shown 
that assays in detergent show RbsC-stimulated rate of hydrolysis, but no increase is 
observed due to RbsB and ribose (Simon, 2011). Assays were run for 60 minutes at room 
temperature, as previously performed. Hydrolysis rate over time was compared with wild-
type levels as a necessary control step. 
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3.5.4 Engineering Cysteines for EPR Spectroscopy 
 Cysteines were introduced to RbsA at sites of interest for EPR spectroscopy using 
the plasmids for cf-RbsAC as the template. The site locations were guided by the homology 
model produced by the Phyre2 server and by results from previous studies of ABC 
transporters (Orelle, et al., 2008; Orelle, et al., 2010; Lewinson, et al. 2010; Hohl, et al., 
2014). Cysteines were introduced both singly and in pairs by the same PCR-based methods 
described above. Mutant plasmids were transformed and purified as described. All 
mutations were confirmed by sequencing. Sites of mutation and rationale for sites will be 




3.5.5 Expressing, Purifying, and Spin-labeling Mutant Proteins 
 All mutant proteins were transformed, expressed, and purified in BL21-AI cell lines 
as previously described (Clifton, et al., 2015) for the wild-type transporter, except for the 
presence of 1 mM β-mercaptoethanol. Typically, mutant RbsAC were co-purified using 
magnesium, ATP, and orthovanadate. Imidazole and β-mercaptoethanol were removed 
after purification by buffer exchange. The exchanged buffer contained 25 mM Tris-HCl 
pH 7.0, 200 mM NaCl, 20% glycerol, 0.05% DDM, and 1 mM each of cofactors. MTSL 
spin label (Toronto Research Chemicals) was dissolved in acetonitrile to a final 
concentration of 200 mM and stored in black 1.5 mL Eppendorf Tubes to shield the label 
from light. Immediately prior to labeling, the stock solution was diluted to 2 mM in Tris-
HCl buffer, pH 7.0. This spin label solution was then added to a final 20-fold molar excess 
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of label to transporter in 15-mL Falcon tubes wrapped in aluminum foil. The reaction 
mixtures were then incubated at 4°C with rocking for overnight labeling.  
 The following morning, samples were centrifuged to remove precipitates, 
concentrated to 500 µL, and subsequently injected onto a Superdex200 10/30 GL column 
pre-equilibrated with buffer with cofactors. This removed both excess label and any 
aggregates produced during labeling. 1-mL fractions were collected and analyzed by SDS-




3.5.6 DTNB Assay for Labeling Efficiency 
 The DTNB reagent was prepared as previously described (Simon, 2011). Samples 
were tested in plate format and reagents optimized for 100 µL reaction volumes. A standard 
curve was generated using DTT samples prepared in 0 – 500 µM final concentrations. Free 
sulfhydryl concentration was measured for all protein samples and compared with a 
standard curve. Total sulfhydryl concentration was determined by extrapolating from 
protein concentration, which was first determined using the BCA assay, as described in an 
earlier chapter. These two measures were used to determine labeling efficiency. Samples 




3.5.7 ATPase Assays of Mutant Experiments 
 All mutants were tested for activity using the protocol previously described. Prior 
to experiments, cofactors were removed by several rounds of buffer exchange into buffer 
lacking cofactors. ATPase measurements were performed as described above in a plate-
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3.5.8 EPR Spectroscopy of Ribose Transporter Mutants 
 Prior to EPR experiments, samples were prepared to test several different cofactor 
and protein combinations. All samples were prepared with the following four 
cofactor/protein combinations: 1) RbsAC with 1 mM Mg-ATP-VO4; 2) RbsABC with 1 
mM Mg-ATP-VO4; 3) RbsAC with Mg-ADP; and 4) RbsABC with ATP-EDTA. Samples 
with cofactor combinations different from the Mg-ATP-VO4 were prepared by several 
rounds of buffer exchange. Samples with RbsB were prepared by the addition of a molar 
excess of RbsB (1.25:1). All samples were concentrated to 50 – 100 µM prior to 
measurements using 30 kDa MWCO spin filters (Amicon). 
 EPR measurements were collected using an X-band Bruker EMX plus with the 
high-sensitivity cavity ER4119HS. Instrument settings for all measurements are listed in 
Table 3.1. 20  µL samples were loaded into 50 µL glass capillaries and placed in quartz 
sample tube held in place in the cavity.  
 EPR spectral files were initially processed using WinEPR to remove the buffer 
baseline. Double integration of spectra was used to calculate the concentration of spin label 
for each sample. Amplitudes were exported to MS Excel for further processing. Specta 





Table 3-1: Instrument settings for data collection using Bruker EMX Plus. 
 
Modulation Frequency 100 kHz 
Modulation Amplitude 3.00 Gauss 
Modulation Phase 0 degrees 
Offset 0% 
Time Constant 20.48 msec 
Conversion Time 60 msec 
Sweep Time 122.88 sec 
Resolution in X 2048 
Number of Scans 30 
Field Width 250 Gauss 
Static Field 3415.797 Gauss 
Microwave Bridge Frequency 9.85 GHz 
Microwave Bridge Attenuation 10 dB 
Microwave Bridge Power 20 mW 
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concentration to calculate a correction factor foe all other samples. These correction factors 
were applied to those samples from each set. Normalized spectra were then plotted using 
Prism (GraphPad). 
 For distance measurements, amplitudes were exported into ASCII files and 
processed using Short Distances, a LabView program written and distributed by Christan 
Altenbach (Altenbach, et al., 2001). The data files required for this included a “Sum of 
Singles Spectra” and the double mutant spectral files. The singles spectra was collected 
using the double mutant proteins and labeling them with a combination of a diamagnetic 
probe in excess of the paramagnetic spin label (4:1 excess). The mutant samples were 
labeled as before, evaluated as described, and the spectra were collected as above. Data 
were processed as above and used to produce a file containing amplitudes in a single 
column. These two files were used by Short Distances to perform a spectral deconvolution 
to yield contributions only from interacting spins. These yielded a distribution of distances 
based on the degree of dipolar coupling, as described earlier. Distances were compared for 





  The following sections describe the results from homology modeling, discuss the 








3.6.1 Homology Modeling RbsA Using Phyre2 Web Server 
 Several homologous proteins were used to generate models of RbsA that resulted 
in scores with 100% confidence by the Phyre2 server (Kelley, et al., 2015). These 
homologous proteins had percent identities with RbsA ranging from 22 – 32%. These 
proteins included both traffic ATPase NBDs and DNA repair enzymes. Although many 
models were the same, based on alignment of the generated PDBs, the chosen model was 
based on BtuD, an ABC transporter NBD.  
Analysis of secondary structure prediction revealed conserved domains were 
modeled as expected, based on structures of similar ABC proteins. Overall, the protein was 
modeled with 40% alpha helical content, 22% beta strand content, and 8% disorder, within 
a range typical for ABC transporter NBDs. Twenty amino acids could not be modeled. As 
expected, many of these were located at the region linking the C-terminal and N-terminal 
NBDs, for which no homologous structure currently exists.  
 In addition, ligand-binding sites were predicted for the model using the 
3DLigandSite application within the Phyre2 server. This application modeled, with 96% 
confidence, the presence of a single ligand binding site at the NBS formed by the NTD, 
which contributes the Walker A and B motif along with catalytic residues, and the CTD 
Signature sequence. Bound ATP was modeled into this site. No second site was modeled 
by this server. The basis for modeling ligand binding was the conservation of the site found 
in 34 proteins of known structure, most of them other ABC proteins. The list of side chains 






3.6.2 Sites of Mutation in RbsA 
 The chosen Phyre2 model was used to identify sites for engineering cysteines. This 
was based on conformational changes of NBDs from crystal structures and functional 
studies, as described in the Methods section. The labeled sites are indicated in Figure 3-
6.  
 Three pairs of mutations were used for EPR experiments to probe RbsA 
conformational changes during the transport cycle. A pair of mutations was placed at the 
predicted contact interface between RbsA and RbsC (H85C and S333C, colored in 
magenta). In crystal structures of the maltose transporter and functional studies using EPR 
spectroscopy, it has been shown that the TMD coupling helix interacts with the NBD Q-
loop, where both of these mutation sites are located. When MBP docks onto the transporter, 
the coupling helix engages this region, resulting in a movement of the Q-loop glutamine 
towards the ATP binding site, where it participates in interactions with the required 
magnesium ion. Thus, this region not only senses the presence of the SBP through 
transmembrane signalling, it also participates in conformational changes by an inward 
rotation of the coupling helices. The placement of two labels across this interface would 
presumably provide information about NBD-NBD distances as well as information about 
signal transduction in the intact system. 
 A second pair of mutations (F14C and I393C, colored in orange) probed 
conformational changes across the consensus NBS. F14C was placed adjacent to the 
Walker A motif of the N-terminal NBD. I393C was placed adjacent to the signature 
sequence of the C-terminal NBD. In studies of the maltose transporter, the helical 
subdomain of one monomer undergoes a rotation towatds the complementary RecA-like 
  
143 
subdomain of the other monomer to facilitate ATP binding. This process is stimulated by 
MBP docking onto the TMD. This pair of mutations would probe this conformational 
change in RbsA. 
 A third pair (cyan) of mutations probed conformational changes across the 
degenerate NBS. R132C essentially mimicked the position of I393C in the degenerate site 
adjacent to its signature sequence. Meanwhile, a C-terminal domain cysteine, V268C, was 
introduced in nearly an identical position as F14C. A construct designed with a nearby 
native cysteine, C264, could not be expressed as either a single mutant or paired with 
another nearby engineered cysteine.  
 In addition to these pairs of mutations, other cysteines were engineered to test the 
validity of the models. For instance, the interface where A443C and S189C (colored red) 
were introduced is not sensitive to conformational changes based on studies of intact ABC 
transporters. These single mutations were thus used as controls for model validity.
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Figure 3-6: Sites of cysteine mutations for site directed spin labeling. Top-down view of 
RbsA model. For double mutant experiments, three pairs were engineered: 1) consensus 
site pair F14C/I393C; 2) Q-loop pair H85C/S333C; and 3) degenerate site pair 
D141C/C264. Control mutations were made to test model validity using non-interacting 
sites of S189C and A443C, a docking surface mutation at Y308C, and an active site 
mutation N89C. Double mutant pairs were used for distance measurements. 
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Finally, a single mutation was placed at N89C (red) as a probe of N-terminal domain ATP 
binding and activity. This region would undergo conformational changes during the 
catalytic cycle in other transporters. Thus, the spin label would be expected to report upon 
conformational changes in nucleotide bound states, and in the absence of nucleotide. 
 Activity of cf-RbsAC was measured at wild-type levels, and introduction of serines 
had no effect on complex assembly. Assembly was used as a general test prior to labeling 
for pursuing mutations to the next steps. The listed mutations were all successfully 
expressed, assembled, and demonstrated activity within 50% of wild-type range after 
labeling. Several other mutants were tested but either did not express or assemble properly. 
These were not used.  
Labeling efficiency of all of these was greater than 90%, based on comparison with 
the standard curve for the DTNB assay. Proteins were concentrated and tested in conditions 




3.6.3 Model Validation Using Non-interacting Protein Regions 
 To test whether the homology model was realistic, single mutations were 
introduced at sites where conformational changes and protein-protein interactions were not 
expected. This hypothesis was based on understanding of structural changes of ABC 
transporters from several crystal structures of the maltose transporter. Using this as a 
rationale, single cysteine mutations were engineered in the N-terminal NBD at S189, and 
in the C-terminal NBD at A443 (FIGURE 3-7A). 
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 EPR experiments were performed in several different conditions, using the cofactor 
combination Mg-ATP-VO4 with both the RbsABC and RbsAC complexes, the cofactor 
combination Mg-ADP with the RbsAC complex, and the combination ATP-EDTA with 
RbsABC. No changes in spectral lines were observed due to the introduction of complex 
proteins or by different combinations of cofactors (FIGURE 3-7B). Measured spectra were 
essentially identical for every condition tested with a mutation data set. All data were 
normalized to the highest concentration of spin label as determined by double integration 
of EPR spectral lines to calculate the area under the curve.  
 As an additional control for the C-terminal NBD, a second single mutation was also 
introduced at a site not expected to produce an NBD-TMD interaction, Y308C (FIGURE 
3-6). This mutation was located on the RecA-like subdomain as part of a β-barrel that 
formed the outer surface of the domain. In structures of BtuCD and MalFGK2, this region 
remains outside of the interaction surface throughout the catalytic cycle. 
 As expected, no changes were observed in the Y308C spectra in any cofactor 
combination nor due to the addition of RbsB (FIGURE 3-8). These results suggest the 
model is valid and the interactions tested thus far are canonical. 
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Figure 3-7: EPR spectra for A443C and S189C single mutations on RbsA. A) Schematic 
diagram of RbsA with expected initial (top) and final (bottom) positions of labels going 
from apo- to ATP-bound state of RbsA. B) A443C mutant spectra with cofactor/protein 
combinations. C) S189C mutant spectra with cofactor/protein combinations. Combinations 




Figure 3-8: EPR spectra for Y308C single mutation on RbsA. A) Schematic diagram of 
RbsA with expected initial (top) and final (bottom) positions of label going from apo- to 
ATP-bound state of RbsA. B) S189C mutant spectra with cofactor/protein combinations. 
Combinations tested include RbsAC with Mg-ATP-VO4, RbsABC with Mg-ATP-VO4, 
and RbsAC with Mg-ADP. 
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3.6.4 Conformational Changes at the TMD-NBD Interface 
 The Q-loop is the conserved major site of interaction between ABC transporter 
TMD coupling helices and the NBD, linking substrate availability with hydrolysis. To 
probe Q-loop conformational changes, mutations were introduced as a pair to Q-loop 
residues H85 (N-terminus) and S333 (C-terminus) (FIGURE 3-9A). These corresponded 
to roughly identical positions. Neither amino acid position participates directly in ATP 
hydrolysis, as seen in other ABC transporter structures. The mutant transporter assembled 
like normal after labeling and produced wild-type levels of activity.  
 The cofactor combination ATP-EDTA simulates a pre-hydrolysis conformation. 
Using this combination in the presence of RbsB, the EPR spectrum of the 85-333 labeled 
transporter produced features with strongly mobile lines (FIGURE 3-9B, green line), at 
least by the standard of labeled proteins. When the same combination of proteins is used 
to form the vanadate-trapped RbsABC complex, a sharp reduction in amplitude of the 
mobile spectral feature was observed (blue line). This was accompanied by a slight 
increase in amplitude in the immobile portion of the spectrum. This change could be 
observed in both the +1 and -1 peaks following normalization of the spectra using the center 
line of the most intense data set.  
 The cofactor combination Mg-ADP simulates the pos-hydrolysis, post-transport 
conformation, and produces during purification the RbsAC complex. Using this cofactor
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Figure 3-9: EPR Spectra for the H85C/S33C double mutant of RbsA. A) Schematic 
diagram showing expected initial and final positions of labeled side chains going from apo- 
to ATP-bound state of RbsA. B) EPR spectra for cofactor/protein combinations of the 85-
333 mutant transporter. Conditions tested include RbsABC with ATP-EDTA (green), 
RbsABC with Mg-ATP-VO4 (blue), and RbsAC with Mg-ADP (purple). Mobile (m) and 
immobile (i) portions of spectra labeled. 
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combination with the labeled 85-333 RbsAC complex resulted in an increase in amplitude 
of the +1 and -1 spectral lines compared with the Mg-ATP-VO4 state (purple line). 
However, the amplitudes of these peaks was less than those observed for the ATP-EDTA 
cofactor combination. Thus, three different types of spectra were recorded for three 
different cofactor combinations. 
 In addition, RbsAC in the presence of Mg-ATP-VO4 was tested, but no difference 
was observed between this spectrum and the RbsABC combination with Mg-ATP-VO4 




3.6.5 Conformational Changes at the Consensus Site 
 EPR spectroscopic measurements of the maltose transporter reveal a rotation of the 
helical subdomain towards its complementary RecA-like subdomain to bind and hydrolyze 
ATP. To probe similar conformational changes in the single active site of RbsA, cysteine 
mutations were introduced across the interface to produce a double mutant using F14C and 
I393C mutations (FIGURE 3-10A). The mutant 14-393 transporter assembled like normal 
during purification and displayed activity within reasonable range of the wild-type 
transporter.  
 Four different conditions were tested for the 14-393 mutant transporter. Using the 
cofactor combination ATP-EDTA in the presence of RbsB produced a spectrum with 
relatively mobile spectral features at the +1 and -1 lines (FIGURE 3-10B, green line).
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Figure 3-10: EPR spectra for the F14C/I393C double mutant of RbsA. A) Schematic 
diagram showing expected initial and final positions of labeled side chains going from apo- 
to ATP-bound state of RbsA. B) EPR spectra for cofactor/protein combinations of the 14-
393 mutant transporter. Conditions tested include RbsABC with ATP-EDTA (green), 
RbsAC with Mg-ATP-VO4 (red), RbsABC with Mg-ATP-VO4 (blue), and RbsAC with 
Mg-ADP (purple). Insets show enlarged spectral features of +1 and -1 peaks, with labeled 
mobile (m) and immobile (i) portions. 
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Two different vanadate-trapped conditions were tested, using RbsAC and RbsABC. These 
conditions had previously been tested with other mutants and had produced no difference 
in spectra between the RbsAC and RbsABC combinations. However, a comparison of these 
two spectra for the 14-393 double mutant revealed a significant different. The vanadate-
trapped RbsAC spectrum (red line) is nearly indistinguishable from the ATP-EDTA 
spectrum, with only a slight reduction in the mobility of the spin label in the former 
condition. However, the RbsABC vanadate-trapped conformation produced a spectrum 
(blue line) with both reduction of the mobile portion and broadening of the +1 and -1 
spectral lines. This type of broadening is characteristic of spin-spin interaction, suggesting 
close proximity of the two spin labels at position 14 and 393. These spectra also suggested 
a difference in conformation between the RbsAC and RbsABC states, though the cofactor 
combinations were the same. 
 Finally, the cofactor combination of Mg-ADP was tested with RbsAC for the 14-
393 double mutant. This combination produced spectral lines (purple) identical to the 




3.6.6 Probing Consensus Site Conformational Changes Using a Single Label 
 In addition to the 14-393 double mutant used earlier, conformational changes of the 
consensus site were also probed at other locations using single labels. These were 
motivated by the attempt to resolve the subdomain rotations typical of active NBDs during 
the hydrolysis cycle. 
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 Several mutants were tested in this location. The N89C mutation was well-tolerated, 
assembled efficiently, and had relatively normal levels of activity. This was labeled as 
before (FIGURE 3-11A). Three different conditions were tested: 1) RbsABC with the 
cofactor combination ATP-EDTA; 2) RbsABC with Mg-ATP-VO4; and 3) RbsAC with 
Mg-ADP. 
 Small spectral changes were observed for this mutant with different cofactor 
combinations. In the ATP-EDTA combination, the spectra were relatively mobile 
(FIGURE 3-11B, blue line). With Mg-ATP-VO4 bound, a slight reduction in amplitude 
is observed in the +1 peak (red line). This reduction was not observed in the Mg-ADP 
cofactor combination (green line). The lack of spectral changes suggested either improper 
probe placement or a lack of significant conformational changes during hydrolysis at this 




3.6.7 Probing Conformational Changes at the Degenerate Site 
 Finally, to probe conformational changes at the site that did not hydrolyze ATP, 
spin labels were introduced at homologous positions as F14C/I393C. Unlike the consensus 
site, the degenerate site did not readily tolerate cysteine mutations, and a construct 
containing the native cysteine C264 could not be expressed. The double mutant 
  
155 
Figure 3-11: EPR spectra for the N89C single mutant. A) Schematic diagram showing 
expected initial and final positions of labeled side chains going from apo- to ATP-bound 
state of RbsA. B) EPR spectra for cofactor/protein combinations of the N89C mutant 
transporter. Conditions tested include RbsABC with ATP-EDTA (blue), RbsABC with 
Mg-ATP-VO4 (red), and RbsAC with Mg-ADP (green). 
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R132C/V268C could be expressed and was shown to assemble normally and be active in 
detergent (FIGURE 3-12A). 
 Three different conditions were tested for the 132-268 double mutant. The 
vanadate-trapped RbsABC complex produced spectral features with relatively mobile +1 
and -1 lines (FIGURE 3-12B, blue line). When the same mutant was tested in the presence 
of Mg-ADP, nearly identical spectral lines were produced (red line). In the ATP-EDTA 
condition, a slight increase in mobility was observed (green line). In all cases, the spectra 
were noisy compared with those for other double mutants, suggesting a labeling 





3.6.8 Distance Measurements Using Short Distances 
 For all double mutants, protein samples were labeled both with MTSL only and 
with a mixture of diamagnetic probe and MTSL (4:1 ratio). This labeling scheme allowed 
for direct measurements of the sum of singles (non-interacting) spectra required for 
distances by the method described by Altenbach and colleagues (2001). Single labeled 
measurements, performed in identical conditions as described above, were then 
deconvoluted from the respective double-MTSL measurements made before. 
Deconvolutions were performed using the “Short Distances” program written by C.
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Figure 3-12: EPR spectra for the R132C/V268C double mutant of RbsA. A) Schematic 
diagram showing expected initial and final positions of labeled side chains going from apo- 
to ATP-bound state of RbsA. B) EPR spectra for cofactor/protein combinations of the 132-
268  mutant transporter. Conditions tested include RbsABC with ATP-EDTA (green), 
RbsAC with Mg-ATP-VO4 (red), RbsABC with Mg-ATP-VO4 (blue). 
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 Altenbach. Distances were determined from the resulting broadening function following 
deconvolution.  
 Distance measurements were made for all cofactor conditions tested before 
(TABLE 3-2). Most measuremed distances were outside of the range of spin-spin 
interactions that could be detected by this method. For the 85-333 double mutant, both the 
Mg-ADP and ATP-EDTA cofactor combinations resulted in distances over 20 Å. For the 
vanadate-trapped state, this same mutant resulted in a distance of 12.8 Å, with a distribution 
of 4.2 Å. These measurements were consistent with qualitative analyses of each spectrum, 
and suggested a closure of domains upon ATP binding. 
 Distance measurements made for the 14-393 double mutant also showed spin-spin 
distances beyond the measureable limit for both the Mg-ADP and ATP-EDTA states. In 
the vanadate-trapped state, this mutant transporter produced distances of 12.4 Å, with a 
distribution of 2.6 Å. These results were consistent with those described for the 85-333 
mutant, and with the qualitative analyses of these spectra. 
 Finally, distances made for the degenerate site double mutant 132-268 showed 
distannces outside the measureable for all cofactor combinations tested. No change was 
observed for the vanadate-trapped state. The results were consistent with qualitative 








Table 3-2: Summary of distances measured for each double mutant. Condition for each 





 RbsA was homology modeled using the Phyre2 server, which identified several 
templates with 100% confidence that successfully modeled all but 20 amino acids of RbsA. 
These amino acids were mostly present within the linker region between the N- and C-
terminal domains, for which no homologue exists in the PDB currently. 
These results suggests that the three-dimensional topology of RbsA is generally 
canonical for ABC transporters, and studies by EPR spectroscopy can provide reasonable 
insights into RbsA function despite the absence of a high-resolution three-dimensional 
structure.  
 The Phyre2 server also contains an application that can predict ligand binding sites. 
The methodology for this has been discussed earlier. Of note is the prediction of a single 
ATP binding site in the consensus NBS of RbsA. This is likely due to the prevalence of 
ABC structures in the PDB with canonical binding sites and the absence of those with non-
canonical degenerate sites, particularly with ligand bound. This may also be a function of 
the differences in the RbsA degenerate site compared with the degenerate sites of proteins 
for which structures exist, such as TM287-288. These proteins contain a defined 
substitution pattern, with a glutamine in place of the conserved switch histidine and a 
glutamate in place of the conserved D-loop aspartate. These side chains appear to support 
a closed, substrate-bound state of the degenerate NBS. RbsA, in contrast, has a serine in 
place of the switch histidine and appears to be missing the D-loop entirely (an RGVG motif 
is present at the region usually where this is found). Currently, no solved structure exists 
with a similar substitution pattern in a degenerate site. 
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 The model for RbsA appears to be reasonable, based on mutations introduced at 
control sites where conformational changes and protein-protein interactions are not 
expected Spin labels were introduced into positions on the outer and lower surfaces of 
RbsA away from regions participating in hydrolysis and transport. These labels reported 
no changes due to cofactors or the presence of RbsC and RbsB. In a global sense, the 
modeled protein could be trusted to guide labeling and better understand RbsA 




3.7.1 NBDs are Pinched Together Upon ATP Binding 
 It appears that RbsA functions in a manner similar to MalK. Labels placed at the 
NBD-TMD interface (85-333 mutant) demonstrate that the NBDs pinch together in the 
intact transporter with Mg-ATP-VO4. This is shown by the significant reduction in 
amplitude of the +1 and -1 spectral lines for this experiment, demonstrating reduced spin 
label mobility. This cofactor combination is expected to produce the outward-facing state 
of the transporter. In this state, it should be expected the coupling helix is docked into the 
Q-loop and the NBDs are fully engaged in binding ATP. 
The amplitude of these same peaks then increases for the Mg-ADP bound state, 
demonstrating increased spin label mobility. This suggests a retraction of the TMD 
coupling helix and possible disengagement of the NBDs away from one another. It has 
been speculated that this represents either an inward-facing or outward-occluded state of 
the transporter (Dawson & Locher, 2006), based on crystallographic evidence. In either 
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case, it would be expected that the substrate had been released from the SBP and TM gating 
was driving it inwards. The increased mobility supports this situation. 
Finally, the amplitude of the +1 and -1 peaks increased further for the ATP-EDTA 
cofactor combination. In co-purification studies, this combination resulted in complete 
dissociation of RbsA from RbsC (Clifton, et al., 2015). It is not clear if such dissociation 
is seen in the context of this experiment. Co-purification studies would fail to capture low-
affinity transient interactions, while EPR can sensitive to these depending on placement of 
the spin labels (Erramilli, Simon, Clifton, & Stauffacher, 2016). However, the increase in 
amplitude certainly supports  a model where the TMD is disengaged from the NBD and 
the NBDs have rotated away from one another in the absence of bound cofactors. Thus, 




3.7.2 RbsB Promotes Conformational Changes in RbsA 
 It has previously been shown that vanadate-trapping can be used to purify both the 
RbsABC and RbsAC complexes, depending on what proteins are included. It was thus not 
expected that structural differences in the NBDs and TMDs existed between these two 
complexes. Vanadate is a potent nanomolar inhibitor of ATPases and forms a very stable 
post-hydrolysis trap. 
 However, EPR experiments of the 14-393 mutant transporter are discriminate 
structurally between these two protein combinations despite identical cofactor 
combinations used. Vanadate-trapped RbsAC only shows a slight reduction in spin label 
mobility compared with either the Mg-ADP cofactor combination or the ATP-EDTA 
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cofactor combination. This is expected based on what is known about NBD-NBD 
association during nucleotide binding. Unexpectedly, a significant spectral difference is 
observed upon introduction of RbsB, showing not just decreased spin label mobility but a 
pronounced broadening typical of at least some degree of spin-spin interaction. This 
suggests that the docking of RbsB to RbsC is promoting a further rotation of the 
subdomains of RbsA towards one another, and provides a mechanism for increased 
hydrolysis activity in RbsA due to RbsB. These results are also consistent with what is 
known about ABC transporter function, that an inward rotation of the helical subdomain 
towards its complementary RecA-like subdomain drives ATP hydrolysis and links TMD-
NBD conformational changes. 
 The Mg-ADP RbsAC spectrum shows similar features to the RbsAC Mg-ADP-
VO4 state. This cofactor combination results in a RbsAC complex, with RbsB dissociating 
post-ATP hydrolysis. This suggests the helical subdomain rotates away from the RecA-
like subdomain following RbsB release, and supports either an inward-facing or outward-
occluded state of the transporter.  
Finally, the ATP-EDTA combination results in a spectrum with the highest spin 
label mobility for this data set. This supports a model where the NBDs of RbsA are 
disengaged fully in the absence of bound cofactor. This may also represent the state of 










3.7.3 Summary of EPR Experiments 
Overall, these results provide the data to construct a transport mechanism that is 
consistent with what is known about ABC transporter function, yet has certain caveats. 
These caveats arise both from these experiments, the substrate binding studies, and the sum 
total of previous observations regarding ribose transporter proteins. In the search for 
general mechanisms, ABC transporter research has led to the identification of at least two 
divergent phenotypes of importers, each with structural and mechanistic differences 
adapted for the nature of their partner proteins and the transported substrates. A transport 




CHAPTER FOUR: CRYSTALLIZATION TRIALS AND 




4.1: The Challenges of Crystallizing Membrane Proteins 
 X-ray crystallography remains the gold standard method for determining protein 
structures at high resolution. The rate determining step for solving structures with this 
method remains obtaining large, well ordered crystals hardy enough to tolerate X-rays for 
sufficient exposures to collect a complete data set. Until alternative structure determination 
methods gain broad applicability, a high-throughput crystallization trial remains the best 
approach for obtaining such crystals to solve protein structures using their X-ray diffraction 
patterns. 
 There is a well-known lag in the progress of membrane protein structure 
determination compared with their soluble counterparts (FIGURE 4-1). This lag is based 
on predictions from the 1970s regarding the pace of protein structure determination (White, 
2004). To date over 117,000 X-ray structures  of over 37,000 unique proteins have been 
deposited to the Protein Data Bank (source: pdb.org). Of these, roughly 1,000 structures 
of slightly more than 600 membrane proteins have been solved and deposited in this 
repository, representing less than one percent of stored coordinate files. Nearly one-third 
of the genomes of many organisms, from the simplest bacteria to man, code for membrane 
proteins (White, 2004). 
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Figure 4-1: The progress of membrane protein structure determination (White 2004). The 
expected growth is based on the growth rate of protein structure determination from the 
date of the first structure (1960) to 1978, when 132 structures had been determined.
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This lag can be accounted for both by the challenge of expressing and stably purifying 
membrane proteins and the difficulties in crystallizing them in their detergent reconstituted 
states (Ostermeier & Michel, 1997). A variety of modern technologies have been 
developed for the purification and handling of membrane proteins in vitro and 
improvements to crystallization and synchrotron technology have overcome significant 
barriers to studying membrane proteins (Bill, et al., 2011). These improvements have only 
slightly improved the rate of progress for determining membrane protein structures. 
The primary challenge remains obtaining well-ordered crystals of membrane 
protein. The growth of such crystals is retarded by the significant bolus of detergent 
molecules that surround solubilized membrane proteins. This shell often masks extrinsic 
regions potentially suitable for the generation of protein-protein contacts required to form 
well-ordered crystals. Further, these shells prevent accessibility to potential contact sites 
within hydrophobic transmembrane domains, required for forming more stable type I 
membrane protein crystals (Ostermeier & Michel, 1997).  
A second problem associated with detergents is their insufficiency in replicating 
the membrane environment, often leading to instability of transmembrane regions. These 
issues have been addressed in part by the development of synthetic detergent molecules 
that better mimic lipids (Moraes, Evans, Sanchez-Weatherby, Newstead, & Stewart, 2014). 
More recently, crystallization using lipid-based media have been popularized and shown 
to be applicable to a variety of membrane protein systems (Caffrey, 2015). A successful 
membrane protein crystallization trial thus requires the application of as many of these 
methods as is reasonably possible. The worthiness of such an endeavor is well-established 
and should be pursued whole-heartedly for all and any membrane proteins at this time.  
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Crystals of the ribose transporter complexes suited to X-ray diffraction experiments 
have remained elusive to obtain, despite extensive trials. The efforts to obtain such crystals 
have involved a variety of techniques, from optimization of purification conditions to the 
type of crystallization medium (detergent, bicelles, lipidic cubic phase) and, more recently, 
the application of phage-display synthetic antibody technology for the generation of 
crystallization chaperones. This chapter describes these efforts and provides a record of the 
current progress towards the ultimate goal of obtaining a high-resolution structure of the 
full ribose transporter complex. We next discuss the basis for each method briefly before 




4.2 The Optimization of Ribose Transporter Expression and Purification 
 Efforts to improve the yield of RbsAC from cell cultures to facilitate extensive 
crystal screening have been documented in Chapter 2. These efforts improved expression 
of RbsAC 10-15 fold over previous methods, and provided the necessary amounts for high-
throughput screening using a variety of crystallization methods.  
 It had previously been determined, following screening during purification, that 
DDM was the optimal detergent for extraction and purification of RbsABC (Clifton, 2005). 
This mild detergent is simultaneously the most popular for membrane protein purification 
and poorly compatible with crystallization experiments, as it forms micelles documented 
to be 70-120 kDa in size when solubilizing transmembrane segments (Oliver, et al., 2013) 
(Clifton, et al., 2016). A well-established correlation exists between detergent chain-length 
and micelle size, with longer chain detergents proving to be more tolerable to a variety of 
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membrane proteins. The choice of long versus short alkyl chain is, however, made only by 
experimental trials, and short detergents often have destabilizing effects on membrane 
proteins by inserting between transmembrane helices and break inter-helica interactions.  
 A host of synthetic detergents have recently been developed and have aided 
crystallization efforts of difficult targets (Chae, et al., 2010). Several of these detergents 
were screened for optimization of RbsABC for crystallization. Most notably, double-tailed 
detergents that have proven efficacy with G-protein coupled receptor signalling complexes 
were tested for compatibility with RbsABC. Further purification of RbsABC and other 
ribose transporter complexes by gel filtration chromatography was also pursued and 
optimized for buffer content. These included the pursuit of complex-stabilizing catalytic 
mutants in lieu of trapping with phosphate analogs such as orthovanadate, and substituting 




4.3 Ribose Transporter Crystallization Trials 
 High-throughput crystallization trials of orthovanadate- and aluminum fluoride-
trapped RbsABC, RbsAC, and RbsBC were pursued using several dozen commercial 
screens (Qiagen, Molecular Dimensions, Anatrace) and in a variety of media (FIGURE 4-
2). These included screens optimized for membrane protein crystallization. A significant 
deterrant to membrane protein crystallization is the phase partitioning effects of 
precipitants on detergents (Koszelak-Rosenblum, et al., 2009). These phase separations 
result in membrane protein denaturation, yet many membrane proteins have crystallized 
near the boundaries of these partitions. This knowledge has resulted in the development of 
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sparse matrix crystal screens with formulations optimized for the phase boundaries of 
popular purification detergents. These screens typically utilize salt concetrations ranging 
from 0.05 to 0.4 M and polyethylene glycol (PEG) concentrations ranging from 2 to 22%, 
as well as a bias towards shorter-chain PEG reagents (source: Hauptman-Woodward 
Institute). These and many other screens were employed for crystallization trials with 
coverage of many common and uncommon protein precipitants.  
 In addition, lipid-based crystal screening was also employed. This involved 
screening with both bicelles and lipidc cubic and sponge phases. Bicelles are bilayered 
micelles, forming from a mixture of short-chain detergent and lipids (FIGURE 4-2B). The 
typical formulation for such studies involves combining dimyristoyl phosphatidylcholine 
(DMPC) and the detergent CHAPSO at ratios ranging from 2.5:1 to 3.5:1 (Ujwal & Bowie, 
2011). These mixtures are then combined with purified membrane proteins, which 
preferentially reconstitute into the lipid bilayers. While not well-defined modules such as 
nanodiscs, bicelles are compatible for crystal screening and typically aggregate to form 
three-dimensional bilayer systems that allow the growth of type I membrane protein 
crystals. Bicelle-reconstituted ribose transporter was screened using many of the same 
commercial crystal screens described above.  
 Recently, lipidic cubic and sponge phases have become popular choices for the 
growth of membrane protein screening. These methods involve reconstitution of 
membrane proteins into three-dimensional bilayer systems (FIGURE 4-2C) formed from 
monoolein lipids. Reconstitution of membrane proteins into lipidic cubic phase (LCP) 
involves mixing the protein solution with molten lipids, which are subsequently cooled and 
hydrated during mixing to produce protein incorporated LCP. During crystallization, the 
  
171 
LCP is perturbed by local dehydrations induced by precipitant solutions, resulting in phase 
changes that allow the growth of type I membrane protein crystals in the lamellar lipid 
phase (Caffrey, 2015) (FIGURE 4-2D). The sponge phase represents an additional 
hydrated phase of LCP with larger pores thought to be accommodating for membrane 
proteins with large extrinsic domains, such as ABC transporters and large signalling 
complexes. Much like with detergents and bicelles, LCP-based crystallization was pursued 
for the trapped RbsABC complex using many of the same crystal screens described above.  
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Figure 4-2: Membrane protein crystallization environments. A) Traditional, detergent-
based (orange) solubilization and crystallization. Protein is green. B) Bicelles are short 
bilayer patches (red) solubilized by short-chain detergents (orange). C) Lipidic cubic 
phases are three-dimensional bilayers that form reservoirs for membrane proteins to diffuse 
and crystallize. D) LCP phase diagram. Hydration (40-50%) results in cubic phase at room 
temperature. Introduction of precipitant causes local dehydration, resulting in lamellar (Lα) 
phase. Figures adapted from Cherezov lab website. 
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4.4 Crystallization Chaperones from Phage Display Technology 
 Crystallization chaperones encompass a variety of proteins and protein-fragments 
that increase the probability of crystallization of a target large molecule (Koide, 2009). 
These chaperones are designed to to reduce the conformational heterogeneity of a protein 
sample and alter the surface chemistry to improve the likelihood of crystal contact 
formation. Chaperones can also provide phasing information for molecular replacement 
based structure determination.  
 Numerous examples demonstrate the success of this method, including many 
notable examples of membrane proteins crystallized with chaperones. These include the 
full-length potassium channel KcsA, the β-adrenergic receptor, and the bacterial drug 
extruder AcrB, all crystallized with bound antibody or engineered protein fragments that 
stabilized the protein or provided valuable contact surfaces to promote crystal growth. 
Given the size of the detergent micelle and the buried surface area of transmembrane 
segments, the latter feature is of particular value for the crystallization of many membrane 
proteins.  
 Traditionally, the generation of crystallization chaperones has involved animal 
immunization to produce monoclonal antibodies, a process that is slow and expensive for 
the production of milligram quantities of protein required for high-throughput 
crystallization trials. Modern methods have relied on either semi-synthetic antibodies, 
cloned from the cDNA from animal sources and produced in bacteria, or fully synthetic 
antibodies using recombinant DNA technology. The latter method takes advantage of 
degenerate oligonucleotides in the polymerase chain reaction (PCR) to produce libraries 
with theoretical diversities of 1010 or higher. This allows the generation of antibodies with 
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a tremendous variety of complimentarity-determining regions (CDRs) for the recognition 
of a vast number of epitopes.  
 The most common approach with synthetic antibody technology is the use of phage 
display for screening target binders. This involves the expression of the heavy- and light-
chain Fab portion of antibodies as part of phage DNA. One chain is engineered with an 
extended linker region that fuses it to a surface protein. The second is expressed as a soluble 
protein and the two dimerize spontaneously and are subsequently expressed on the phage 
surface. This allows for convenient and rapid screening to identify high-affinity binding 
partners (FIGURE 4-3). Library diversity is achieved by positional variation of CDR 
regions, formed by the six combined loops of the heavy- and light-chains of the Fab 
molecule (Sidhu & Koide, 2007). Thus, recombinant DNA technology has allowed for 
complete independence from the natural immune system for antibody production.  
 The process for screening and identifying high-affinity binders using phage display 
has been well-established (Paduch, et al., 2013). Typically, target molecules are 
immobilized and screened through several rounds of selection. By reducing the amount of 
target immobilized in each round, a handful of robust binding partners can be selected for. 
Interestingly, selection for membrane proteins in detergent proved difficult by this method. 
This difficulty was ascribed to the peturbation of membrane protein structure by detergent, 
resulting in conformational heterogeniety that prevented successful and reproducible 
selection of antibodies by phage display. This problem was solved by the application of 
nanodisc technology to reconstitute membrane proteins into well-defined modules. These 
modules could then be fed into the phage display pipeline to generate binders with great 
specificity (Dominik, et al., 2016). Re-screening the best binders in detergent-reconstituted 
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membrane proteins allowed for the application of this technology to a format amenable to 
crystallization trials.  
 By collaborating with researchers in the Kossiakoff laboratory at the University of 
Chicago, antibody binders specific to ribose transporter proteins were screened and 
selected for using a phage display library and a recently established membrane protein 
methodology (Dominik & Kossiakoff, 2015). The selection strategy involved individual 
screening of RbsA and RbsB, detergent-based screening of RbsAC and RbsBC, and 
nanodisc-reconstituted screening of RbsABC in the vanadate-trapped state. Although a 
process for reconstituting RbsABC successfully into nanodiscs has been described in an 
earlier chapter, this method had yet to be developed at the time of this phage display 




































Figure 4-3: Sequence of phage display selection protocol. The phage display antibody 
library is incubated with immobilized target. Non-binding phages are washed off, and 
specific binders are removed and the sub-library is amplified in bacterial hosts. The process 
is repeated with the sub-library for several rounds, following which specific binders are 
validated as purified Fab fragments against targets in vitro. 
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of reconstitution success during this time. However, some progress was made at this time 
and these ribose transporter nanodiscs were screened as described in the upcoming sections. 
Binders from these selections were then expressed and purified from bacterial sources and 





4.5 Methods and Materials 
 In the following sections, the methods and materials for ribose transporter 
purification, crystallization in detergents and lipids, and for the generation of antibody 




4.5.1 Detergent Screening for RbsABC by Size-exclusion Chromatography 
 RbsABC was purified as previously described (Clifton, et al., 2015). Following 
purification by affinity chromatography using Ni-NTA resin, the complex solutions were 
either dialyzed or buffer-exchanged to remove imidazole. All required cofactors were 
included in the dialysis/exchange buffers. Buffer exchange was performed by a 
combination of PD10 desalting columns (BIO-RAD) and centrifugal spin filters with the 
appropriate MWCO (Amicon) using buffer without imidazole. Proteins were concentrated 
to final sample volumes of 500 µL (typically 40-50 µM) for the Superdex200 10/30 or 2.0 
mL for the Superdex200 16/60 and spun for 10 minutes on a table-top centrifuge 
(Eppendorf) at maximum RPM (14k) to clear aggregates. Centrifuged samples were 
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transferred to fresh autoclaved 1.5-mL Eppendorf tubes and typically did not contain 
visible signs of precipitation. 
 Samples were injected into either the Superdex200 10/30 or 16/60 GL columns pre-
equilibrated with at least two column volumes of buffer containing 20 mM Tris-HCl pH 
8.0, 200 mM NaCl, 20% glycerol, 1 mM each of cofactors, and one of the following 
detergents at concentrations 2-3 times the published CMC values: DDM (0.05%), C12E8 
(0.02%), LMNG (0.02%), UDM (0.03%), and Fos-choline 12 (0.1%). All detergent 
products were purchased from Anatrace. Progress of the elutions was monitored by 
computer using built-in A280 detection. Fractions were collected using either 1-mL 




4.5.2 Ribose Transporter Crystallization Trials 
 All three ribose transporter complexes were screened in detergent-solubilized states 
using DDM. Following Ni-NTA purification, complexes were further purified by gel 
filtration chromatography using the Superdex200 16/60 GL. The purification buffer was as 
described above with the appropriate cofactors, where required. Fractions containing 
monodisperse protein complexes were combined and concentrated to a range of protein 
concentrations, from 50 – 200 µM. Glycerol was then removed by overnight dialysis in 
buffer containing the required cofactors. 
 Crystallization experiments were setup with a variety of membrane protein sparse 
matrix crystal screens, including MemGold1, MemGold2, MemStart, MemSys, MemFac, 
and MORPHEUS (Molecular Dimensions). Other screens, such as JCSGI-IV, Classics 1-
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2, and Pro-complex (Qiagen), were also employed for crystal screening. Both sitting drop 
and hanging drop crystallization experiments were pursued using several protein 
concentrations (50 – 200 µM) and three different screening temperatures (4, 12, and 20°C). 
Drop volumes consisted of 200 nL protein with 200 nL of precipitant solution. Experiments 
were monitored daily for two weeks, then weekly for six months, then monthly thereafter. 
Screens that resulted in over 80% protein precipitation were re-screened at lower protein 
concentrations.  
 In addition to detergent-based screening, in meso screening was also pursued using 
RbsABC with either orthovanadate or aluminum fluoride as a trapping agent. Aluminum 
fluoride was substituted for vanadate following gel filtration using two rounds of dialysis 
for 4-8 hours each. Aluminum fluoride was prepared as previously described (Oldham & 
Chen, 2011).  
 For bicelles, a mixture of DMPC and CHAPSO was prepared as previously 
described (Ujwal & Bowie, 2011). Bicelle solutions were prepared in water at pH 7.0 at 
35% final concentrations using a DMPC/CHAPSO ratio of 2.8:1. RbsABC was 
concentrated to 50 – 200 µM and mixed with the bicelles solution at a 4:1 ratio. This 
solution was kept on ice overnight to allow complete reconstitution. Crystallization 
experiments were setup in hanging-drop trays using 200 nL protein and precipitant 
volumes. Trays were screened at 4, 20, and 37°C.  
 For LCP, pure monoolein lipids (Avanti) were heated to 100°C for 5-10 minutes. 
Molten lipids were transferred to a pre-warmed Hamilton syringe and mixed with RbsABC 
solution (prepared as above) at a 1:1 final ratio. RbsABC (protein concentration: 50 – 75 
µM) had previously been transferred to a second syringe, and the two syringes were 
  
180 
connected as previously described (Caffrey, 2015) taking great care to prevent the 
formation of air bubbles. Mixing was performed for several minutes by moving the syringe 
pistons back and forth to produce cubic phase. This resulted in a clear solution containg 
protein-incorporated LCP. When glycerol was present in the protein solution, a gray-
colored solution was produced with small precipitates, suggesting incompatibility.  
 Sandwich-plate crystallization experiments were setup using the same screens 
mentioned above. Drop volumes contained 50 nL protein solution and 300 nL precipitant. 
Trays were stored at room temperature to prevent temperature-induced phase changes of 
monoolein lipids. Bicelle and LCP trays were monitored for several months as described 
above. Crystals were screened using UV-fluorescence detection and by home source X-ray 




4.5.3 Phage Display Antibody Selection for Ribose Transporter Proteins 
 The following sub-sections describe steps in phage display selection for complexes 
and individual components of the ribose transporter. The selection strategy involved 
labeling individual components RbsA and RbsB separately using biotin linkers (NHS-
biotin for RbsA and RbsB and maleimide-biotin for RbsA). In addition, MSP was 
biotinylated using NHS-biotin for selection in nanodiscs. These labels contained linker 
regions of 20-25 Å (EZ-Link-NHS-PEG4-Biotin and EZ-Link-SS-PEG2-Biotin, both 
purchased from Thermo), providing the appropriate length to prevent steric hindrance of 
antigenic sites by magnetic beads.  
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Six separate selection experiments were designed: 1) NHS-RbsA, 2) maleimide-
linked RbsA (mal-RbsA, for convenience), 3) NHS-RbsB, 4) mal-RbsA with RbsC (and 
cofactors), 5) NHS-RbsB with RbsC, and 6) RbsABC in biotinylated nanodiscs (with 
cofactors). In addition, an additional selection involving RbsABC in nanodiscs with an 
excess of RbsA and RbsB (to promote complex formation) was performed, for a total of 
seven phage display experiments. All selection experiments were performed in the 
Kossiakoff lab at the University of Chicago. RbsABC nanodiscs and empty nanodiscs were 
prepared as described in Chapter 2 using biotin-labeled MSP1D1 for RbsABC and 




4.5.3.1 Biotinylation of Ribose Transporter Components and MSP 
 RbsC, RbsA, and RbsB were purified using his-tagged constructs as previously 
described (Clifton, et al., 2015). TCEP-HCl was used as a cysteine reducing agent for RbsA 
and was removed by buffer exchange immediately prior to biotinylation. Both proteins 
were concentrated to 20 – 25 µM prior to labeling. Protein concentrations were measured 
using the Bradford Assay and determined against a BSA standard curive.  
 All labels were first dissolved in DMSO to produce stock solutions with final 
concentrations of 20 mM. The stock solutions were then diluted 10-fold in protein buffer 
prior to labeling. A 10-fold excess of the desired biotin label (NHS-biotin for MSP, RbsA 
and RbsB, maleimide-biotin for RbsA) was added to each protein. Labeling was performed 
at room temperature for 30 minutes and, for the NHS reaction, quenched by the addition 
of 5 mM final Tris-HCl pH 7.5. Excess label was removed by PD10 desalting columns, 
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and proteins were further purified by gel filtration chromatography using a Superdex200 
10/30 GL column. Fractions containing labeled protein were pooled, concentrated to 10 
µM, and flash frozen at -80°C. 
 Prior to selection, the efficiency of biotinylation was evaluated by pull-down 
experiments using streptavidin-coated magnetic beads (Streptavidin MagneSphere 
Paramagnetic Beads, Promega) and a pull-down stand (Promega). Beads (100-200 µL) 
were washed three times with the requisite protein buffer. Beads were briefly incubated 
with target proteins, washed three times, and then boiled in SDS-PAGE sample buffer for 
five minutes. In addition, for selection experiments using labeled RbsA and RbsB in 
complex with RbsC, protein-bead samples were further incubated with RbsC (and 
cofactors) and washed three times to remove excess RbsC. Beads were boiled as above. 




4.5.3.2 Phage Library Sorting 
 Seven independent sorting experiments were performed as described above. All 
selection experiments were performed using sAB Library E (Miller, et al., 2012). For 
experiments involving only soluble protein components, four rounds of selection were 
performed. For experiments involving complexes and nanodiscs, an additional fifth round 
was pursued, as described (Dominik, et al., 2016). For experimental convenience, all 
buffers, except for nanodiscs, contained the same components: 25 mM Tris-HCl pH 7.5, 
200 mM NaCl, 0.05% DDM, and 1 mM each of magnesium, ATP, and orthovanadate 
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(Buffer A). For nanodiscs, DDM was excluded from the buffer (Buffer B). In addition, all 
buffers were supplemented with 1% BSA.  
 In addition to choice of labeling, the sorting strategy included both competitive and 
subtractive selection. For RbsABC nanodisc samples, empty unlabeled nanodiscs were 
used throughout the selection process as soluble competitors to subtract nanodisc-binding 
phages. In addition, excess RbsC was maintained throughout sorting for complex-specific 
phage selection. This strategy was intended to combat the complex destabilizing effects of 
high-affinity phage binders and bias towards phages recognizing epitopes away from 
surfaces involving RbsAC and RbsBC complex formation. A similar strategy was 
employed in RbsABC nanodiscs to maintain an excess of soluble, unlabeled RbsA and 
RbsB. 
 Each round of selection was performed as previously described (Dominik & 
Kossiakoff, 2015). On the first day of the selection phages were precleared with 
streptavidin beads. The first two rounds were performed by immobilizing target proteins 
using 200 nM samples. This was reduced in rounds 3-5 to 20 nM. Competitors were 
maintained throughout as described above. Bound phages at the end of each selection were 
eluted as described for either soluble proteins (Paduch, et al., 2013) or nanodiscs (Dominik 
& Kossiakoff, 2015). Following round 3 and through round 5, an aliquot of phage-infected 
cells was plated for each selection in 10-fold serial dilutions to evaluate enrichment from 
round to round. Plates were imaged and stored each morning.  
Selection for NHS-RbsA and mal-RbsA was stopped after four rounds. All other 
samples completed five rounds of selection. Following the final round of sorting, single 
phage colonies from all the selections were picked randomly and streaked onto separate 
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plates. These colonies were then grown overnight and used to prepare glycerol stocks. 
Glycerol stocks were subsequently frozen for long-term use. sABS were named according 
to labeling strategy. From the RbsA alone selection, sABs were named NAR (NHS-RbsA) 
or MAR (mal-RbsA) followed by their position on the plate. From the RbsB selection, 
sABs were named NBR. For selection performed with RbsA in the presence of RbsC, sABs 
were named MARC. For selection performed with RbsB in the presence of RbsC, sABs 
were named MBC. For selection performed with RbsABC nanodiscs, sABs were named 




4.5.3.3 Primary Single-Point Phage ELISA Experiments 
 Single-point phage ELISA was used as the primary validation step for binding 
affinities of synthetic antibodies in the phage format, and was performed as previously 
described (Dominik & Kossiakoff, 2015). The night before each ELISA experiment, 
phages were amplified from the glycerols stocks by infection and subsequent overnight 
cultures. Amplified phage particles were diluted ten-fold for ELISA experiments. As above, 
both Buffer A and Buffer B contained 1% BSA. 
 ELISA plates were coated overnight with Neutravidin (2 mg/mL) and blocked with 
either Buffer A or Buffer B, and then washed with buffer three times. Experimental wells 
were coated with 20 nM labeled proteins. Phages were allowed to bind and then washed 
three times with buffer. Plates were incubated with HRP-conjugated anti-M13 antibody 
and then washed three times with buffer. TMB solution was prepared and added and, 
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following 2 minutes for development, blocked by the addition of HCl. The absorbance of 
each well was measured at 450 nm.  
 Each sAB clone with A450 signal above 0.2 (four times above background) was 
selected for sequencing. Phages from these wells were streaked onto a fresh plate and 
grown overnight. The plate was sent for colony PCR. Unique clones were selected and 





4.5.3.4 Secondary Single-Point Phage ELISA 
 As an additional validation, secondary ELISA in the phage format was performed 
to identify complex- and conformation-specific binders. ELISA experiments were 
performed for labeled RbsA and RbsB in the presence of RbsC and either RbsBC or RbsAC 
with cofactors present in all buffers. In addition, epitope mapping was performed for RbsA 
using the N-terminal NBD construct [ (Clifton, 2005), (Armstrong, Tabernero, Zhang, 
Hermodson, & Stauffacher, 1998)] as both a soluble competitor and as a labeled protein in 
ELISA experiments. The N-terminal domain construct was purified as previously 
described (Clifton 2005), and labeled using the same biotinylation strategy described above. 
All generated phages were tested against these sample conditions to identify unique 









4.5.3.5 Cloning and Purification of unique sABs 
 Several unique sABs from each selection strategy were chosen for cloning on the 
basis of ELISA signal strength and location of epitope. Twenty-one sAB genes were 
amplified by PCR and then sub-cloned into the expression vector pSVF4 as previously 
described (Paduch, et al., 2013). Fourteen of the cloned sABs were then transformed into 
BL21-DE3 cells and expressed and purified as previously described (Paduch 2013). Of 
these, purified synthetic antibodies that expressed at sufficient levels were dialyzed 
overnight following purification (50 mM Tris-HCl pH 7.5, 100 mM NaCl), concentrated 




4.5.3.6 Antibody-Antigen Complex Formation in Vitro 
 Synthetic antibodies were tested for the ability to form complexes with RbsA, 
RbsABC, and RbsB. Complex formation was evaluated by gel filtration chromatography 
using a Superdex200 10/30 GL column. All complex buffers contained cofactors as needed. 
RbsABC-sAB complex formation was tested in detergent (0.05% DDM). Elution was 
monitored by A280. Fractions (1 mL) were collected and evaluated by SDS-PAGE. 
 Complex formation with RbsA was tested in the presence of magnesium, ATP, 
vanadate and the following sABs: NAR09, NAR10, MA22, and MA36. In addition, the 
following sABS were used in combination to test the success of epitope mapping: NAR09 
and NAR10, NAR09 and MA22, and NAR10 with MA22.  
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 Complex formation witih RbsB was tested with the sAB NBR51 in the absence of 
cofactors. For RbsB experiments, buffer without DDM and containing only 10 mM Tris-
HCl, pH 8.0, was used for all SEC experiments. 
 Complex formation with RbsABC was tested with all of the above sABs 
individually in the presence of magnesium, ATP, and vanadate, and also with the sABs 
MAC70 (RbsA with RbsC), NDC91, and NDC92, from the selection with nanodiscs.  
 To form complexes, sABs were added at a 1.25:1 molar excess over protein or 
protein complexes and mixed and briefly incubated on ice. 500 µL samples from each 
complex formation sample was injected. Binding was evaluated by shifts of the protein 
elution profiles to lower retention volumes and the presence of sAB bands (25 kDa) on 
SDS-PAGE. All gel filtration experiments were run for 1.5-2 column volumes to allow 
elution of unbound sABs. Following completion of experiments, columns were cleaned by 
1 mg/mL pepsin solution in 50 mM acetic acid (2 CVs) followed by 0.5 M NaOH (3-5 





 Results from detergent-optimization, crystallization trials, and phage display 




4.6.1 Detergent-Optimization Results 
 Five different detergents were screened for buffer optimization. These included 
DDM, which has been tested extensively but not previously used in gel filtration 
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experiments. Elution profiles for four other detergents were compared to DDM-
reconstituted RbsABC in the presence of cofactors.  
 DDM-reconstituted RbsABC eluted at approximately approximately 12.5 mL from 
the Superdex200 10/30 (FIGURE 4-4, blue curve). RbsABC was subsequently exchanged 
during gel filtration into LMNG at a concentration 3 times over CMC (FIGURE 4-4, green 
curve). Ribose transporter proteins primarily eluted in the void volume (~7.5 mL) and 
precipitated in the fractions shortly after, indicating poor compatibility. Tests in 
concentrations ranging from CMC to an order of magnitude higher did not produce better 
results (data not shown).  
 RbsABC was also exchanged into Fos-choline 12 in a similar fashion (FIGURE 4-
4, red curve). The complex appeared to be destabilized and RbsA and RbsB eluted at higher 
retention volumes. RbsC eluted in the aggregate fraction. A small amount of complex 
appeared to elute at the expected retention volume but could not be detected using 
Coomassie-staining SDS-PAGE. 
 The detergents UDM and C12E8 were tested using the Superdex200 16/60. On this 
column, DDM-reconstituted RbsABC eluted at roughly 60 mL retention volume 
(FIGURE 4-5, blue curve). RbsABC exchanged into UDM eluted in the void volumne, 
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Figure 4-4: Elution profile of RbsABC in the detergents DDM, LMNG, and Fos-choline 
evaluated using Superdex200 10/30 GL column. Void volume = 7.5 mL. 

















Figure 4-5: Elution profile of RbsABC in the detergents DDM, UDM, and C12E8, 
evaluated using a Superdex200 16/60 column. Void volume = 38 mL. 



















suggesting aggregation (FIGURE 4-5, red curve). Fractions containing these proteins 
developed precipitation shortly after elution. RbsABC in C12E8 (FIGURE 4-5, green 
curve) eluted in part in the void volume and in part at a lower retention volume than 
expected (48 mL). Fractions containing RbsABC were tested for activity but found to show 
no RbsC-stimulated activity in RbsA, as is expected in detergent (data not shown). This 





4.6.2 Crystallization Trials of the Ribose Transporter Complexes 
 Following extensive screening, only one RbsABC crystallization condition 
provided protein crystals (FIGURE 4-6). These crystals arose from the Pro-complex 
screen using RbsABC in bicelles at 200 µM concentration, and precipitant conditions 
included 25% polyacrylic acid sodium salt (PAANa) and 0.1 M potassium dihydrogen 
phosphate buffer. Crystals were evaluated by UV fluorescence, which confirmed the 
content was protein. The crystals were fragile and disappeared within two weeks. Attempts 
to harvest the crystals failed. 
 Optimization of these crystals was pursued using a grid screen, with PAANa 
ranging in concentration from 10 to 40% and buffer pH ranging from 6.5 to 9.0. Protein 
concentration was varied from 50 to 200 µM, with crystal size and number varying 
proportional to protein concentration. Small crystals reappeared shortly after setup, but 






































Figure 4-6: RbsABC crystals in PAANa and dihdyrogen phosphate. Above: brightfield 
image at 200X maginifcation. Below: UV fluorescence image (measured at 340 emission 
at same magnification). 
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4.6.3 Results of Phage Display Library Sorting 
 Results for sorting experiments have been broken into sections for convenience. 




4.6.3.1 Control Pull-down Experiments of Labeled Proteins 
 Following RbsA and RbsB labeling with biotin reagents, excess unreacted label 
was removed using desalting columns and gel-filtration chromatography (data not shown). 
NHS-RbsA, mal-RbsA, and NHS-RbsB were then tested for efficiency of labeling by 
sample pull-down experiments using streptavidin paramagnetic beads. The proteins were 
tested alone and then for their ability to retain RbsC during pull-down experiments. As a 
control, unlabeled RbsC was also tested with beads for non-specific binding.  
 For all experiments, the following samples were prepared and analyzed by SDS-
PAGE. Experimental buffers included cofactors and detergent in all cases for convenience. 
The initial protein sample was run in lanes marked “input”. Following incubation of the 
sample with beads and subsequent pull-down, a sample was collected and marked “flow-
through”. These beads were washed three times; wash 3 was collected and run on the gel. 
Samples were then incubated either with RbsC or a buffer blank (marked “detergent wash”). 
The flow-through was again collected and ran on the gel (FT2). The beads were again 
washed three times; wash 3 was collected and run on the gel. Finally, the remaining beads 
were dissolved in SDS sample buffer, boiled, and subsequently loaded and run on the gel. 
This fraction is marked “beads”. 
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 In FIGURE 4-7, pull-down results from NHS-labeled RbsB and RbsA are shown 
using a stain-free gel visualized by protein fluorescence emission detection. Bands for 
RbsA in the beads fraction are readily visible, along with streptavidin (lane 9). In addition, 
excess, unbound RbsA is also visible in the flow-through (lane 10). 
 RbsB was not visible by this detection method. This result is expected given an 
analysis of the RbsB amino acid sequence reveals a complete absence of aromatic amino 
acids. To visualize RbsB, Coomassie staining followed by imaging was employed 
(FIGURE 4-8). Following imaging, RbsB became readily apparent in the beads fraction, 
demonstrating a successful pull-down.  
 Further, analysis of the beads fraction with the RbsC control (lanes 14 and 15 in 
both 4-7 and 4-8) demonstrated RbsC does not bind non-specifically to streptavidin beads 
(lane 15). In all lanes containing streptavidin, a second band is apparent; this is a 
streptavidin dimer.  
 In lanes 1-6 of FIGURE 4-9, mal-RbsA was tested for successful pull-downs and 
visualized by stain-free gels using protein fluorescence. The RbsA band is apparent in the 
beads fraction (lanes 2), with a smaller amount of unbound mal-RbsA present in the flow-
through. The darker streptavidin monomer and dimer bands are also apparent. 
 In lanes 8-12, the ability of NHS-RbsB to pull-down RbsC was tested. The input 
was omitted here. In the beads fraction, bands for RbsC and streptavidin are readily 
apparent. However, RbsB once again required Coomassie staining to visualize. These 
results are shown in FIGURE 4-10. Bands for RbsB, RbsC, and streptavidin can be found 
in the beads fraction (lane 8). Excess, unbound RbsC is also present in the flow-through 
following incubation with NHS-RbsB (lanes 11 in 4-9 and 4-10). 
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 Finally, the ability of both NHS-RbsA and mal-RbsA to pull-down RbsC was tested 
and visualized on stain-free gels using protein fluorescence (FIGURE 4-11). In the beads 
fraction of both (lanes 1 and 6), bands for RbsA, RbsC, and streptavidin are clearly visible. 
Excess RbsC in the flow-through is present, as expected. These results demonstrated that 
proteins were successfully labeled and able to pull-down unlabeled RbsC in a similar 
fashion to purification with affinity chromatography. Based on these successful pull-downs, 




FIGURE 4-7: Pull-down of NHS-RbsB and NHS-RbsA. RbsB and RbsA labeled with 
NHS-PEG4-Biotin. 1 = RbsB Input, 2 = RbsB-NHS + Beads (final), 3 = FT following 
RbsB pull-down, 4 = W3 following pull-down, 5 = FT2 following detergent wash, 6 = W3-
2, 7 = Standards, 8 = RbsA Input, 9 = RbsA-NHS + Beads (final), 10 = FT1, 11 = W3-1, 
12 = FT2, 13 = W3-2. Fractions from Control Reactions with RbsC run on each gel (gel 1 
– Input and beads fraction; gel 2 – FT1 and W3-1 fraction; gel 3 – FT2 and W3-2 fractions). 
14 = RbsC Input, 15 = RbsC + beads (following wash steps). 
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Figure 4-8: Coomassie staining of pull-down of NHS-RbsB and NHS-RbsA. RbsB is now 
visible by staining. RbsB and RbsA labeled with NHS-PEG4-Biotin. 1 = RbsB Input, 2 = 
RbsB-NHS + Beads (final), 3 = FT following RbsB pull-down, 4 = W3 following pull-
down, 5 = FT2 following detergent wash, 6 = W3-2, 7 = Standards, 8 = RbsA Input, 9 = 
RbsA-NHS + Beads (final), 10 = FT1, 11 = W3-1, 12 = FT2, 13 = W3-2. Fractions from 
Control Reactions with RbsC run on each gel (gel 1 – Input and beads fraction; gel 2 – FT1 
and W3-1 fraction; gel 3 – FT2 and W3-2 fractions). 14 = RbsC Input, 15 = RbsC + beads 
(following wash steps). 
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FIGURE 4-9: Pull-down of mal-RbsA and NHS-RbsB incubated with RbsC. RbsA is 
labeled with mal-PEG2-Biotin and RbsB is labeled with NHS-PEG4-Biotin. 1 = RbsA 
Input, 2 = RbsA-Mal + Beads (final), 3 = FT following RbsA pull-down, 4 = W3 following 
pull-down, 5 = FT2 following detergent wash, 6 = W3-2, 7 = Standards, 8 = RbsB + RbsC 
+ beads (final), 9 = FT1, 10 = W3-1, 11 = FT2 after RbsC, 12 = W3-2. Fractions from 
Control Reactions with RbsC run on each gel (gel 1 – Input and beads fraction; gel 2 – FT1 
and W3-1 fraction; gel 3 – FT2 and W3-2 fractions). 13 = RbsC FT, 14 = RbsC W3. 
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FIGURE 4-10: Coomassie staining of pull-down of mal-RbsA and NHS-RbsB incubated 
with RbsC. RbsB is now visible by staining. RbsA is labeled with mal-PEG2-Biotin and 
RbsB is labeled with NHS-PEG4-Biotin. 1 = RbsA Input, 2 = RbsA-Mal + Beads (final), 
3 = FT following RbsA pull-down, 4 = W3 following pull-down, 5 = FT2 following 
detergent wash, 6 = W3-2, 7 = Standards, 8 = RbsB + RbsC + beads (final), 9 = FT1, 10 = 
W3-1, 11 = FT2 after RbsC, 12 = W3-2. Fractions from Control Reactions with RbsC run 
on each gel (gel 1 – Input and beads fraction; gel 2 – FT1 and W3-1 fraction; gel 3 – FT2 
and W3-2 fractions). 13 = RbsC FT, 14 = RbsC W3. 
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Figure 4-11: Pull-down of NHS-RbsA and mal-RbsA, both incubated with RbsC. RbsA is 
labeled with NHS-PEG4-Biotin in lanes 1-5 and with mal-PEG2-Biotin in lanes 6-10. 1 = 
RbsA-NHS+ RbsC + Beads (final), 2 = FT1 , 3 = W3-1, 4 = FT2 after RbsC addition, 5 = 
W3-2, 6 = RbsA-Mal + RbsC + Beads (final), 7 = FT1, 8 = W3-1, 9 = FT2 after RbsC 
addition, 10 = W3-2, 11 = standards. Fractions from Control Reactions with RbsC run on 
each gel (gel 1 – Input and beads fraction; gel 2 – FT1 and W3-1 fraction; gel 3 – FT2 and 
W3-2 fractions). 12 = RbsC FT2, 13 = RbsC W3-2. 
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4.6.3.2 Phage Display Library Sorting Results 
 Phage display sorting was performed for the following targets: 1) NHS-RbsA, 2) 
mal-RbsA, 3) NHS-RbsB, 4) mal-RbsA with RbsC, 5) NHS-RbsB with RbsC, 6) RbsABC 
in biot-MSP1D1 nanodiscs, and 7) RbsABC in biot-MSP1D1 nanodiscs with excess RbsB 
and RbsA for competitive selection. For samples 4) and 5), RbsC was added at every step 
to ensure complex formation with target protein was maintained. A similar technique was 
employed for sample 7) with RbsB and RbsA. All sorting was performed in buffers with 
cofactors and detergent, except for nanodisc sample buffers, which contained only 
cofactors.  
 Soluble proteins were immobilized at target concentrations of 200 nM at the start 
of selection, while nanodiscs were immobilized at 2 µM. Where required, RbsC was added 
at final concentrations of 1 µM. All protein concentrations were determined by Bradford 
assays. For the second round of selection, target concentration was reduced 2-fold. For the 
final rounds of selection, target concentration was reduced 10-fold from starting 
concentrations. In addition, empty, unlabeled nanodiscs were employed as soluble 
competitors for subtractive selection during these rounds. Following round 3, control pull-
downs without proteins of phage sub-libraries were also tested for specific binding.  
 Following round 4 of selection, phages from each selection and control were 
amplified and plated as serial dilutions (10-1 to 10-4) on LB media containing ampicillin, as 
previously described (Dominik 2015) (FIGURE 4-12). Dilutions were streaked on plates 
to resolve individual colonies produced by sublibrary infection.  
 Selection for samples 1, 2, 4, and 5 showed significant enrichment of phages over 
background levels. Significantly higher numbers of colonies were present in samples with 
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target (+) than without (-). Library sorting for these samples was halted at this point and 
phages were carried to the next step. Unexpectedly, sample 3, which contained soluble 
RbsB, showed little enrichment of phages over background levels. 
 Selection proceeded an additional round for samples 3, 6, and 7 and samples were 
similarly plated (FIGURE 4-13). Following this round, serial dilutions of sample 3 showed 
significant enrichment of phages over background levels, indicating a successful selection 
strategy. Both samples 6 and 7 showed little enrichment over samples containing either 
empty nanodiscs or no protein.  
 At the completion of selection, sublibraries were produced for each target that 
showed significant enrichment over background levels, except for nanodisc samples. 
Phages from both round 3 and round 4 of selection (or round 4 and round 5 for nanodiscs) 
were used to infect E. coli cell cultures in the presence of helper phage and subsequently 
plated separately on LB-ampicillin media for overnight growth. The following morning, 
two dozen colonies from each plate were selected and amplified in 96-well deep block 
format overnight. Cells were spun down and phages were isolated and diluted ten-fold for 
ELISA experiments. The phages were also replated and colonies were sent for sequencing 




Figure 4-12: Round 4 of phage library sorting. Phages were used to infect cells and serial 
dilutions were plated following infection. Top panel: Comparison of selection for samples 
1, 2, 3 from pull-downs containing labeled proteins (+) over those with beads alone (-). 




Figure 4-13: Round 5 of phage library sorting. Phages were used to infect cells and serial 
dilutions were plated following infection. Top panel: Comparison of selection for sample 
3 in pull-downs with (+) and without (-) proteins. Bottom panel: Comparison of selection 
for samples with proteins (+), samples with empty nanodiscs (N-), and samples without 
labeled proteins (-). 
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4.6.3.3 Initial Validation Using Phage ELISA 
 ELISA experiments were performed for phage sublibraries using 20 nM target 
concentration to immobilize protein on wells. ELISA experiments were performed in a 
format mirroring selection. NHS-RbsA, mal-RbsA, NHS-RbsB, and RbsABC nanodiscs 
were immobilized on ELISA plates. Much like for selection samples 4) and 5), RbsC was 
added throughout ELISA experiments. Excess RbsA and RbsB were also employed for 
ELISA experiments of selection sample 7). Following several rounds of washing, bound 
phages were detected using HRP-conjugated anti-M13 antibody. Background wells lacking 
proteins were prepared and tested for all phages.  
 Selections for NHS- and mal-RbsA showed significant enrichment of phages 
following round 4, as evaluated by the improvement in ELISA signal for these sublibraries 
(FIGURE 4-14, top and middle panels) over background levels (red = protein; black = 
phage only controls). Similarly, NHS-RbsB sublibraries showed significant enrichment 
following rounds 4 and 5 (FIGURE 4-14, bottom panel). For NHS-RbsB, samples from 
rounds 3, 4, and 5 were used due to limited numbers of colonies yielded after overnight 
plating. 
 Interestingly, selections with mal-RbsA and NHS-RbsB yielded different ELISA 
results compared with selections for these proteins alone (FIGURE 4-15). For mal-RbsA, 
few high quality binders were produced following selection with RbsC as a soluble 
competitor (4-15, top panel).  For NHS-RbsB (bottom panel), enrichment following round 
3 was significantly improved due to the presence of RbsC as a soluble competitor. 
 Finally, ELISA results for nanodisc samples (FIGURE 4-16) showed very few 
binders with signal elevated above background levels. This was the case both for selection 
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with RbsABC nanodiscs (top panel) and for RbsABC nanodiscs with RbsA and RbsB as 
soluble competitors. This was unsurprising given the lack of enrichment previously seen 
in the sorting experiments.  
 Following ELISA experiments, signals were cross-referenced to sequencing results 
and sorted according to signal strength and uniqueness of CDR amino acid identities. Based 
on these experiments, 12-24 high- to medium quality binders were chosen from each 
selection sublibrary, for a total of 95 from all selections combined and frozen as glycerol 
stocks. These phages were named based on their selection strategy and numbered according 




4.6.3.4 Secondary ELISA for Additional Validation of Targets Prior to Cloning 
 Given limited resources for expression, purification, and crystal screening of 
protein-sAB complexes for structure determination, secondary validation of phage ELISA 
was pursued using the master population of unique binders chosen from the initial ELISA 
experiments and sequencing results. Phages from master plate glycerol stocks were used 
to infect E. coli cells and grown overnight at 37°C with shaking. The following morning, 
cells were pelleted and phages were transferred to a separate plate. Ten-fold dilutions of 
phage stocks were prepared for use with ELISA experiments. 
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Figure 4-14: Phage ELISA of sublibraries for rounds 3 and 4 (and round 5 for RbsB) from 
selection samples 1, 2, 3. For RbsA-NHS, round 3 is A1 - H3 and round 4 is A4 - H6. For 
RbsA-mal, round 3 is A7 – H9 and round 4 is A10 – H12. For RbsB, round 3 is A1 – H3, 
round 4 is A3 – H4, and round 5 is A5 – H6. Sample signal given in red. Phage only wells 
(black) lack target protein. Dotted line is typical background level. 
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Figure 4-15: Phage ELISA of sublibraries for rounds 3 and 4 from selection samples 4 and 
5. For RbsA-mal with RbsC, round 3 is A1 - H3 and round 4 is A4 - H6. For RbsB-NHS 
with RbsC, round 3 is A7 – H9 and round 4 is A10 – H12. Sample signal given in red. 
Phage only wells (black) lack target protein. Dotted line is typical background level. 
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Figure 4-16: Phage ELISA of sublibraries for rounds 4 and 5 from selection samples 6 and 
7. For RbsABC (Sample 6) in biot-MSP1D1, round 4 is A1 – H3 and round 5 is A4 to H6. 
For RbsABC (Sample 7) in biot-MSP1D1 with soluble competitors, round 4 is A7 – H9 
and round 5 is A10 – H12. Sample signal given in red. Phage only wells (black) lack target 
protein. Dotted line is typical background level. 
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Figure 4-17: Map of Phage Master Plate from Ribose Transporter Sorting Experiments. 
Top panel: Selected wells from phage ELISA experiments (see Figures 4-14 – 4-16). Wells 
are color-coded to match selection experiment. Orange = NHS-RbsA, Yellow = mal-RbsA, 
Blue = NHS-RbsB, Pink = mal-RbsA with RbsC, Purple = NHS-RbsB with RbsC, NDC = 
combined phages from nanodisc sublibrary. 
Bottom panel: Wells renamed according to selection strategy for convenient reference. 
Color-coding from top panel is preserved. NAR01-NAR21 = phages from NHS-RbsA, 
MA22-MA45 = phages from mal-RbsA, NBR51-NBR67 = phages from NHS-RbsB, 
MAC70 = phages from mal-RbsA with RbsC, MBC71-MBC82 = phages from NHS-RbsB 
with RbsC, NDC91-99 = phages fron nanodiscs. Plate is stored in Kossiakoff lab and is 
named “SPS1”. 
1 2 3 4 5 6 7 8 9 10 11 12
A A4 E4 A5 H12 E12 G8 H5 C3 F10 D10 B8
B D4 E5 D5 A10 C11 D11 H4 F3 A10 A8 B9
C B4 F5 G5 F10 E10 G9 G3 E6 G11 H10 B12
D B1 H4 H6 D7 B12 B11 D3 A3 G12 G4 D12
E F6 D3 B5 G12 C12 G11 E3 H3 C10 H5
F C5 D6 E11 A12 D10 D4 A4 C4 D11 C2
G C4 B6 F11 G10 F12 B3 H6 D5 F11 G12
H E6 D2 H10 H7 C10 F5 A5 C11 E10 A12
1 2 3 4 5 6 7 8 9 10 11 12
A NAR01 NAR09 NAR17 MA25 MA33 MA41 NBR54 NBR62 MBC72 MBC80 NDC96
B NAR02 NAR10 NAR18 MA26 MA34 MA42 NBR55 NBR63 MBC73 MBC81 NDC97
C NAR03 NAR11 NAR19 MA27 MA35 MA43 NBR56 NBR64 MBC74 MBC82 NDC98
D NAR04 NAR12 NAR20 MA28 MA36 MA44 NBR57 NBR65 MBC75 NDC91 NDC99
E NAR05 NAR13 NAR21 MA29 MA37 MA45 NBR58 NBR66 MBC76 NDC92
F NAR06 NAR14 MA22 MA30 MA38 NBR51 NBR59 NBR67 MBC77 NDC93
G NAR07 NAR15 MA23 MA31 MA39 NBR52 NBR60 MAC70 MBC78 NDC94
H NAR08 NAR16 MA24 MA32 MA40 NBR53 NBR61 MBC71 MBC79 NDC95
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4.6.3.4.1 Identifying Complex-Specific Binders – Part 1 
 Complex-specific phages were tested for using a competition binding ELISA. In 
these experiments, labeled RbsA (both NHS and mal), NHS-RbsB, and newly labeled 
NHS-RbsC were immobilized onto ELISA plates. Cognate binding partners were included 
as soluble competitors throughout the ELISA experiments in the presence of 1 mM 
magnesium, ATP, and orthovanadate.  
 The first set of experiments tested the following sub-population of phages from the 
master plate, given by columns: 3, 4, 6, 7, 9, and 10 (FIGURES 4-18 – 4-20). This selection 
sampled phages from each sub-population from every sorting experiment. Each phage was 
tested using 11 different immobilized proteins and complexes. The conditions, given with 
their color-coding and pattern used on ELISA bar graphs, are l) NHS-RbsA (blue, solid); 
2) mal-RbsA (blue, dotted); 3) NHS-RbsB (red, solid); 4) NHS-RbsC (green, solid); 5) 
NHS-RbsA + RbsC (blue, thin stripes); 6) mal-RbsA + RbsC (blue, thick stripes); 7) NHS-
RbsB + RbsC (red, checked); 8) NHS-RbsC with RbsA (white with green border); 9) NHS-
RbsC with RbsB (green and white stripes); 10) mal-RbsA with RbsBC (dark blue, solid); 
and 11) NHS-RbsB with RbsAC (purple). 
 Initially, high background signal was observed for all experiments. This was 
attributed to the presence of orthovanadate, which turns yellow when HCl is added. HCl 
quenches the color development reaction of HRP. For these data sets, all background signal 
was subtracted using phage-only wells. For subsequent ELISA experiments, vanadate was 
reduced 10-fold in concentration with no detriment. This has previously been shown to be 
tolerable to RbsABC complex formation (Clifton, et al., 2016).  
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  Phages obtained from RbsA sorting experiments (columns 3, 4, and 6) 
demonstrated no cross-reactivity with other immobilized proteins. These phages also 
produced robust ELISA signals in wells where immobilized RbsA was included with 
cognate complex proteins. However, no signal was obtained from wells containing 
immobilized RbsB or RbsC where RbsA was included to form complexes.  
 Phages obtained from RbsB sorting experiments produced strong signals where 
RbsB was immobilized. Strong ELISA signals were also produced in wells that contained 
mal-RbsA immobilized with RbsBC and cofactors. However, many RbB phages from the 
NBR subpopulation also produced strong signals in wells containing only RbsA, 
suggesting cross-reactivity and incomplete selection. 
 Immobilized RbsC produced no ELISA signal in wells where it was the only protein. 
Interestingly, in wells with RbsC and binding partners, ELISA signals arose only phages 
from nanodisc selections (NDC), suggesting complex recognition. These phages also 
recognized RbsA and RbsB when RbsC was present.  
 Many results were ambiguous due to the background signal of vanadate. In the 
following experiments, vanadate concentrations were reduced. 
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Figure 4-18: Single-point phage ELISA testing columns 3 and 4 from SPS1 Master Plate 
(See figure 4-17). The conditions, given with their color-coding and pattern used on ELISA 
bar graphs, are l) NHS-RbsA (blue, solid); 2) mal-RbsA (blue, dotted); 3) NHS-RbsB (red, 
solid); 4) NHS-RbsC (green, solid); 5) NHS-RbsA + RbsC (blue, thin stripes); 6) mal-
RbsA + RbsC (blue, thick stripes); 7) NHS-RbsB + RbsC (red, checked); 8) NHS-RbsC 
with RbsA (white with green border); 9) NHS-RbsC with RbsB (green and white stripes); 
mal-RbsA with RbsBC (dark blue, solid); and 11) NHS-RbsB with RbsAC (purple).
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Figure 4-19: Single-point phage ELISA testing columns 6 and 7 from SPS1 Master Plate 
(See figure 4-17). The conditions, given with their color-coding and pattern used on ELISA 
bar graphs, are l) NHS-RbsA (blue, solid); 2) mal-RbsA (blue, dotted); 3) NHS-RbsB (red, 
solid); 4) NHS-RbsC (green, solid); 5) NHS-RbsA + RbsC (blue, thin stripes); 6) mal-
RbsA + RbsC (blue, thick stripes); 7) NHS-RbsB + RbsC (red, checked); 8) NHS-RbsC 
with RbsA (white with green border); 9) NHS-RbsC with RbsB (green and white stripes); 
mal-RbsA with RbsBC (dark blue, solid); and 11) NHS-RbsB with RbsAC (purple).
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Figure 4-20: Single-point phage ELISA testing columns 9 and 10 from SPS1 Master Plate 
(See figure 4-17). The conditions, given with their color-coding and pattern used on ELISA 
bar graphs, are l) NHS-RbsA (blue, solid); 2) mal-RbsA (blue, dotted); 3) NHS-RbsB (red, 
solid); 4) NHS-RbsC (green, solid); 5) NHS-RbsA + RbsC (blue, thin stripes); 6) mal-
RbsA + RbsC (blue, thick stripes); 7) NHS-RbsB + RbsC (red, checked); 8) NHS-RbsC 
with RbsA (white with green border); 9) NHS-RbsC with RbsB (green and white stripes); 
10) mal-RbsA with RbsBC (dark blue, solid); and 11) NHS-RbsB with RbsAC (purple).
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4.6.3.4.2 Identifying Complex Specific Binders – Part 2 
 The remaining phages were tested by single-point ELISA in a similar fashion, 
employing similar testing conditions. These conditions, given with their color-coding and 
pattern used on ELISA bar graphs, are l) NHS-RbsA (blue, solid); 2) mal-RbsA (blue, 
dotted); 3) NHS-RbsB (red, solid); 4) NHS-RbsC (green, solid); 5) NHS-RbsA + RbsBC 
(blue, thin stripes); 6) mal-RbsA + RbsC (blue, thick stripes); 7) NHS-RbsB + RbsAC (red, 
checked); 8) NHS-RbsC with RbsA (white with green border); 9) NHS-RbsC with RbsB 
(green and white stripes); 10) mal-RbsA with RbsBC (dark blue, solid); and 11) NHS-
RbsC with RbsA and RbsB (purple). Phages from columns 2, 5, and 8 were tested using 
this conditions with cofactors (FIGURES 4-21 and 4-22). 
 In addition, phages from part 1 with high background signal were re-tested using 
the reduced vanadate concentrations. These included primarily RbsB phage subpopulations, 
which were tested to determine if cross-reactivity signals were simply a consequence of 
vanadate background. Testing conditions were identical to those described above 
(FIGURE 4-23). 
 The results for untested phages were consistent with those observed in the previous 
ELISA experiments (FIGURE 4-21). Wells with immobilized RbsA produced strong 
ELISA signals from RbsA phage subpopulations, as expected. These phages showed no 
cross-reactivity with wells containing immobilized RbsB or RbsC, including where RbsA 
was present as a soluble cofactor.  
 Untested phages from the RbB subpopulation showed less cross-reactivity with 
wells containing immobilized RbsA alone (FIGURE 4-22). These phages gave moderate 
ELISA signals for wells with immobilized RbsB. Interestingly, these same phages gave 
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robust ELISA signals in wells with soluble RbsBC present as a cofactor, suggesting the 
ability to bind to RbsB in the context of ribose transporter complexes.  
 Retested phages from RbsB sorting experiments also showed reduced cross-
reactivity with RbsA-alone wells (FIGURE 4-23, top panel). However, relatively high 
ELISA signals for these same wells were obtained with phages from RbsBC sorting 
experiments (FIGURE 4-23, middle panel and MBC subpopulation).  
Finally, wells with immobilized RbsC with and without cognate binding partners 







Figure 4-21: Single-point phage ELISA testing columns 2 and 5 from SPS1 Master Plate 
(See figure 4-17). These conditions, given with their color-coding and pattern used on 
ELISA bar graphs, are l) NHS-RbsA (blue, solid); 2) mal-RbsA (blue, dotted); 3) NHS-
RbsB (red, solid); 4) NHS-RbsC (green, solid); 5) NHS-RbsA + RbsBC (blue, thin stripes); 
6) mal-RbsA + RbsC (blue, thick stripes); 7) NHS-RbsB + RbsAC (red, checked); 8) NHS-
RbsC with RbsA (white with green border); 9) NHS-RbsC with RbsB (green and white 




Figure 4-22: Single-point phage ELISA testing column 8 from SPS1 Master Plate (See 
figure 4-17). These conditions, given with their color-coding and pattern used on ELISA 
bar graphs, are l) NHS-RbsA (blue, solid); 2) mal-RbsA (blue, dotted); 3) NHS-RbsB (red, 
solid); 4) NHS-RbsC (green, solid); 5) NHS-RbsA + RbsBC (blue, thin stripes); 6) mal-
RbsA + RbsC (blue, thick stripes); 7) NHS-RbsB + RbsAC (red, checked); 8) NHS-RbsC 
with RbsA (white with green border); 9) NHS-RbsC with RbsB (green and white stripes); 



































Figure 4-23: Single-point phage ELISA re-testing columns 7, 9, and 10 from SPS1 Master 
Plate (See figure 4-17). These conditions, given with their color-coding and pattern used 
on ELISA bar graphs, are l) NHS-RbsA (blue, solid); 2) mal-RbsA (blue, dotted); 3) NHS-
RbsB (red, solid); 4) NHS-RbsC (green, solid); 5) NHS-RbsA + RbsBC (blue, thin stripes); 
6) mal-RbsA + RbsC (blue, thick stripes); 7) NHS-RbsB + RbsAC (red, checked); 8) NHS-
RbsC with RbsA (white with green border); 9) NHS-RbsC with RbsB (green and white 




4.6.3.4.3 Mapping RbsA using Single Point ELISA 
 Initial ELISA experiments showed the highest quality binders were available for 
RbsA. Since an N-terminal domain structure of RbsA has previously been determined 
(Armstrong, Tabernero, Zhang, Hermodson, & Stauffacher, 1998), epitope mapping using 
phage ELISA was performed to test if any phages bound to the C-terminal domain. The 
goal was to determine if antibodies exist that could stabilize this region, making it more 
amenable for crystallization.  
 The N-terminal domain construct for RbsA (residues 1-244) was previously 
designed and shown to express stably at high levels (Clifton, 2005). This construct was 
purified as previously described and subsequently labeled with both NHS and maleimide 
linkers, as done before for full-length RbsA. The maleimide linker took advantage of the 
single cysteine present on the N-terminal domain (NTD). 
 Phages were prepared as described earlier. ELISA plates were prepared and coated 
with either no protein, NHS-RbsANTD, mal-RbsANTD, or NHS-RbsAFL (for full-length 
RbsA). Binding was tested in the presence of cofactors, as before, taking care to use 
reduced vanadate concentrations. All phage subpopulations produced from RbsA sorting 
experiments were tested for binding to either RbsANTD or RbsAFL. As negative controls, 
some phages from RbsB sorting were included.  
 Of the 45 phages tested from the RbsA subpopulation, 23 produced signals for 
either RbsANTD labeled version (FIGURES 4-24 and 4-25). Of this group of phages, 
only 9 produced signals resembling those produced for full-length RbsA. As an additional 
control, soluble NTD RbsA was included as a competitor in a separate ELISA experiment. 
These results were identical to those produced for immobilizing NTD RbsA (data not 
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shown). In addition, no cross-reactivity with RbsB phages was observed. This suggested 
the population included phages specific for full-length RbsA or NTD-RbsA, and perhaps 
some that bound only to the C-terminal domain. Experiments with the C-terminal domain 




4.6.3.5 Cloning into Expression Vectors and Purifying Phages 
 With considerations for time and resources, a small group of phages from the initial 
population of 95 were chosen for cloning into expression vectors, as described in the 
methods section. The choice was based on strength of ELISA signal, diversity of epitopes, 
and recognition of ribose transporter complexes. Cloning was performed using a previously 
described protocol. Successful cloning reactions were confirmed by sequencing results 
using primers specific for both heavy- and light-chains. 
Twelve clones were then expressed and purified using previously described protocols 
(Paduch 2013). Of these, eight expressed at sufficient levels to carry over to in vitro studies 
(NAR09, NAR10, MA22, MA36, NBR51, MAC70, NDC91, and NDC92). Three of these 
expressed at significantly high levels and were expressed and purified in greater amounts, 
in anticipation of crystallization experiments. Interestingly, of the four with low expression 
levels, two were from MBC subpopulations and two from nanodisc sorting experiments. 
Additional optimization of poorly expressed sABs was not pursued at this time. 
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Figure 4-24: Single-point phage ELISA using immobilized RbsA-NTD. ELISA signals 
compared for: 1) phage alone (black); 2) NHS-labeled RbsA-NTD (blue); 3) maleimide-
labeled RbsA-NTD (red); and 4) NHS-labeled RbsA-FL (full-length, green). Phages from 
all RbsA subpopulations (columns 1-6 of SPS1 master) were tested. See Figure 4-17. 
ELISA was performed as described earlier. 
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Figure 4-25: Single-point phage ELISA using immobilized RbsA-NTD. ELISA signals 
compared for: 1) phage alone (black); 2) NHS-labeled RbsA-NTD (blue); 3) maleimide-
labeled RbsA-NTD (red); and 4) NHS-labeled RbsA-FL (full-length, green). Phages from 
all RbsA subpopulations (columns 1-6 of SPS1 master) were tested. See Figure 4-17. 
ELISA was performed as described earlier. 
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4.6.3.6 In Vitro Complex Formation Experiments 
 Following sAB purification, the ability of reformatted antibodies to recognize 
epitopes in vitro was tested using gel-filtration chromatography. Prior to injection, sABs 
were added to proteins at a molar excess, mixed, and incubated briefly. Binding was 
evaluated by shifts to lower retention volumes on the chromatogram.  
 RbsA was tested with NAR09, NAR10, MA22, and MA36. In addition, 
combinations of antibodies were tested based on epitope-mapping results from RbsA-FL 
versus RbsA-NTD. Combinations included NAR09 with NAR10, NAR09 with MA22, and 
NAR10 with MA22. These tests were motivated by improving RbsA crystallizability and 
increasing the complex size for potential applicability to cryo-EM studies. 
 RbsA eluted from size-exclusion columns at lower retention volumes in the 
presence of all tested antibodies (FIGURE 4-26A). RbsA alone eluted at 14.9 mL run 
volume, while RbsA with sABs eluted at approximately 13.8 mL. Fractions were analyzed 
by SDS-PAGE and revealed the presence of additional bands at 25 kDa (data not shown), 
indicating co-elution of sABs. These bands corresponded to the heavy and light chains, 
which run separately after addition of SDS sample buffer. 
 Combinations of antibodies were also tested for binding to RbsA (FIGURE 4-26B). 
Antibodies were combined at the same molar excess over RbsA, mixed, and injected onto 
the column after brief incubation on ice. Both the NAR09/MA22 (4-26B) and the 
NAR10/MA22 (not shown) combinations eluted at the same volume as RbsA with single 
sABs, suggesting both could not bind at the same time. However, the NAR09/NAR10 
combination eluted at a slightly lower retention volume (13.2 mL). Analysis of the fractions 
by SDS-PAGE was, as expected, ambiguous for the presence of two sABs. The column 
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was subsequently recalibrated with known standards. The known 158 kDa standard eluted 
at approximately 13.3 mL. This would also represent the rough molecular weight of RbsA 
(55.3 kDa) plus two antibodies (50 kDa each). Additional analyses using RbsA and sABs 
in the presence of cofactors have not yet been pursued.  
 All eight purified sABs were also tested for binding to the detergent-reconstituted 
RbsABC complex in the presence of cofactors. All antibodies were concentrated to higher 
concentrations using 10 kDA MWCO spin filters to combat dilution effects when 
combined with RbsABC. The stock concentration following this procedure was generally 
80 – 100 µM. As before, sABs were added to RbsABC, mixed, and then allowed to 
incubate briefly on ice. Samples were injected onto the SEC and 1 mL fractions were 
collected. Binding of sABs to RbsABC was evaluated by analysis of chromatograms for 
shifts to lower retention volumes and then by SDS-PAGE.  
 Of the 8 antibodies, only one, NBR51, resulted in a shift on the chromatogram to a 
lower retention volume (FIGURE 4-27A). SDS-PAGE analysis of the elution fractions 
revealed the presence of heavy- and light-chains in the elution fraction with RbsABC. The 
result was unexpected, as the sABs were produced in RbsB sorting and had previously not 
bound to complexes during ELISA experiments.  
 As a control step, NBR51 binding to RbsB alone during gel-filtration experiments 
was tested. RbsB elutes at ~15.9 mL of the run volume. Addition of NBR51 produced no 
noticeable shift of RbsB (FIGURE4-27B) and eluted from the SEC in the second column 
volume, as other unbound sABs typically have done. The results strongly suggested 
NBR51 was binding non-specifically to RbsABC, and perhaps interacting with the 
hydrophobic detergent core. Protein elution profiles are typically symmetrically distributed 
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when the molecules are monodisperse; the asymmetric peak shift caused by NBR51 
addition likely meant this was not the case. 
 Additional tests of sAB binding and characterization have yet to be pursued and 






Figure 4-26: Superdex200 10/30 GL elution profiles of RbsA (blue) with antibodies either 
singly (A) or in combination (B). 
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Figure 4-27: A) Superdex200 10/30 GL elution profiles of vanadate-trapped RbsABC (blue) 
and in the presence of antibodies (color-coded above). B) Superdex200 10/30 elution 




 Crystallization trials of ribose transporter complexes have yet to produce 
diffraction-quality crystals despite extensive screening in a variety of media, from 
detergents to lipids. While protein crystals have been achieved, the identity of these crystals 
has yet to be determined. This awaits the growth of hardy, harvestable crystals that can be 
tested by X-ray diffraction methods. Optimization trials are currently being pursued to 
improve the quality of these crystals.  
 The inability of RbsABC to tolerate different detergents is disappointing, if 
unsurprising. The only detergent that appeared to produce a well-behaved elution on size-
exclusion chromatography was C12E8. Additional optimization may result in a condition 
where this detergent can be used for RbsABC crystallization. While DDM remains the 
most popular detergent for membrane protein crystallization and more crystals obtained 
with this detergent than not, the success rate as a whole is pedestrian at best and wanting 
for better methods. Newer, lipid-like detergents are available that may be worth pursuing. 
Screening RbsABC in different LCP lipids is also currently in progress. Alternatively, 
cloning RbsABC from other organisms may prove to be a more successful pursuit, and 
these experiments should be attempted in the near future. 
 The results from phage display sorting are promising, and have at least produced 
three high-quality binders for the NBD, RbsA, for which no structure currently exists. 
Unsurprisingly, it appears these antibodies recognize regions of RbsA involved in protein-
protein interactions, based on the absence of antibody binding to ribose transporter 
complexes, and thus these sites are expected to be highly antigenic. Crystallization trials 
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of RbsA-Fab complexes will soon be pursued in the hopes that some crystals can be 
obtained. Further characterization of these current binders will also be pursued.  
 The question of whether RbsA binds one or two antibodies remains unanswered. 
Analytical ultracentrifuge experiments and multi-angle light scattering are both available 
tools that can address these ambiguities. These extend the size of RbsA significantly and 
may aid crystallization trials. 
 In addition, epitope mapping using purified sABs will soon be pursued to identify 
other unique phage binders to reformat and clone into expression vectors. These will 
provide additional crystallization reagents and hopefully produce a handful that can 
recognize and bind specifically to the RbsABC complex. No antibodies from the current 
batch that were expressed and purified recognize the transport complex. It appears NBR51 
does not recognize RbsB, and likely interacted with the detergent or transport complex by 
non-specific hydrophobic interactions. This is not an uncommon property of these 
antibodies (Dominik, 2015). ELISA results pointed to the potential of MBC subpopulations 
that appeared to recognzie complexes. Attempts to express two clones from this group 
failed. Several others remain and will be cloned and expressed in the hope that some can 
be produced in quantities sufficient for crystallization experiments. 
 An additional possibility will be to pursue a new selection. Nanodiscs had 
previously not been optimized at the time selection was pursued. Unsurprisingly, binders 
from that selection are poor-quality and do not specifically recognize any ribose transporter 
proteins. Indeed, the most successful selection appears to be for RbsA alone, which 
produced 45 high-quality binders that have no cross-reactivity with other proteins. 
Currently only 5 of these were produced in high quantities, and more will be cloned, 
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expressed, and purified as needed. The nanodisc selection experiments will be pursued 
again in the near future to obtain high-quality crystallization chaperones for RbsABC. 
 Ultimately, the difficulty in crystallizing RbsABC may arise from conformational 
heterogeneity. Antibodies may resolve this issue. In addition, identifying high-quality 
binders for RbsABC may extend the range of the complex for structural studies by cryo-
EM. The current complex size is 150 kDa; binding one or two antibodies extend the 
complex into a size range that make these experiments somewhat practical. These options 
will be pursued with enthusiasm in the near future in the hopes of finally obtaining a high-
resolution map of the complex. 
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5.1 The Ribose Transport Cycle 
 The ultimate goal of this study is to better understand the function of this unusual 
ABC transporter at high resolution. While we still await a crystal structure to provide this 
level of detail, assembly experiments and EPR data have provided sufficient mechanistic 
information required to construct a transport model for the ribose transporter. In the search 
for general principles of ABC transporter function, perhaps this knowledge can be applied 
to other unusual ABC systems.  
 Assembly experiments have demonstrated that three different transport complexes 
can be isolated depending on the protein and cofactor combinations used (Clifton, et al., 
2015). In the absence of cofactors, the RbsBC complex is isolated, and RbsA is dissociated 
from the inner membrane complex. In the presence of non-hydrolyzable analogs or 
nucleotide and orthovanadate, the full transport complex RbsABC is isolated. In the 
presence of Mg-ADP, the RbsAC complex is isolated, with RbsB dissociating from its 
binding site on RbsC. Despite the unusual set of complexes and the single active NBD of 
RbsA, these complexes assemble in a canonical manner: one molecule of RbsB docks onto 
a transmembrane domain homodimer formed by RbsC, which associates with one molecule 
of RbsA consisting of two NBDs (Clifton, et al., 2016).  
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 SDSL EPR experiments of RbsB show that in the cofactor-free RbsBC complex, 
the lobes of RbsB remain at least partially together in the closed state of the protein. In the 
vanadate-trapped full complex, the lobes of RbsB are driven completely apart, a state where 
ribose is released following hydrolysis. Finally, the Mg-ADP bound state of the transport 
complex shows the lobes of RbsB close together once again, a conformation that likely 
drives RbsB dissociation from the transport complex. These results are consistent with the 
assembly experiments and provide a pathway for ribose release from RbsB due to ATP 
hydrolysis (Erramilli, Simon, Clifton, & Stauffacher, 2016). 
 SDSL EPR experiments of RbsA now demonstrate that the NBDs of RbsA undergo 
closure in the vanadate-trapped RbsABC complex. Further, the presence of RbsB promotes 
subdomain rotation, providing the structural basis for RbsB stimulated hydrolysis activity 
of RbsA. This transmembrane signalling, where the SBP regulates the hydrolysis cycle of 
the NBDs, is typical for ABC importers and demonstrates canonical behavior for the 
consensus site of RbsA. During this process, it appears ATP is bound but not hydrolyzed 
at the degenerate site, which may provide cooperativity for ATP hydrolysis in RbsA. This 
RbsB- and ribose-stimulated hydrolysis and cooperativity are demonstrated in ATPase 
activity assays from nanodiscs. 
 Post-hydrolysis, the NBDs dissociate in the Mg-ADP bound conformation. This 
likely represents the inward-facing state of the transporter, but could also represent the 
outward-occluded conformation. This ambiguity cannot be resolved with a high-resolution 
crystal structure. RbsA then appears to dissociate from RbsC when the bound nucleotide 
is removed. Whether this state is physiological remains unclear. Given cellular ATP 
concentrations, it is likely that nucleotide is rapidly recycled, and may briefly result in a 
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full or partial dissociation of RbsA from RbsC. This would resolve a significant conflict in 
this system: how RbsA traffics to and associates with the cell membrane in the absence of 
RbsC. If the need for this is obviated by rapid nucleotide exchange, then the model is 
complete until higher resolution information can be obtained. 
 Assuming rapid exchange of nucleotide and a constant association of RbsA with 
RbsC, a transport model can be described as follows. Ribose-bound RbsB docks onto the 
Mg-ATP bound state of the inner membrane RbsAC complex, likely in an intermediate 
conformation resembling the pre-translocation state of the maltose transporter or the 
cytoplasmic-occluded conformation of BtuCD. This docking promotes domain closure in 
RbsA and ATP hydrolysis by the single active site, and simultaneously drives the lobes of 
RbsB apart, releasing ribose to transporter. Here the transporter is clearly in the outward-
facing state, with the NBDs of RbsA tightly associated, the coupling helices of RbsC fully 
engaged with their complementary Q-loops, and RbsB stably forced into an open 
conformation. The γ-phoshpate is then released, destabilizing the NBD-NBD interactions 
of RbsA and leading to an inward-facing or outward-occluded state. This results in 
conformational changes in RbsC sufficient to transport ribose into the cytoplasm. RbsB 
follows the conformational changes of RbsC, with its lobes pinching together until its 
interaction with RbsC is destabilized and it dissociates. The transport cycle is completed, 
nucleotide is exchanged, and the transporter awaits a freshly-loaded RbsB to initiate the 








5.2 What about RbsC? 
 The RbsB and RbsA data complement each other and provide a structural 
mechanism for linking ribose release from RbsB with stimulation of ATP hydrolysis in 
RbsA. The observations from these experiments, however, stand in contrast to what is 
currently known about RbsC. 
 RbsC has a predicted ten transmembrane helices per monomer, based on cysteine 
scanning mutagenesis. Its closest homolog is BtuC, with which it shares 25% identity. 
Comparison of the model generated from cysteine scanning mutagenesis with the structure 
of BtuC shows a conservation of structure that is reasonable (Stewart & Hermodson, 2003). 
For instance, the coupling helix of RbsC, defined by a conserved EAA motif found in all 
ABC transporters, lies between TM helices 6 and 7. This is a typical feature of Type II 
ABC importers. Type I importers typically contain the coupling helix between TM helices 
4 and 5. In addition, the scanning experiments reveal a large loop between TM helices 5 
and 6. In the structure of Type II importers, this loop forms a short TM helix, termed 5a, 
that forms the periplasmic gate for these transporters. Since it is primarily located within a 
solvent-exposed vestibule that forms the receiving site for the transported substrate, it is 
expected that this region have solvent accessible cysteines. Thus, it is likely the gating for 
RbsC occurs in a highly similar manner as BtuC and other type II importers  
Given the similarity, this exposes a conundrum that cannot be resolved by the 
current structural understanding of type II importers. While rigid-body motions of the 




Figure 5-1: Transport cycle for ribose transporter. Grey bar is cell membrane. Ribose is 
brown pentagon, ATP is blue circle, and ADP is purple circle. RbsB is green, RbsC is red, 
and RbsA is colored by catalytic domain (orange) and helical domain (light blue). Left to 
right: RbsB captures ribose and delivers it to RbsC, which stimulates RbsA to bind ATP 
while driving open RbsB simultaneously, releasing ribose to the outward-facing 
translocation channel. ATP is bound at both consensus and degenerate sites. ATP is 
hydrolyzed by the consensus site, and interactions stabilizing the helical and catalytic 
domains in the consensus site are destabilized. As the helical domain disengages, this 
drives RbsC to an inward-open conformation and simultaneously resulting in RbsB 




 the conformational changes of type II importers are typically limited to rotations of 
the gating helices to allow alternating access of the translocation channel to the periplasm 
and cytoplasm. These movements facilitate substrate delivery down a channel that lacks a 
clear binding site, unlike the maltose transporter and other type I importers. 
 The lack of rigid body movements of type II TMDs also limits the conformational 
changes possible for their cognate binding proteins. Typically, the SBPs for these systems 
also undergo limited conformational changes to bind and release their substrates. Their 
affinity for these substrates is typically lower compared to SBPs found in type I importers. 
On the other hand, the SBPs bind the TMDs with low nanomolar affinity. Consequently, 
substrate release is driven by the increased affinity of the SBP with the TMD. This is 
accomplished by a slight rotation of the lobes away from one another. 
 While the RbsB-RbsC interaction is patterned in a type II manner, it is clear both 
from crystal structures of RbsB and the EPR data that RbsB undergoes fairly significant 
conformational changes during the transport cycle, from ribose binding to subsequent 
release. No obvious pathway exists for the TMDs of a type II system to undergo such 
significant changes, which would certainly require rigid body rotations.  
 It is also clear that RbsA undergoes fairly significant conformational changes. Here, 
however, both type I and type II importers are similar. Cytoplasmic gating in the latter 
system, provided by coupling helices and TM helical translations, drives fairly large 
conformational changes, similar to those observed in type I importers. The inward rotations 
reported from EPR experiments by RbsA support this model. How hydrolysis at a single 




5.3 Type I, II, Or Something Else? 
 Three types of bacterial ABC importers have recently been identified. These 
include two models of canonical ABC importers based on structure-function studies of the 
maltose (type I) and vitamin B12 (type II) transporters. A third type of importer, the ECF 
transporters, have recently been included in ths family as a separate class of importer. These 
are very different structurally from the former two classes and operate by a different 
alternating access mechanism, though also fueled by ATP-hydrolysis in dimeric NBDs. 
 Is this type-setting sufficient, or can these proteins even been described in terms of 
types? As studies of increasing sophistication of the two types have been conducted, the 
major difference appears to be structurally. In both cases, regulation of hydrolysis is driven 
essentially by the binding protein, linking ATP utilization with transport in an efficient 
manner. The structures of the TMDs and SBPs used by each type provide the essential 
functional difference. Type I TMDs pair with SBPs from clusters with flexible hinge 
regions. This pairing results in rigid body rotations of type I TMDs to drive open the 
binding protein, releasing substrate into a well-defined binding pocket within the TMD. 
This transient site releases substrate as the TMD shifts from outward open to inward open, 
which also destabilizes its interaction with the SBP. 
Type II TMDs pair with SBPs from clusters with rigid hinges. The SBPs dock into 
grooves in the TMDs, inducing a slight rotation of SBP lobes to release the substrate into 
the translocation channel. Rearrangements of the gating helices allow the substrate to slide 




 It appears the ribose transporter has a mismatch of type I SBP with type II TMD. 
How the SBP interacts with the TMD is an open question, and one that will require a high-
resolution structure to answer. Whether other such systems exist is a matter of improved 
knowledge of the TMDs of putative ABC importers. Few systems exist with a RbsA-type 
protein, and it remains to be seen whether the ribose transporter is a molecular oddity or 
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A.1 Purification of TEV Protease 
 TEV protease was expressed from glycerol stocks procured as a gift from the 
Mesecar Research Lab at Purdue University. The protein was purified with TALON resin 
using the protocol from their lab. Following purification, TEV protease fractions were 
pooled and dialyzed overnight into 50 mM Tris-HCl, pH 8.0, 25% glycerol, 5 mM EDTA, 
2 mM DTT. The final concentration, determined by A280 using the estimated extinction 
coefficient, was typically 0.8 – 1.4 mg/mL TEV protease. The sample was transferred as 
1 mL aliquots into 1.5 mL Eppendorf Tubes, which were flash frozen in liquid nitrogen 




A.2 Summary of RbsA Catalytic Mutations 
 A full list of RbsA mutations and their impact on transporter function can be found 
on the following page. All mutations were produced by Huide Zhang by site-directed 
mutagenesis. Transport was assayed in liposomes using C-14 labeled ribose. Swarm 
assays were performed on solid media made with ribose as the sole carbon source. 
Chemotaxis was studied using a capillary-based technique that assayed cell migration due 
to ribose. Cell lines used for this study are indicated and stored at -80 ºC.
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- 100 100 100 100 ABC 
K43R Walker A 0 - 5-10 0 BC 
S44A Walker A 0 - 10 0 BC 
Q86A Q-loop 0 10 85 60 BC 
S143A Signature 100 - 100 90 ABC 
D166A Walker B 100 - 10 0 BC 
E167Q Walker B 0 - 0 0 ABC 
E167A Walker B 0 10 10 10 ABC 
H199A H-loop 0 35 75 0 ABC 
H199R H-loop 0 0 0 0 BC 
R291A Walker A 40 - 40 75 ABC 
R291K Walker A 60 60 85 90 ABC 
L395P Signature 40 - - 30 BC 
L395V Signature 50 - - 50 ABC 
E421Q Walker B 10 - - - ABC 
E167Q/ 
E421Q 
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